```json
{
  "1004 Venture Partners": ["New York, NY"],
  "1315 Capital": ["Philadelphia, PA"],
  "1435 Capital": ["McLean, VA"],
  "1cBio": ["San Jose, CA"],
  "20/20 OptimEyes Technologies": ["Houston, TX"],
  "2048 Ventures": ["New York, NY"],
  "2Flo Ventures": ["San Francisco, CA"],
  "360biolabs": ["Melbourne, Australia"],
  "3B Future Health Ventures": ["Basel, Switzerland"],
  "3DBioFibR Inc.": ["Halifax, Nova Scotia, Canada"],
  "3E Bioventures Capital": ["Beijing, China", "Shanghai, China", "San Francisco, CA"],
  "3SBio Inc.": ["Shenyang, China", "Beijing, China", "Shanghai, China", "San Diego, CA"],
  "3Z": ["Beijing, China"],
  "3i Partners (Impact India Investment Partners, LLC)": ["Houston, TX"],
  "42nd Street Healthcare Partners": ["New York, NY"],
  "4B Technologies": ["Calgary, Alberta, Canada"],
  "4BIO Capital": ["London, UK"],
  "4M Therapeutics, Inc": ["South San Francisco, CA"],
  "4Moving Biotech": ["Illkirch-Graffenstaden, France"],
  "5 Horizons Capital": ["Zug, Switzerland"]
}
```
```json
{
  "5Y Capital": [
    "Hong Kong",
    "Shanghai, China",
    "Beijing, China",
    "Shenzhen, China"
  ],
  "6 Dimensions Capital": [
    "Shanghai, China",
    "Boston, MA, USA"
  ],
  "64x Bio": [
    "Emeryville, CA, USA"
  ],
  "7G BioVentures": [
    "Shanghai, China"
  ],
  "AAA Family Office": [
    "Dubai, UAE"
  ],
  "ABION Inc.": [
    "Seoul, South Korea"
  ],
  "ADvantage Therapeutics Inc.": [
    "South San Francisco, CA, USA"
  ],
  "AELIS FARMA": [
    "Bordeaux, France"
  ],
  "AI Proteins": [
    "Boston, MA, USA"
  ],
  "AIM -HI Accelerator Fund": [
    "Philadelphia, PA, USA"
  ],
  "AIVITA Biomedical, Inc.": [
    "Irvine, CA, USA"
  ],
  "ALSA Ventures": [
    "London, UK"
  ],
  "AN Ventures": [
    "Singapore"
  ],
  "ANTABIO SAS": [
    "Labège, France"
  ],
  "ARC Medical Inc.": [
    "Singapore"
  ],
  "ARCH": [
    "Chicago, IL, USA",
    "San Francisco, CA, USA",
    "Seattle, WA, USA",
    "New York, NY, USA"
  ],
  "ARENSIA Exploratory Medicine": [
    "Chisinau, Moldova",
    "Kharkiv, Ukraine",
    "Tbilisi, Georgia",
    "Bucharest, Romania",
    "Minsk, Belarus"
  ],
  "ARPA -H": [
    "Washington, D.C., USA",
    "Boston, MA, USA",
    "Dallas, TX, USA"
  ],
  "ART MEDICAL": [
    "Ra'anana, Israel"
  ],
  "ASDERA LLC": [
    "Rockville, MD, USA"
  ]
}
```
```json
{
  "ATEL Ventures, Inc.": [
    "San Francisco, CA, USA",
    "San Jose, CA, USA",
    "Los Angeles, CA, USA",
    "San Diego, CA, USA",
    "Denver, CO, USA",
    "Dallas, TX, USA",
    "Houston, TX, USA",
    "Atlanta, GA, USA",
    "Chicago, IL, USA",
    "Boston, MA, USA",
    "New York, NY, USA",
    "Philadelphia, PA, USA",
    "Washington, D.C., USA",
    "Phoenix, AZ, USA",
    "Portland, OR, USA",
    "Seattle, WA, USA"
  ],
  "ATEM Capital": [
    "Boston, MA, USA"
  ],
  "AUM Biosciences": [
    "Singapore",
    "Whippany, NJ, USA"
  ],
  "AV8 Ventures": [
    "Palo Alto, CA, USA"
  ],
  "AXA Investment Managers": [
    "Paris, France",
    "London, UK",
    "Hong Kong",
    "New York, NY, USA",
    "Sydney, Australia",
    "Tokyo, Japan",
    "Milan, Italy",
    "Madrid, Spain",
    "Zurich, Switzerland",
    "Frankfurt, Germany",
    "Brussels, Belgium",
    "Dubai, UAE",
    "Singapore",
    "Santiago, Chile",
    "Bogota, Colombia",
    "Mexico City, Mexico",
    "Sao Paulo, Brazil",
    "Seoul, South Korea",
    "Shanghai, China",
    "Taipei, Taiwan",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Amsterdam, Netherlands",
    "Stockholm, Sweden"
  ],
  "AZBio": [
    "Phoenix, AZ, USA"
  ],
  "Aagami, Inc.": [
    "San Diego, CA, USA",
    "Pune, Maharashtra, India"
  ],
  "Abacus Bioscience": [
    "San Diego, CA, USA"
  ],
  "Abalos Therapeutics GmbH": [
    "Düsseldorf, Germany"
  ],
  "AbbVie": [
    "North Chicago, IL, USA",
    "South San Francisco, CA, USA",
    "Redwood City, CA, USA",
    "Cambridge, MA, USA",
    "Worcester, MA, USA",
    "Ludwigshafen, Germany",
    "Singapore",
    "Tokyo, Japan",
    "Shanghai, China",
    "Sydney, Australia",
    "Dublin, Ireland",
    "Madrid, Spain",
    "Milan, Italy",
    "Paris, France",
    "Basel, Switzerland",
    "Toronto, Canada",
    "Mexico City, Mexico",
    "Sao Paulo, Brazil",
    "Buenos Aires, Argentina",
    "Seoul, South Korea",
    "Taipei, Taiwan",
    "Bangkok, Thailand",
    "Istanbul, Turkey",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Vienna, Austria",
    "Brussels, Belgium",
    "Copenhagen, Denmark",
    "Helsinki, Finland",
    "Athens, Greece",
    "Budapest, Hungary",
    "Oslo, Norway",
    "Lisbon, Portugal",
    "Stockholm, Sweden",
    "Manila, Philippines",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Ho Chi Minh City, Vietnam",
    "New Delhi, India",
    "Riyadh, Saudi Arabia",
    "Dubai, UAE",
    "Johannesburg, South Africa",
    "Bogota, Colombia",
    "Lima, Peru",
    "Santiago, Chile",
    "Auckland, New Zealand"
  ],
  "Able Sciences, Inc.": [
    "Madison, CT, USA"
  ],
  "Accelagen Pty Ltd": [
    "Melbourne, Victoria, Australia"
  ],
  "Accequa AB, Minemed AI, Gabather AB": [
    "Lund, Sweden",
    "Basel, Switzerland",
    "New York, NY, USA",
    "Stockholm, Sweden"
  ],
  "Accession Therapeutics": [
    "Oxford, UK"
  ],
  "Accropeutics": [],
  "Ace Vision Group": [
    "Sunnyvale, CA, USA"
  ],
  "Aceras Life Sciences, LLC": [
    "San Diego, CA, USA"
  ],
  "Ackermans & van Haaren": [
    "Antwerp, Belgium"
  ],
  "Actinium Pharmaceuticals": [
    "New York, NY, USA"
  ],
  "Acuris Partners": [
    "Singapore"
  ]
}
```
```json
{
  "AdAlta Limited": [
    "Bundoora, Victoria, Australia",
    "Parkville, Victoria, Australia"
  ],
  "Adaptimmune": [
    "Abingdon, Oxfordshire, UK",
    "Rockville, Maryland, USA"
  ],
  "Adelphi Ventures": [
    "Menlo Park, California, USA"
  ],
  "AdimaBioVentures": [
    "Boston, Massachusetts, USA"
  ],
  "Aditum Bio": [
    "New York, New York, USA"
  ],
  "Adjuvant Partners": [
    "San Francisco, California, USA",
    "Cambridge, Massachusetts, USA"
  ],
  "Adrenomed AG": [
    "Hennigsdorf, Brandenburg, Germany"
  ],
  "Adva Biotechnology Ltd": [
    "Kadima Zoran, Israel"
  ],
  "AdvaMed": [
    "Washington D.C., USA"
  ],
  "Advanced Test Equipment Rentals": [
    "San Diego, California, USA",
    "Santa Clara, California, USA",
    "Sacramento, California, USA",
    "Los Angeles, California, USA",
    "Toronto, Ontario, Canada"
  ],
  "Aegis Capital Corp": [
    "New York, New York, USA",
    "Dallas, Texas, USA",
    "Boca Raton, Florida, USA",
    "Holbrook, New York, USA"
  ],
  "Aegle Therapeutics Corporation": [
    "Miami, Florida, USA"
  ],
  "Aevice Health Pte Ltd": [
    "Singapore"
  ],
  "Affilogic": [
    "Nantes, France"
  ],
  "Affinia Therapeutics": [
    "Waltham, Massachusetts, USA"
  ],
  "Aflac Ventures Japan": [
    "Tokyo, Japan"
  ],
  "Agent Capital": [
    "Cambridge, Massachusetts, USA"
  ],
  "Agilent Technologies": [
    "Santa Clara, California, USA",
    "Folsom, California, USA",
    "Wilmington, Delaware, USA",
    "Waldbronn, Germany",
    "Tokyo, Japan",
    "Shanghai, China",
    "Singapore",
    "Bangalore, India",
    "Stockport, UK"
  ],
  "Agilex Biolabs": [
    "Thebarton, South Australia, Australia",
    "Melbourne, Victoria, Australia",
    "Brisbane, Queensland, Australia"
  ],
  "Aglaia Oncology Funds": [
    "Rotterdam, Netherlands"
  ]
}
```
```json
{
  "Agrithera Inc": [
    "2480, chemin Sainte-Foy, Québec, QC G1V 0A6, Canada"
  ],
  "AiM Medical Robotics": [
    "Fort Lauderdale, Florida, USA"
  ],
  "Aikium Inc.": [
    "Menlo Park, California, USA"
  ],
  "AilseBio": [
    "판교테크노밸리, 판교이노베이션랩 A동 502호, 220, Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea"
  ],
  "Aimbio": [
    "Aimbio Building, 40-14, Docheop-ro 522beon-gil, Opo-eup, Gwangju-si, Gyeonggi-do, Republic of Korea"
  ],
  "Aimed Bio Inc.": [
    "6F, Bupyeong-ro 228beon-gil 12, Guro-gu, Seoul, 08381, Republic of Korea"
  ],
  "Aivo Biosciences, Inc.": [
    "San Francisco, California, USA"
  ],
  "Aixial Group": [
    "Levallois-Perret, France",
    "Paris, France",
    "Lyon, France",
    "Toulouse, France",
    "Nantes, France",
    "Brussels, Belgium",
    "London, UK",
    "Munich, Germany",
    "Madrid, Spain",
    "Milan, Italy",
    "Warsaw, Poland",
    "Lisbon, Portugal",
    "Bucharest, Romania",
    "Prague, Czech Republic",
    "Zug, Switzerland",
    "San Diego, California, USA",
    "Montreal, Quebec, Canada"
  ],
  "Ajinomoto": [
    "Tokyo, Japan (Headquarters)",
    "Fort Lee, New Jersey, USA",
    "Itasca, Illinois, USA",
    "Raleigh, North Carolina, USA",
    "Los Angeles, California, USA",
    "Mexico City, Mexico",
    "São Paulo, Brazil",
    "Lima, Peru",
    "Buenos Aires, Argentina",
    "Bogotá, Colombia",
    "Paris, France",
    "Hamburg, Germany",
    "London, UK",
    "Milan, Italy",
    "Madrid, Spain",
    "Warsaw, Poland",
    "Moscow, Russia",
    "Istanbul, Turkey",
    "Bangkok, Thailand",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Singapore",
    "Hanoi, Vietnam",
    "Manila, Philippines",
    "Beijing, China",
    "Shanghai, China",
    "Guangzhou, China",
    "Hong Kong, China",
    "Seoul, South Korea",
    "Taipei, Taiwan",
    "Mumbai, India",
    "Sydney, Australia",
    "Cairo, Egypt",
    "Lagos, Nigeria"
  ],
  "Ajinomoto Corporate Venture Capital": [
    "Operates within Ajinomoto's global network, primarily from Tokyo, Japan (headquarters)"
  ],
  "Akadeum Life Sciences, Inc.": [
    "2350 Green Road, Suite 100, Ann Arbor, MI 48105, USA"
  ],
  "Albion VC": [
    "17-19 Cockspur Street, London, SW1Y 5BL, UK"
  ],
  "AlbionVC": [
    "17-19 Cockspur Street, London, SW1Y 5BL, UK"
  ],
  "Aleon Pharma International, Inc.": [
    "105 South Columbia Street, Chapel Hill, NC 27514, USA"
  ],
  "Alerce Investment Management": [
    "Av. Apoquindo 3000, Oficina 501, Las Condes, Santiago, Chile"
  ],
  "Alessa Therapeutics, Inc.": [
    "One Kendall Square, Building 100, Suite B112, Cambridge, MA 02139, USA"
  ],
  "Algen": [
    "Via Dell'Artigianato, 16, 40016 San Giorgio di Piano BO, Italy"
  ],
  "Algok Bio Inc.": [
    "Daejeon Techno Park, Techno Building B, Room B410, 292, Dunsan-ro, Seo-gu, Daejeon, Republic of Korea"
  ],
  "Alignment Ventures": [
    "Menlo Park, California, USA"
  ],
  "Alkapharmics SARL": [
    "Avenue du Vert Chasseur 38 B, 1332 Genval, Belgium"
  ]
}
```
```json
{
  "Allegro": [
    "Irvine, CA, USA"
  ],
  "Allele Capital Partners, LLC": [
    "San Francisco, CA, USA"
  ],
  "Allez Health Inc.": [
    "San Francisco, CA, USA"
  ],
  "Alliance for Regenerative Medicine": [
    "Washington, DC, USA",
    "London, UK",
    "Brussels, Belgium",
    "Tokyo, Japan"
  ],
  "Alliance for mRNA Medicines": [
    "Washington, DC, USA"
  ],
  "AllosteRx Capital Management": [
    "Boston, MA, USA"
  ],
  "Alloy Therapeutics": [
    "Boston, MA, USA",
    "Chapel Hill, NC, USA",
    "Athens, GA, USA",
    "Basel, Switzerland",
    "Cambridge, UK"
  ],
  "Ally Bridge Group": [
    "New York, NY, USA",
    "Hong Kong",
    "Shanghai, China"
  ],
  "Aloe Therapeutics, Inc": [
    "Irvine, CA, USA"
  ],
  "Alpha Bioventure LLC": [
    "Seoul, South Korea"
  ],
  "AlphaLife Sciences Group": [
    "New York, NY, USA"
  ],
  "AlphaMol Science AG": [
    "Zug, Switzerland",
    "Zurich, Switzerland",
    "Shanghai, China"
  ],
  "Alphyn Biologics, Inc.": [
    "Jupiter, FL, USA",
    "Philadelphia, PA, USA"
  ],
  "Alpina Biotechnology": [
    "Cambridge, MA, USA"
  ],
  "AltMedical Ltd.,Co.": [
    "Bangkok, Thailand"
  ],
  "Altis Biosystems": [
    "Chapel Hill, NC, USA"
  ],
  "Altius Bioventures": [
    "London, UK"
  ],
  "Altpep Corporation": [
    "Tokyo, Japan"
  ],
  "Alveolus Bio": [
    "San Francisco, CA, USA"
  ],
  "Alyea Therapeutics": [
    "Boston, MA, USA"
  ]
}
```
```json
{
  "Alzheimers Drug Discovery Foundation": [
    "New York, NY, USA"
  ],
  "AmacaThera Inc.": [
    "London, ON, Canada"
  ],
  "Amadix": [
    "Valladolid, Spain",
    "Madrid, Spain"
  ],
  "Amarna Therapeutics BV": [
    "Leiden, Netherlands"
  ],
  "Amaro Therapeutics, Inc.": [
    "Lexington, MA, USA"
  ],
  "Amivas Inc": [
    "Rockville, MD, USA"
  ],
  "Amplitude Ventures": [
    "Montreal, QC, Canada",
    "Vancouver, BC, Canada",
    "Toronto, ON, Canada"
  ],
  "Ananda Immunotherapies": [
    "Barcelona, Spain"
  ],
  "Anaxis Pharma": [
    "Paris, France"
  ],
  "Andera partners": [
    "Paris, France",
    "London, UK"
  ],
  "Angel Investor": [
    "N/A"
  ],
  "Angelini Ventures": [
    "Rome, Italy"
  ],
  "Angiex Inc.": [
    "Cambridge, MA, USA"
  ],
  "Angiotensin Therapeutics": [
    "N/A"
  ],
  "Anodyne Nanotech, Inc.": [
    "Dallas, TX, USA"
  ],
  "Antiverse": [
    "Cardiff, UK"
  ],
  "AnuBio": [
    "Dublin, Ireland"
  ],
  "Apeiron Investment Group - Elevat3 Capital": [
    "Limassol, Cyprus"
  ],
  "Apis Health Angels": [
    "Switzerland"
  ],
  "ApoStrata, LLC": [
    "Chapel Hill, NC, USA"
  ]
}
```
```json
{
  "Apollo Health Ventures": [
    "Berlin, Germany",
    "Boston, USA"
  ],
  "AptaBio Therapeutics Inc": [
    "Gyeonggi-do, South Korea"
  ],
  "Aqilion AB": [
    "Lund, Sweden"
  ],
  "Aqua Partners LLC": [
    "New York, USA"
  ],
  "Aqualung Therapeutics, Corp.": [
    "Tucson, Arizona, USA"
  ],
  "Aquillius Ventures": [
    "Boston, USA"
  ],
  "Arc Bio Communications": [
    "San Diego, California, USA"
  ],
  "Argentum Peak": [
    "Boston, USA"
  ],
  "ArgoBio Studio": [
    "Cambridge, Massachusetts, USA"
  ],
  "Arog Pharmaceuticals, Inc.": [
    "Las Vegas, Nevada, USA"
  ],
  "Arovella Therapeutics": [
    "Melbourne, Australia"
  ],
  "Arrowfield Capital": [
    "Boston, Massachusetts, USA"
  ],
  "Artery Therapeutics, Inc.": [
    "Newark, California, USA"
  ],
  "Artiman Ventures": [
    "Palo Alto, California, USA"
  ],
  "Artin Bioscience": [
    "New Delhi, India"
  ],
  "Aruna Bio": [
    "Athens, Georgia, USA"
  ],
  "Asabys Partners": [
    "Barcelona, Spain"
  ],
  "Asahi Kasei Pharma Corporation": [
    "Tokyo, Japan",
    "Kawasaki, Japan",
    "Fuji, Japan",
    "Ibaraki, Japan",
    "London, UK",
    "Düsseldorf, Germany",
    "New York, USA"
  ],
  "Asahi Kasei Ventures": [
    "Menlo Park, California, USA"
  ],
  "Ascendia Pharmaceutical Solutions": [
    "North Brunswick, New Jersey, USA"
  ]
}
```
```json
{
  "Ascendiant Capital Fund, LP": [
    "Irvine, CA, USA",
    "New York, NY, USA"
  ],
  "Ascension Ventures": [
    "St. Louis, MO, USA"
  ],
  "Aspect Biosystems": [
    "Vancouver, BC, Canada"
  ],
  "Aspiro Therapeutics, Inc.": [
    "No current public office locations found (historically associated with Santa Monica, CA, USA)"
  ],
  "Astellas Pharma": [
    "Tokyo, Japan (Global HQ)",
    "Northbrook, IL, USA (US HQ)",
    "London, UK (EMEA HQ)",
    "Singapore (Asia/Oceania HQ)",
    "Tsukuba, Japan (Research)",
    "Westborough, MA, USA",
    "San Francisco, CA, USA",
    "Seattle, WA, USA",
    "Markham, ON, Canada",
    "Sydney, Australia",
    "Munich, Germany",
    "Paris, France",
    "Madrid, Spain",
    "Milan, Italy",
    "Beijing, China",
    "Shanghai, China"
  ],
  "Astellas Venture Management LLC": [
    "South San Francisco, CA, USA",
    "Tokyo, Japan"
  ],
  "Astex Pharmaceuticals": [
    "Pleasanton, CA, USA",
    "Cambridge, UK"
  ],
  "AstriVax": [
    "Leuven, Belgium"
  ],
  "Astrizi Bio": [
    "Boston, MA, USA"
  ],
  "Astrocyte Pharmaceuticals": [
    "Southborough, MA, USA"
  ],
  "Asymchem Clinical": [
    "Tianjin, China (HQ of Asymchem Group)",
    "TEDA, China",
    "Shanghai, China",
    "Beijing, China",
    "Shenyang, China",
    "Morrisville, NC, USA",
    "Boston, MA, USA",
    "San Francisco, CA, USA",
    "The Woodlands, TX, USA",
    "Basel, Switzerland",
    "Copenhagen, Denmark"
  ],
  "Asymchem Group": [
    "Tianjin, China (HQ)",
    "TEDA, China",
    "Shanghai, China",
    "Beijing, China",
    "Shenyang, China",
    "Morrisville, NC, USA",
    "Boston, MA, USA",
    "San Francisco, CA, USA",
    "The Woodlands, TX, USA",
    "Basel, Switzerland",
    "Copenhagen, Denmark"
  ],
  "AthenaDAO": [
    "No physical office locations (Decentralized/Remote organization)"
  ],
  "Atheneos Ventures": [
    "Cambridge, MA, USA"
  ],
  "Atheris": [
    "Sherbrooke, Quebec, Canada"
  ],
  "Atlas Capital": [
    "New York, NY, USA (Atlas Capital Group)",
    "Los Angeles, CA, USA (Atlas Capital Group)"
  ],
  "Atom Bioworks": [
    "Vancouver, BC, Canada"
  ],
  "Atombeat, a DP Technology Company": [
    "Camarillo, CA, USA (DP Technology HQ)",
    "Leonberg, Germany",
    "Lyon, France",
    "Milan, Italy",
    "Warwick, UK",
    "Yokohama, Japan",
    "Shanghai, China",
    "Bangalore, India",
    "São Paulo, Brazil"
  ],
  "Atomic Striper LLC": [
    "No public physical office locations found (likely small/home-based business)"
  ],
  "Aurealis Therapeutics": [
    "Basel, Switzerland (HQ)",
    "Kuopio, Finland"
  ]
}
```
```json
{
  "Aureka Biotechnologies, Inc.": [
    "Pune, India"
  ],
  "Aurigene Oncology Limited": [
    "Bengaluru, India",
    "Hyderabad, India",
    "Waltham, MA, USA"
  ],
  "AurorA Science": [
    "San Diego, CA, USA",
    "Boston, MA, USA",
    "Basel, Switzerland"
  ],
  "AustinPx LLC": [
    "Austin, TX, USA"
  ],
  "Autobio Diagnostics (Invitro Diagnostics)": [
    "Zhengzhou, Henan, China",
    "Shanghai, China"
  ],
  "Autoimmunity BioSolutions": [
    "San Carlos, CA, USA"
  ],
  "Avance Clinical": [
    "Adelaide, SA, Australia",
    "Melbourne, VIC, Australia",
    "Brisbane, QLD, Australia",
    "Sydney, NSW, Australia",
    "Perth, WA, Australia",
    "Auckland, New Zealand",
    "Singapore",
    "Seoul, South Korea",
    "Kuala Lumpur, Malaysia",
    "Taipei, Taiwan",
    "Bangkok, Thailand",
    "Manila, Philippines"
  ],
  "Avant Bio II": [
    "South San Francisco, CA, USA"
  ],
  "Avata Biosciences": [
    "Menlo Park, CA, USA"
  ],
  "Avecris Pte. Ltd.": [
    "Singapore"
  ],
  "Avectas": [
    "Dublin, Ireland"
  ],
  "Avego": [
    "Cork, Ireland",
    "Redwood City, CA, USA"
  ],
  "AviadoBio": [
    "London, UK",
    "Boston, MA, USA"
  ],
  "Avidity Biosciences": [
    "La Jolla, CA, USA"
  ],
  "Avistone Biotechnology": [
    "Shanghai, China",
    "Boston, MA, USA"
  ],
  "Avobis Bio": [
    "St. Louis, MO, USA"
  ],
  "Awen GmbH": [
    "Munich, Germany"
  ],
  "Axcynsis Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "Axil Capital Advisors": [
    "New York, NY, USA"
  ],
  "Ayass Bioscience LLC": [
    "Frisco, TX, USA"
  ]
}
```
```json
{
  "Ayuvant Inc.": [
    "Boston, MA, USA"
  ],
  "Azitra, Inc.": [
    "Branford, CT, USA"
  ],
  "B3ARTX": [
    "New York, NY, USA"
  ],
  "B3ar Therapeutics": [
    "New York, NY, USA"
  ],
  "BERNINA BioInvest": [
    "Steinhausen, Switzerland"
  ],
  "BIAL": [
    "S. Mamede do Coronado, Portugal",
    "Madrid, Spain",
    "Milan, Italy",
    "Frankfurt, Germany",
    "London, UK"
  ],
  "BIO": [
    "Washington, D.C., USA"
  ],
  "BIO KOREA Organizing Committee": [
    "Seoul, South Korea"
  ],
  "BIOLIGHT Life Sciences Ltd.": [
    "Netanya, Israel"
  ],
  "BIOTECanada": [
    "Ottawa, ON, Canada"
  ],
  "BKW Partners": [
    "San Francisco, CA, USA"
  ],
  "BNC Korea Co., Ltd.": [
    "Daegu, South Korea"
  ],
  "BOHE Angel Fund": [
    "Beijing, China"
  ],
  "BOLD Capital Partners": [
    "Newport Beach, CA, USA"
  ],
  "BRESLIN AG": [
    "Baar, Switzerland"
  ],
  "BROTHERS Partners Europe": [
    "London, UK"
  ],
  "BTB Ventures": [
    "San Francisco, CA, USA"
  ],
  "BVCF": [
    "Shanghai, China"
  ],
  "Bachem": [
    "Bubendorf, Switzerland",
    "Vionnaz, Switzerland",
    "Torrance, CA, USA",
    "Vista, CA, USA",
    "St. Helens, UK",
    "Saffron Walden, UK",
    "Weil am Rhein, Germany"
  ],
  "Backed VC": [
    "London, UK"
  ]
}
```
```json
{
  "BairesDev": [
    "San Francisco, California, USA",
    "New York, New York, USA",
    "London, UK",
    "Madrid, Spain",
    "Buenos Aires, Argentina",
    "Montevideo, Uruguay",
    "Mexico City, Mexico",
    "São Paulo, Brazil",
    "Bogotá, Colombia",
    "San José, Costa Rica"
  ],
  "Baiya Phytopharm. Co., Ltd.": [
    "Beijing, China"
  ],
  "Band of Angels": [
    "Silicon Valley, California, USA"
  ],
  "Banook / Keosys": [
    "Nancy, France",
    "Paris, France",
    "Montreal, Canada",
    "New York, New York, USA",
    "London, UK",
    "Mannheim, Germany"
  ],
  "Barcode Nanotech": [
    "Rockville, Maryland, USA"
  ],
  "Barings": [
    "Charlotte, North Carolina, USA",
    "Boston, Massachusetts, USA",
    "New York, New York, USA",
    "London, UK",
    "Dublin, Ireland",
    "Frankfurt, Germany",
    "Luxembourg City, Luxembourg",
    "Milan, Italy",
    "Paris, France",
    "Singapore",
    "Hong Kong",
    "Tokyo, Japan",
    "Sydney, Australia"
  ],
  "Barrington Angels": [
    "Barrington, Illinois, USA"
  ],
  "Barrington James": [
    "Horley, UK",
    "London, UK",
    "New York, New York, USA",
    "San Diego, California, USA",
    "Miami, Florida, USA",
    "Frankfurt, Germany",
    "Singapore",
    "Tokyo, Japan",
    "Suzhou, China",
    "Basel, Switzerland",
    "Zürich, Switzerland"
  ],
  "BayMed Venture Partners": [
    "San Francisco, California, USA"
  ],
  "Bayer": [
    "Leverkusen, Germany",
    "Whippany, New Jersey, USA",
    "Berlin, Germany",
    "São Paulo, Brazil",
    "Shanghai, China",
    "Tokyo, Japan"
  ],
  "Bayland Capital": [
    "Oakland, California, USA"
  ],
  "Baylink Biosciences": [
    "Hayward, California, USA"
  ],
  "Bectas Therapeutics Inc.": [
    "Boston, Massachusetts, USA"
  ],
  "Bee Connected Group": [
    "London, UK"
  ],
  "Beech Biotech SA": [
    "Buenos Aires, Argentina"
  ],
  "Beijing CorreGene Biotechnology Co., Ltd": [
    "Beijing, China"
  ],
  "Beijing Inno Medicine Co., Ltd.": [
    "Beijing, China"
  ],
  "Belgian Trade Commission (AWEX)": [
    "Brussels, Belgium",
    "New York, New York, USA",
    "London, UK",
    "Paris, France",
    "Berlin, Germany",
    "Tokyo, Japan",
    "Shanghai, China",
    "São Paulo, Brazil"
  ],
  "Ben Franklin Technology Partners of Southeastern PA": [
    "Philadelphia, Pennsylvania, USA"
  ],
  "Benzinga": [
    "Detroit, Michigan, USA"
  ]
}
```
```json
{
  "Berkeley Angel Network": [
    "Berkeley, California, USA"
  ],
  "Betawave Ventures": [
    "San Francisco, California, USA"
  ],
  "Bexion Pharmaceuticals, Inc.": [
    "Covington, Kentucky, USA"
  ],
  "Beyond Next Ventures Inc.": [
    "Tokyo, Japan"
  ],
  "BeyondBridge&Co. Pte. Ltd": [
    "Singapore"
  ],
  "Bi -Path Bio": [
    "Houston, Texas, USA"
  ],
  "Big4Bio": [
    "San Francisco Bay Area, California, USA"
  ],
  "Bill and Melinda Gates Foundation": [
    "Seattle, Washington, USA",
    "Washington D.C., USA",
    "London, UK",
    "Beijing, China",
    "Delhi, India"
  ],
  "Binhui Biopharmaceutical Co., Ltd": [
    "Zhengzhou, China"
  ],
  "Bio 9 Ventures": [
    "Menlo Park, California, USA"
  ],
  "Bio Capital Impact Fund": [
    "London, UK"
  ],
  "BioCentury": [
    "Palo Alto, California, USA",
    "Washington D.C., USA",
    "London, UK"
  ],
  "BioCina": [
    "Adelaide, South Australia, Australia"
  ],
  "BioDuro -Sundia": [
    "San Diego, California, USA",
    "Princeton, New Jersey, USA",
    "Shanghai, China",
    "Beijing, China",
    "Wuhan, China",
    "Guangzhou, China",
    "Chengdu, China",
    "Chongqing, China",
    "Harbin, China",
    "Changsha, China"
  ],
  "BioGlobal Consulting Group": [
    "San Francisco, California, USA",
    "Foster City, California, USA"
  ],
  "BioIdeations": [
    "Princeton, New Jersey, USA"
  ],
  "BioInvest": [
    "Milan, Italy"
  ],
  "BioLizard": [
    "Ghent, Belgium",
    "Basel, Switzerland"
  ],
  "BioNJ": [
    "Trenton, New Jersey, USA"
  ],
  "BioNova Pharmaceuticals Ltd.": [
    "Taipei, Taiwan"
  ]
}
```
```json
{
  "BioPharm Strategy": [
    "Boston, MA, USA"
  ],
  "BioPharma Connections LLC": [
    "West Chester, PA, USA"
  ],
  "BioPharma Dive": [
    "Washington, D.C., USA"
  ],
  "BioPharmaceuticals Consulting Group": [
    "San Diego, CA, USA"
  ],
  "BioResearchAI. Co.,Ltd.": [
    "Seoul, Republic of Korea"
  ],
  "BioRock Ventures": [
    "Cambridge, MA, USA"
  ],
  "BioSingularity Institute / BioSingularity Ventures": [
    "Cambridge, MA, USA",
    "Barcelona, Spain"
  ],
  "BioSpace": [
    "San Francisco, CA, USA"
  ],
  "BioStem Technologies": [
    "Sunrise, FL, USA"
  ],
  "BioStock": [
    "Lund, Sweden"
  ],
  "BioStrategies LC": [
    "Salt Lake City, UT, USA"
  ],
  "BioSuperior Technology, Inc.": [
    "Shenzhen, China"
  ],
  "BioTools Innovator": [
    "Los Angeles, CA, USA"
  ],
  "BioWorld": [
    "London, UK"
  ],
  "Bioarchitech Ltd": [
    "Dundee, Scotland, UK"
  ],
  "Bioceptive Holdings (BHLS)": [
    "Research Triangle Park, NC, USA"
  ],
  "Biocom": [
    "San Diego, CA, USA",
    "Los Angeles, CA, USA",
    "San Francisco Bay Area, CA, USA",
    "Sacramento, CA, USA",
    "Tokyo, Japan"
  ],
  "Biocytogen Pharmaceuticals": [
    "Beijing, China",
    "East Walpole, MA, USA",
    "Germany",
    "Australia"
  ],
  "Bioidea Group": [
    "Buenos Aires, Argentina"
  ],
  "Biolabs -NYULangone": [
    "New York, NY, USA"
  ]
}
```
```json
{
  "Biomia": [
    "Milan, Italy"
  ],
  "Biomica": [
    "London, UK"
  ],
  "Biomissile Pharmaceuticals": [
    "San Francisco, CA, USA"
  ],
  "Biorelate": [
    "Manchester, UK"
  ],
  "Biorevert Inc": [
    "New York, NY, USA"
  ],
  "Bios Partners": [
    "Fort Worth, TX, USA"
  ],
  "Bioscience Equity Partners S.A": [
    "Geneva, Switzerland"
  ],
  "Bioscience Navigators Global LLC": [
    "Washington, DC, USA"
  ],
  "Biosolution": [
    "Seoul, South Korea"
  ],
  "Biotech Mountains BV": [
    "Maastricht, Netherlands"
  ],
  "BiotechExec": [
    "Carlsbad, CA, USA"
  ],
  "BiotechTV": [
    "San Carlos, CA, USA"
  ],
  "Biotechnology Innovation Organization (BIO)": [
    "Washington, DC, USA"
  ],
  "Biotts SA": [
    "Wrocław, Poland"
  ],
  "Bioverge Ventures": [
    "San Francisco, CA, USA"
  ],
  "Bioviida Venture Studio": [
    "Helsinki, Finland"
  ],
  "Biovision Ventures": [
    "Palo Alto, CA, USA"
  ],
  "Black Opal Ventures": [
    "New York, NY, USA"
  ],
  "Blackhawk Innovation": [
    "Boulder, CO, USA"
  ],
  "Blanver": [
    "Cotia, São Paulo, Brazil"
  ]
}
```
```json
{
  "Bloomberg News": [
    "New York, USA",
    "London, UK",
    "Tokyo, Japan",
    "Singapore",
    "Hong Kong",
    "Dubai, UAE",
    "Frankfurt, Germany",
    "San Francisco, USA",
    "Washington D.C., USA",
    "Mumbai, India"
  ],
  "Blue Goose Capital": [
    "New York, USA"
  ],
  "BlueOx Healthcare Partners": [
    "Minneapolis, USA"
  ],
  "Bluepoint Partners": [
    "New York, USA",
    "Greenwich, USA"
  ],
  "Bluestar Investment Managers": [
    "Cape Town, South Africa",
    "Johannesburg, South Africa"
  ],
  "BobcatBio": [
    "New York, USA"
  ],
  "Boom Capital": [
    "San Francisco, USA"
  ],
  "Borealis Biosciences, Inc.": [
    "Boston, USA"
  ],
  "Boryung Corp.": [
    "Seoul, South Korea",
    "Boston, USA",
    "Plano, USA",
    "Huntsville, USA"
  ],
  "Boston Harbor Angels": [
    "Boston, USA"
  ],
  "BoxOne Ventures": [
    "New York, USA"
  ],
  "Bpifrance - Life Sciences VC": [
    "Paris, France"
  ],
  "Brabant Development Agency (BOM)": [
    "Den Bosch, Netherlands"
  ],
  "Brace Pharma Capital": [
    "New York, USA"
  ],
  "BrainScope Company, Inc.": [
    "Bethesda, USA"
  ],
  "Braingels": [
    "Barcelona, Spain"
  ],
  "Brainify.ai": [
    "London, UK"
  ],
  "Brandon Capital": [
    "Melbourne, Australia",
    "Sydney, Australia",
    "London, UK",
    "Auckland, New Zealand",
    "Palo Alto, USA"
  ],
  "Brazen Capital": [
    "Miami, USA"
  ],
  "Breakpoint Therapeutics GmbH": [
    "Munich, Germany"
  ]
}
```
```json
{
  "BreakthroughT1D": [
    "New York, NY, USA",
    "Numerous regional offices worldwide (e.g., Washington D.C., Boston, Chicago, Los Angeles, Dallas, Atlanta, and international chapters)"
  ],
  "Brenus Pharma": [
    "Boulogne-Billancourt, France",
    "Boston, MA, USA"
  ],
  "BriaCell Therapeutics Corp.": [
    "Vancouver, BC, Canada",
    "Berkeley, CA, USA"
  ],
  "Bridge Link Capital": [
    "Palo Alto, CA, USA"
  ],
  "Bridgewest Group": [
    "La Jolla, CA, USA"
  ],
  "Bridgewest Ventures": [
    "La Jolla, CA, USA"
  ],
  "BrightEdge - American Cancer Society": [
    "Atlanta, GA, USA"
  ],
  "BrightPath Bio": [
    "Brisbane, QLD, Australia"
  ],
  "BrilliantStrings Therapeutics": [
    "San Diego, CA, USA"
  ],
  "Broad Street Angels": [
    "Philadelphia, PA, USA"
  ],
  "Brookline Capital Markets": [
    "New York, NY, USA"
  ],
  "Buck Institute": [
    "Novato, CA, USA"
  ],
  "Builders VC": [
    "San Francisco, CA, USA",
    "Seattle, WA, USA"
  ],
  "BullFrog AI": [
    "Frederick, MD, USA"
  ],
  "ButoBeiwe": [],
  "C4U Corporation": [
    "Tokyo, Japan"
  ],
  "CABHI Ventures": [
    "Toronto, ON, Canada"
  ],
  "CARTx Therapeutics": [
    "Brisbane, QLD, Australia"
  ],
  "CBC": [
    "Singapore",
    "Shanghai, China",
    "Beijing, China",
    "New York, NY, USA"
  ],
  "CBCC Family Office": []
}
```
```json
{
  "CCRM Enterprises Inc.": [
    "Toronto, Canada"
  ],
  "CD Capital": [
    "London, UK"
  ],
  "CDIB Capital Healthcare Ventures II L.P.": [
    "Taipei, Taiwan",
    "Shanghai, China",
    "Hong Kong",
    "Singapore",
    "Seoul, South Korea"
  ],
  "CELLeBRAIN": [
    "Cambridge, MA, USA"
  ],
  "CEPI": [
    "Oslo, Norway",
    "London, UK",
    "Washington D.C., USA"
  ],
  "CG Life": [
    "Chicago, IL, USA",
    "San Diego, CA, USA",
    "Washington D.C., USA",
    "Boston, MA, USA",
    "Raleigh, NC, USA"
  ],
  "CLI Ventures": [
    "San Francisco, CA, USA"
  ],
  "CLSA Capital Partners": [
    "Hong Kong",
    "Singapore",
    "London, UK",
    "New York, NY, USA",
    "Sydney, Australia",
    "Tokyo, Japan"
  ],
  "CMAX Clinical Research": [
    "Adelaide, Australia",
    "Brisbane, Australia"
  ],
  "CNCure Co., Ltd.": [
    "Seoul, South Korea"
  ],
  "CPC Scientific": [
    "San Jose, CA, USA",
    "Suzhou, China"
  ],
  "CR Ventures": [
    "Boston, MA, USA"
  ],
  "CRB Health Tech": [
    "St. Louis, MO, USA",
    "San Diego, CA, USA",
    "Boston, MA, USA",
    "Research Triangle Park, NC, USA",
    "Dublin, Ireland",
    "Basel, Switzerland"
  ],
  "CRISPR QC, Inc.": [
    "San Diego, CA, USA"
  ],
  "CRS clinical research": [
    "Bochum, Germany",
    "Mannheim, Germany",
    "Berlin, Germany"
  ],
  "CS Genetics": [
    "San Francisco, CA, USA"
  ],
  "CT Innovations": [
    "Rocky Hill, CT, USA"
  ],
  "CTFH": [
    "Hong Kong"
  ],
  "CTI Clinical Research and Consulting": [
    "Covington, KY, USA",
    "London, UK",
    "Tokyo, Japan",
    "Paris, France"
  ],
  "California Biomanufacturing Center": [
    "Sacramento, CA, USA"
  ]
}
```
```json
{
  "California Israel Chamber of Commerce": [
    "San Francisco Bay Area, California, USA"
  ],
  "Calvine Partners LLP": [
    "London, UK"
  ],
  "Cambrian Growth Partners": [
    "San Francisco, California, USA"
  ],
  "Camino Science": [
    "San Francisco, California, USA"
  ],
  "Cancer Research Horizons": [
    "London, UK",
    "Cambridge, UK",
    "Manchester, UK",
    "Glasgow, UK"
  ],
  "CancerVax, Inc.": [
    "Carlsbad, California, USA"
  ],
  "Cantex Pharmaceuticals": [
    "Horsham, Pennsylvania, USA"
  ],
  "Cantilever Investors": [
    "San Francisco, California, USA"
  ],
  "Capital BioVentures": [
    "Bethesda, Maryland, USA"
  ],
  "Capital Global Partners": [
    "London, UK"
  ],
  "Capital One": [
    "McLean, Virginia, USA",
    "Richmond, Virginia, USA",
    "Plano, Texas, USA",
    "New York, New York, USA",
    "San Francisco, California, USA",
    "Chicago, Illinois, USA",
    "Washington D.C., USA",
    "Hyderabad, India",
    "Bengaluru, India",
    "Toronto, Canada",
    "London, UK"
  ],
  "Carbon Wave, Inc": [
    "Irvine, California, USA"
  ],
  "Cardiac Wire": [
    "Austin, Texas, USA"
  ],
  "Carina Biotech": [
    "Adelaide, Australia"
  ],
  "Carl Zeiss Microscopy, LLC": [
    "Pleasanton, California, USA"
  ],
  "Carroll & Morrisette Consulting LLC": [
    "Alexandria, Virginia, USA"
  ],
  "Cascade Pharmaceutics": [
    "Seattle, Washington, USA"
  ],
  "Catalent Pharma Solutions": [
    "Somerset, New Jersey, USA",
    "Bloomington, Indiana, USA",
    "Philadelphia, Pennsylvania, USA",
    "Schorndorf, Germany",
    "Anagni, Italy",
    "Brussels, Belgium",
    "Shanghai, China",
    "Bathgate, Scotland, UK"
  ],
  "Catalyst Healthcare Consulting": [
    "Raleigh, North Carolina, USA"
  ],
  "Catalytic Impact Foundation": [
    "Alexandria, Virginia, USA"
  ]
}
```
```json
{
  "Cathay Capital": [
    "Paris, France",
    "Shanghai, China",
    "Beijing, China",
    "New York, New York, USA",
    "San Francisco, California, USA",
    "Munich, Germany",
    "Singapore"
  ],
  "Cbio A/S": [
    "Copenhagen, Denmark"
  ],
  "Cell and Gene Therapy Catapult": [
    "London, UK",
    "Stevenage, UK",
    "Edinburgh, UK"
  ],
  "CellARTs": [
    "Munich, Germany"
  ],
  "CellFE Inc.": [
    "Berkeley, California, USA"
  ],
  "Cellectar Biosciences Inc.": [
    "Madison, Wisconsin, USA"
  ],
  "Cellergy Pharma Inc.": [
    "Tel Aviv, Israel"
  ],
  "Cellevate AB": [
    "Lund, Sweden"
  ],
  "Cellino": [
    "Cambridge, Massachusetts, USA"
  ],
  "Cellis AG": [
    "Zürich, Switzerland"
  ],
  "CelluGenix": [
    "Stockholm, Sweden"
  ],
  "Cellxlife": [
    "Singapore"
  ],
  "Cenos Therapeutics": [
    "San Francisco, California, USA"
  ],
  "Cenyx Biotech Inc.": [
    "Boston, Massachusetts, USA"
  ],
  "CereCura Nanotherapeutics Inc.": [
    "New York, New York, USA"
  ],
  "Cereno Scientific": [
    "Gothenburg, Sweden"
  ],
  "Certa Therapeutics": [
    "Melbourne, Australia"
  ],
  "Certara": [
    "Princeton, New Jersey, USA",
    "Parsippany, New Jersey, USA",
    "San Diego, California, USA",
    "Raleigh, North Carolina, USA",
    "Philadelphia, Pennsylvania, USA",
    "Boston, Massachusetts, USA",
    "San Francisco, California, USA",
    "Lexington, Kentucky, USA",
    "Washington D.C., USA",
    "Dallas, Texas, USA",
    "Tampa, Florida, USA",
    "Phoenix, Arizona, USA",
    "Sheffield, UK",
    "London, UK",
    "Cambridge, UK",
    "Paris, France",
    "Milan, Italy",
    "Basel, Switzerland",
    "Munich, Germany",
    "Frankfurt, Germany",
    "Berlin, Germany",
    "Stockholm, Sweden",
    "Utrecht, Netherlands",
    "Tokyo, Japan",
    "Shanghai, China",
    "Hyderabad, India",
    "Sydney, Australia"
  ],
  "Certest Pharma": [
    "Zaragoza, Spain"
  ],
  "Certified Genetool": [
    "San Diego, California, USA"
  ]
}
```
```json
{
  "ChainGen Bio": [
    "Seoul, South Korea"
  ],
  "Chardan": [
    "New York, NY, USA",
    "Miami, FL, USA"
  ],
  "Chariot Biosciences, Inc.": [
    "Houston, TX, USA"
  ],
  "CheckOrphan": [
    "Zug, Switzerland"
  ],
  "ChemLex Pte. Ltd.": [
    "Singapore"
  ],
  "Chemical & Engineering News": [
    "Washington, D.C., USA"
  ],
  "Chemical Angels Network": [
    "Doylestown, PA, USA"
  ],
  "Chengdu Huajian Science Co., Ltd.": [
    "Chengdu, China"
  ],
  "Chengdu Huitai Biomedicine Co., Ltd": [
    "Chengdu, China"
  ],
  "Cheryl Rogers Consulting": [
    "Boulder, CO, USA"
  ],
  "Chimeric Therapeutics Limited": [
    "Melbourne, Australia",
    "San Diego, CA, USA"
  ],
  "Chimeron Bio": [
    "State College, PA, USA",
    "San Diego, CA, USA"
  ],
  "Chordia Therapeutics Inc.": [
    "Kashiwa, Chiba, Japan"
  ],
  "Chrysalis BioTherapeutics": [
    "Galveston, TX, USA"
  ],
  "Cidara": [
    "San Diego, CA, USA"
  ],
  "Cigma": [
    "N/A - Company name too generic; specific biotech entity not identified without further context."
  ],
  "Cilcare": [
    "Montpellier, France",
    "Boston, MA, USA"
  ],
  "Cincinnati Children's Hospital": [
    "Cincinnati, OH, USA"
  ],
  "CinoCore Health": [
    "San Antonio, TX, USA"
  ],
  "Circio AB": [
    "Oslo, Norway"
  ]
}
```
```json
{
  "Citeline": [
    "New York, NY, United States",
    "London, England, United Kingdom",
    "Boston, MA, United States",
    "Sheffield, England, United Kingdom",
    "Tokyo, Japan"
  ],
  "Clairity": [
    "San Diego, CA, United States"
  ],
  "Clarify Health": [
    "San Francisco, CA, United States",
    "New York, NY, United States",
    "Houston, TX, United States",
    "Cambridge, MA, United States",
    "Seattle, WA, United States"
  ],
  "Clarivate Plc": [
    "London, England, United Kingdom",
    "Philadelphia, PA, United States",
    "Boston, MA, United States",
    "New York, NY, United States",
    "San Francisco, CA, United States",
    "Bangalore, India",
    "Beijing, China",
    "Singapore",
    "Tokyo, Japan",
    "Madrid, Spain"
  ],
  "Class Bravo Ventures": [
    "San Diego, CA, United States"
  ],
  "Clear Street LLC": [
    "New York, NY, United States",
    "Dallas, TX, United States",
    "London, England, United Kingdom",
    "West Palm Beach, FL, United States"
  ],
  "Clearbridge Health Ltd": [
    "Singapore",
    "Hong Kong",
    "Manila, Philippines",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Bangalore, India"
  ],
  "Cleveland Clinic Ventures": [
    "Cleveland, OH, United States"
  ],
  "ClexBio": [
    "Oslo, Norway"
  ],
  "Clexio Biosciences": [
    "Dublin, Ireland",
    "Lausanne, Switzerland"
  ],
  "Click Therapeutics": [
    "New York, NY, United States"
  ],
  "Co -win Ventures": [
    "Shanghai, China"
  ],
  "CoDevCo LLC": [
    "Philadelphia, PA, United States"
  ],
  "Coagulant Therapeutics": [
    "South San Francisco, CA, United States"
  ],
  "Code Biotherapeutics, Inc.": [
    "King of Prussia, PA, United States"
  ],
  "Codon Capital": [
    "San Francisco, CA, United States"
  ],
  "Cognito Therapeutics": [
    "Cambridge, MA, United States"
  ],
  "Cohesion Bureau": [
    "New York, NY, United States"
  ],
  "Coho VC": [
    "New York, NY, United States"
  ],
  "Collaborative Drug Discovery": [
    "Burlingame, CA, United States"
  ]
}
```
```json
{
  "Collage Venture Partners LLC": [
    "New York, NY, USA",
    "San Francisco, CA, USA"
  ],
  "Comac Medical": [
    "Sofia, Bulgaria",
    "Varna, Bulgaria",
    "Skopje, North Macedonia",
    "Belgrade, Serbia",
    "Bucharest, Romania",
    "Zagreb, Croatia",
    "Ljubljana, Slovenia",
    "Sarajevo, Bosnia and Herzegovina",
    "Tirana, Albania",
    "Pristina, Kosovo",
    "Podgorica, Montenegro",
    "Kyiv, Ukraine",
    "Chișinău, Moldova",
    "Tbilisi, Georgia",
    "Yerevan, Armenia",
    "Boston, MA, USA"
  ],
  "Combined Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "Commercial Eyes, a PLG company": [
    "Melbourne, VIC, Australia"
  ],
  "Company (Placeholder)": [
    "N/A (No specific company or locations provided for this placeholder)"
  ],
  "Concept Bio": [
    "New York, NY, USA"
  ],
  "Conform Medical": [
    "San Diego, CA, USA"
  ],
  "Conner Strong & Buckelew": [
    "Marlton, NJ, USA (Headquarters)",
    "Philadelphia, PA, USA",
    "Wilmington, DE, USA",
    "New York, NY, USA",
    "Stamford, CT, USA",
    "Orlando, FL, USA",
    "Fort Lauderdale, FL, USA",
    "Atlanta, GA, USA",
    "Boston, MA, USA"
  ],
  "Consulate General of Canada, San Francisco": [
    "San Francisco, CA, USA"
  ],
  "Content Carnivores, LLC": [
    "Denver, CO, USA"
  ],
  "Continuum Health Ventures": [
    "New York, NY, USA"
  ],
  "Convergence Partners": [
    "Johannesburg, South Africa",
    "Ebene, Mauritius"
  ],
  "Cortado Ventures": [
    "Oklahoma City, OK, USA"
  ],
  "Corundum Neuroscience": [
    "No specific public physical office found, likely research-based or virtual"
  ],
  "Corundum Systems Biology": [
    "No specific public physical office found, likely research-based or virtual"
  ],
  "Cosm Medical": [
    "Toronto, ON, Canada"
  ],
  "Coval Biopharma Co., Ltd.": [
    "Shanghai, China",
    "Hong Kong, China"
  ],
  "Covenant Venture Capital": [
    "Menlo Park, CA, USA"
  ],
  "Crimson Peak, LLC": [
    "No specific public physical office found or difficult to identify without more context"
  ],
  "Cross -Border Impact Ventures": [
    "Toronto, ON, Canada",
    "London, UK"
  ]
}
```
```json
{
  "Cross Border Partners, LLC": [
    "New York, NY"
  ],
  "Cross Pollinate Capital, LLC": [
    "San Francisco, CA"
  ],
  "Crosswave Management Inc.": [
    "New York, NY"
  ],
  "Cryoport Systems": [
    "Irvine, CA",
    "Houston, TX",
    "Morris Plains, NJ",
    "Leiden, Netherlands",
    "Horsham, UK",
    "Singapore",
    "Osaka, Japan",
    "Stuttgart, Germany",
    "Paris, France",
    "Dublin, Ireland",
    "Manchester, UK"
  ],
  "Cryostasis Inc": [
    "No easily verifiable public locations found for a current, distinct company with this name."
  ],
  "Cullgen Inc.": [
    "San Diego, CA",
    "Shanghai, China"
  ],
  "Cultivation Capital": [
    "St. Louis, MO",
    "Chicago, IL"
  ],
  "CuraFi": [
    "San Diego, CA"
  ],
  "Curam Therapeutics": [
    "Menlo Park, CA"
  ],
  "Cure.": [
    "New York, NY"
  ],
  "CureDuchenne Ventures": [
    "Newport Beach, CA"
  ],
  "CureLab Oncology": [
    "Framingham, MA",
    "Moscow, Russia"
  ],
  "CureMeta": [
    "San Diego, CA"
  ],
  "Curia": [
    "Albany, NY",
    "Rensselaer, NY",
    "Burlington, MA",
    "Frederick, MD",
    "Princeton, NJ",
    "Cambridge, MA",
    "Glasgow, Scotland, UK",
    "Carlsbad, CA",
    "Florence, SC",
    "Indianapolis, IN",
    "Cork, Ireland",
    "Juncos, Puerto Rico",
    "San Diego, CA"
  ],
  "Curie Capital": [
    "New York, NY"
  ],
  "Curie.Bio": [
    "San Francisco, CA",
    "Boston, MA"
  ],
  "Curome Biosciences Co., Ltd.": [
    "Seoul, South Korea"
  ],
  "Currus Biologics": [
    "San Francisco, CA"
  ],
  "Custom Biologics": [
    "Melbourne, FL"
  ],
  "Cuttlefish Communications": [
    "Portland, OR"
  ]
}
```
```json
{
  "Cynata Therapeutics Ltd": [
    "Melbourne, Australia"
  ],
  "Cyrus Therapeutics": [
    "Chapel Hill, North Carolina, USA"
  ],
  "Cystic Fibrosis Foundation": [
    "Bethesda, Maryland, USA"
  ],
  "Cytel Inc.": [
    "Waltham, Massachusetts, USA",
    "Pune, India",
    "London, UK",
    "Paris, France",
    "Munich, Germany",
    "Basel, Switzerland"
  ],
  "CytoSorbents Corporation": [
    "Monmouth Junction, New Jersey, USA",
    "Berlin, Germany"
  ],
  "Cytocares (Shanghai) Inc.": [
    "Shanghai, China"
  ],
  "CytomX Therapeutics": [
    "South San Francisco, California, USA"
  ],
  "Cytovance Biologics": [
    "Oklahoma City, Oklahoma, USA"
  ],
  "DEL BioPharma LLC": [
    "Princeton, New Jersey, USA"
  ],
  "DFB Pharmaceuticals": [
    "Fort Worth, Texas, USA"
  ],
  "DJK BioConsult": [
    "San Carlos, California, USA"
  ],
  "Daejoong Life Science": [
    "Seoul, South Korea"
  ],
  "Daewoong Pharmaceutical": [
    "Seoul, South Korea",
    "Englewood Cliffs, New Jersey, USA",
    "Jakarta, Indonesia",
    "Shanghai, China"
  ],
  "Daiichi Sankyo, Inc.": [
    "Basking Ridge, New Jersey, USA",
    "Tokyo, Japan"
  ],
  "Danen capital": [
    "Shanghai, China"
  ],
  "DavosPharma": [
    "Bridgewater, New Jersey, USA"
  ],
  "De Montfort University": [
    "Leicester, UK",
    "Dubai, UAE"
  ],
  "DeBere Partners": [
    "London, UK"
  ],
  "Debiopharm Innovation Fund SA": [
    "Lausanne, Switzerland"
  ],
  "Decheng Capital": [
    "Shanghai, China",
    "Menlo Park, California, USA"
  ]
}
```
```json
{
  "DeepCure": [
    "Boston, MA",
    "Tel Aviv, Israel"
  ],
  "DeepWork Capital": [
    "Orlando, FL"
  ],
  "Defand Therapeutics": [
    "Cambridge, England, UK"
  ],
  "Defence Therapeutics Inc.": [
    "Vancouver, Canada",
    "Sherbrooke, Canada"
  ],
  "Degron Therapeutics": [
    "Cambridge, MA"
  ],
  "Delian Capital": [
    "New York, NY"
  ],
  "Delin Ventures Ltd": [
    "London, UK"
  ],
  "Deliver Biosciences": [
    "San Francisco Bay Area, CA"
  ],
  "Delos Capital": [
    "New York, NY"
  ],
  "Delve Bio": [
    "San Carlos, CA"
  ],
  "Demy -Colton": [
    "New York, NY"
  ],
  "Denovo Biopharma LLC": [
    "La Jolla, CA",
    "Hangzhou, China"
  ],
  "Departure Capital": [
    "San Francisco, CA"
  ],
  "Dermaliq Therapeutics Inc.": [
    "Carlsbad, CA"
  ],
  "DiMe": [
    "Boston, MA"
  ],
  "Diadem Biotherapeutics": [
    "Copenhagen, Denmark"
  ],
  "Diakonos Oncology": [
    "Austin, TX"
  ],
  "Dicot Pharma AB": [
    "Uppsala, Sweden"
  ],
  "DigiLife, LLC": [],
  "Digital Networks PLC": [
    "London, UK"
  ]
}
```
```json
{
  "Digital Times Korea": [
    "22, Sejong-daero 21-gil, Jung-gu, Seoul, South Korea",
    "929, Sangmu-daero, Seo-gu, Gwangju, South Korea",
    "90, Centum Jungang-ro, Haeundae-gu, Busan, South Korea",
    "2336, Dalgubeol-daero, Suseong-gu, Daegu, South Korea",
    "189, Daedeok-daero, Seo-gu, Daejeon, South Korea"
  ],
  "DigitalDx Ventures": [
    "2360 Middlefield Rd, Suite 101, Redwood City, CA 94063, USA"
  ],
  "Dignify Therapeutics": [
    "11100 Penny Rd., Raleigh, NC 27606, USA"
  ],
  "Dimericon Therapeutics AG": [
    "Josef-Engert-Straße 13, 93053 Regensburg, Germany"
  ],
  "Diorasis Therapeutics Corporation": [
    "1000 Massachusetts Ave, Cambridge, MA 02138, USA"
  ],
  "Divamics Inc.": [
    "Irvine, CA, USA"
  ],
  "Dong -A ST": [
    "20, Cheonho-daero, Dongdaemun-gu, Seoul, South Korea",
    "580-1, Gyeonggi-daero, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea",
    "21, Sandan-ro, Seobuk-gu, Cheonan-si, Chungcheongnam-do, South Korea",
    "198, Jijeong-gil, Cheongni-myeon, Sangju-si, Gyeongsangbuk-do, South Korea"
  ],
  "DoriNano": [
    "3F, Seoul-TechOne Bldg., 141-11, Samseong-ro, Gangnam-gu, Seoul, South Korea"
  ],
  "Doron Therapeutics": [
    "Ra'anana, Israel"
  ],
  "Double U Fund/ Crosswork Pre -IPO Funf": [
    "13th Floor, 55, Eulji-ro, Jung-gu, Seoul, South Korea"
  ],
  "Dr.PARK": [],
  "DrNose": [
    "704, 7F, SmartHub, 994, Hanchon-ro, Danwon-gu, Ansan-si, Gyeonggi-do, South Korea"
  ],
  "Drawbridge Health": [
    "2350 Qume Drive, San Jose, CA 95131, USA"
  ],
  "Droia Ventures": [
    "Technologielaan 3, B-3001 Leuven, Belgium"
  ],
  "Dx&Vx": [
    "28, Beobwon-ro 11-gil, Songpa-gu, Seoul, South Korea"
  ],
  "Dydo Pharma, Inc.": [
    "2-1-7 Nishi-Shimbashi, Minato-ku, Tokyo, Japan",
    "1-5-10 Oroshimachi Higashi, Wakabayashi-ku, Sendai-shi, Miyagi, Japan",
    "4-13-1 Nishi-Hasegawa-cho, Atsuta-ku, Nagoya-shi, Aichi, Japan",
    "1-5-18 Minami-Funaba, Chuo-ku, Osaka-shi, Osaka, Japan",
    "2-1-3 Hakataeki Higashi, Hakata-ku, Fukuoka-shi, Fukuoka, Japan"
  ],
  "EA Pharma Co., Ltd.": [
    "2-4-1 Nihonbashi, Chuo-ku, Tokyo 103-8472, Japan",
    "1-1-103 Kitahigata, Kawashima, Gifu 509-0109, Japan",
    "2-3-11 Azusawa, Itabashi-ku, Tokyo 174-0043, Japan",
    "Sapporo, Japan",
    "Sendai, Japan",
    "Nagoya, Japan",
    "Osaka, Japan",
    "Hiroshima, Japan",
    "Fukuoka, Japan"
  ],
  "EB Shaw Securities, LLC": [
    "1111 Brickell Avenue, Suite 1050, Miami, FL 33131, USA"
  ],
  "EBD Group": [
    "2000 L Street NW, Suite 200, Washington D.C., 20036, USA",
    "Zeil 127, 60313 Frankfurt am Main, Germany"
  ],
  "ECI Therapeutics": [
    "3438 E. Lake Lansing Road, Ste 120, East Lansing, MI 48823, USA"
  ]
}
```
```json
{
  "EGB Ventures": [
    "Bangalore, India",
    "Delhi, India"
  ],
  "ENTENTE Network": [
    "London, UK"
  ],
  "EPM Group Inc": [
    "New York, NY, USA",
    "Costa Mesa, CA, USA"
  ],
  "EVERSANA": [
    "Milwaukee, WI, USA",
    "Chicago, IL, USA",
    "Burlington, MA, USA",
    "New York, NY, USA",
    "Stamford, CT, USA",
    "Toronto, ON, Canada",
    "Basel, Switzerland",
    "Dublin, Ireland",
    "Manchester, UK",
    "Bangalore, India",
    "Tokyo, Japan"
  ],
  "EVEXTA BIO": [
    "Tampa, FL, USA"
  ],
  "Earli": [
    "South San Francisco, CA, USA"
  ],
  "Eckuity Capital": [
    "New York, NY, USA",
    "Boston, MA, USA",
    "San Francisco, CA, USA",
    "Basel, Switzerland"
  ],
  "EdgeOne Venture Partners": [
    "San Francisco, CA, USA"
  ],
  "Edigene": [
    "Beijing, China",
    "Guangzhou, China",
    "Cambridge, MA, USA"
  ],
  "EditForce, Inc.": [
    "Fukuoka, Japan",
    "Tokyo, Japan"
  ],
  "Eight Bridges": [
    "New York, NY, USA"
  ],
  "Eight Roads Ventures": [
    "London, UK",
    "Boston, MA, USA",
    "Shanghai, China",
    "Mumbai, India",
    "Singapore",
    "Tokyo, Japan"
  ],
  "Eisai Co., Ltd.": [
    "Tokyo, Japan",
    "Tsukuba, Japan",
    "Woodcliff Lake, NJ, USA",
    "Andover, MA, USA",
    "Hatfield, UK",
    "Frankfurt, Germany",
    "Paris, France",
    "Madrid, Spain",
    "Milan, Italy",
    "Beijing, China",
    "Gurgaon, India",
    "Singapore",
    "Sydney, Australia",
    "São Paulo, Brazil",
    "Mississauga, Canada"
  ],
  "Eisai Innovation Inc": [
    "Cambridge, MA, USA"
  ],
  "Eleva GmbH": [
    "Braunschweig, Germany"
  ],
  "Elix, Inc.": [
    "Tokyo, Japan"
  ],
  "Elixirgen Scientific": [
    "Baltimore, MD, USA",
    "Yokohama, Japan"
  ],
  "Ellipses Pharma Ltd": [
    "London, UK"
  ],
  "Elpis Biopharmaceuticals": [
    "New York, NY, USA"
  ],
  "Emerald Bioventures, LLC": [
    "Boston, MA, USA"
  ]
}
```
```json
{
  "Emory Drug Development Fund": [
    "Atlanta, Georgia, USA"
  ],
  "Empath Biosciences, Inc": [
    "San Francisco, California, USA"
  ],
  "Endless Frontier Labs": [
    "New York, New York, USA"
  ],
  "Endpoints Capital Pty Ltd": [
    "Sydney, New South Wales, Australia"
  ],
  "Endpoints News": [
    "Boston, Massachusetts, USA",
    "New York, New York, USA",
    "Washington D.C., USA",
    "Raleigh, North Carolina, USA",
    "London, UK",
    "Tokyo, Japan",
    "Singapore",
    "Tel Aviv, Israel"
  ],
  "Endurance28": [
    "Washington D.C., USA"
  ],
  "Endure Biotherapeutics, Inc.": [
    "San Diego, California, USA"
  ],
  "Engine Ventures": [
    "Cambridge, Massachusetts, USA"
  ],
  "Enhanc3d Genomics": [
    "London, UK"
  ],
  "Enquyst Technologies Inc": [
    "Berkeley, California, USA"
  ],
  "Ensante": [
    "San Diego, California, USA"
  ],
  "Enterprise Singapore": [
    "Singapore",
    "Bangkok, Thailand",
    "Beijing, China",
    "Chengdu, China",
    "Chongqing, China",
    "Guangzhou, China",
    "Ho Chi Minh City, Vietnam",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Manila, Philippines",
    "Mumbai, India",
    "New Delhi, India",
    "Seoul, South Korea",
    "Shanghai, China",
    "Shenzhen, China",
    "Sydney, Australia",
    "Taipei, Taiwan",
    "Tokyo, Japan",
    "Yangon, Myanmar",
    "Berlin, Germany",
    "Dubai, UAE",
    "Frankfurt, Germany",
    "Istanbul, Turkey",
    "London, UK",
    "Paris, France",
    "Moscow, Russia",
    "Los Angeles, California, USA",
    "New York, New York, USA",
    "San Francisco, California, USA",
    "Sao Paulo, Brazil",
    "Washington D.C., USA"
  ],
  "Enveric Biosciences, Inc.": [
    "Naples, Florida, USA"
  ],
  "Envisagenics": [
    "New York, New York, USA"
  ],
  "Eos BioInnovation": [
    "San Diego, California, USA"
  ],
  "Epidarex Capital": [
    "Edinburgh, UK",
    "Bethesda, Maryland, USA"
  ],
  "Epigenetix Inc": [
    "San Diego, California, USA"
  ],
  "Epiliquid Holding, Inc": [
    "Lausanne, Switzerland"
  ],
  "Epion Therapeutics, Inc.": [
    "Boston, Massachusetts, USA"
  ],
  "Erevna Inc": [
    "San Francisco, California, USA"
  ]
}
```
```json
{
  "Erez Capital": [
    "New York, NY, USA"
  ],
  "Ergomed Clinical Research": [
    "Guildford, UK",
    "London, UK",
    "Durham, NC, USA",
    "Princeton, NJ, USA",
    "Houston, TX, USA",
    "San Antonio, TX, USA",
    "Chicago, IL, USA",
    "San Diego, CA, USA",
    "Phoenix, AZ, USA",
    "Indianapolis, IN, USA",
    "Paris, France",
    "Munich, Germany",
    "Warsaw, Poland",
    "Bucharest, Romania",
    "Moscow, Russia",
    "Belgrade, Serbia",
    "Kyiv, Ukraine",
    "Zagreb, Croatia",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Sofia, Bulgaria",
    "Sarajevo, Bosnia and Herzegovina",
    "Madrid, Spain",
    "Milan, Italy",
    "Basel, Switzerland",
    "Amsterdam, Netherlands",
    "Copenhagen, Denmark",
    "Stockholm, Sweden",
    "Oslo, Norway",
    "Helsinki, Finland",
    "Ghent, Belgium",
    "Vienna, Austria",
    "Athens, Greece",
    "Dublin, Ireland",
    "Lisbon, Portugal",
    "Tallinn, Estonia",
    "Riga, Latvia",
    "Vilnius, Lithuania",
    "Istanbul, Turkey",
    "Cape Town, South Africa",
    "Tel Aviv, Israel",
    "Cairo, Egypt",
    "Casablanca, Morocco",
    "Dubai, UAE",
    "Riyadh, Saudi Arabia",
    "Sydney, Australia",
    "Melbourne, Australia",
    "Auckland, New Zealand",
    "Seoul, South Korea",
    "Tokyo, Japan",
    "Shanghai, China",
    "Bengaluru, India",
    "Singapore",
    "Kuala Lumpur, Malaysia",
    "Manila, Philippines",
    "Bangkok, Thailand",
    "Buenos Aires, Argentina",
    "São Paulo, Brazil",
    "Santiago, Chile",
    "Bogota, Colombia",
    "Mexico City, Mexico",
    "Lima, Peru",
    "Toronto, Canada",
    "Montreal, Canada"
  ],
  "EsoCap AG": [
    "Basel, Switzerland"
  ],
  "Esousa Holdings": [
    "New York, NY, USA"
  ],
  "Esperante Ventures": [
    "San Francisco, CA, USA"
  ],
  "Esphera SynBio": [
    "Madrid, Spain"
  ],
  "EuBiologics Co., Ltd.": [
    "Chuncheon, South Korea",
    "Seoul, South Korea"
  ],
  "EuMentis Therapeutics": [
    "Boston, MA, USA"
  ],
  "Eureka Biotechnology": [
    "Wuxi, China",
    "Shanghai, China",
    "Beijing, China"
  ],
  "Eurofins CDMO Alphora": [
    "Toronto, ON, Canada"
  ],
  "Evaluate": [
    "London, UK",
    "Boston, MA, USA",
    "Tokyo, Japan",
    "New York, NY, USA"
  ],
  "Evariste": [
    "No clear public location found for a relevant company"
  ],
  "Evecxia Therapeutics": [
    "Durham, NC, USA"
  ],
  "EverEx": [
    "No clear public location found for a relevant company"
  ],
  "Evexia Fund": [
    "Luxembourg City, Luxembourg"
  ],
  "Evidence Ventures": [
    "San Francisco, CA, USA"
  ],
  "Evox Therapeutics": [
    "Oxford, UK",
    "Boston, MA, USA"
  ],
  "ExCellThera": [
    "Montreal, QC, Canada"
  ],
  "Exact Therapeutics AS": [
    "Oslo, Norway",
    "London, UK"
  ],
  "Exogene": [
    "Palo Alto, CA, USA"
  ]
}
```
```json
{
  "Exolvo Biosciences": [
    "Salt Lake City, Utah, USA"
  ],
  "Exthymic": [
    "Chapel Hill, North Carolina, USA"
  ],
  "Extracellular Vesicles and Circulating Nucleic Acids": [],
  "Eyam": [],
  "Eyegenex": [
    "Durham, North Carolina, USA"
  ],
  "FGK Clinical Research GmbH": [
    "Munich, Germany",
    "Berlin, Germany",
    "Basel, Switzerland",
    "Leiden, Netherlands",
    "Vienna, Austria",
    "Paris, France",
    "Madrid, Spain",
    "Milan, Italy",
    "Lisbon, Portugal",
    "Warsaw, Poland",
    "Budapest, Hungary",
    "Bucharest, Romania",
    "Prague, Czech Republic",
    "Istanbul, Turkey",
    "London, UK"
  ],
  "FIMECS, INC.": [
    "Kawasaki, Kanagawa, Japan"
  ],
  "FIZE Medical": [
    "Warsaw, Poland"
  ],
  "FNCT Biotech, Inc.": [
    "Seattle, Washington, USA"
  ],
  "FORCE Family Office": [
    "New York, New York, USA"
  ],
  "FUJIFILM Cellular Dynamics, Inc.": [
    "Madison, Wisconsin, USA",
    "Bothell, Washington, USA"
  ],
  "FUJIFILM Diosynth Biotechnologies": [
    "Billingham, UK",
    "Holly Springs, North Carolina, USA",
    "Research Triangle Park, North Carolina, USA",
    "College Station, Texas, USA",
    "Watertown, Massachusetts, USA",
    "Thousand Oaks, California, USA",
    "Hillerød, Denmark",
    "Yangpu, Shanghai, China"
  ],
  "Fairmount Funds": [
    "Toronto, Ontario, Canada"
  ],
  "Fankhauser Arealentwicklung AG": [
    "Langenthal, Switzerland"
  ],
  "Fapon": [
    "Dongguan, China",
    "San Diego, California, USA",
    "Boston, Massachusetts, USA",
    "Wuxi, China",
    "Shanghai, China",
    "Suzhou, China",
    "Shenzhen, China"
  ],
  "Farquhar VC": [
    "Sydney, Australia"
  ],
  "Fast Company": [
    "New York, New York, USA"
  ],
  "Fast Track Initiative": [
    "Tokyo, Japan"
  ],
  "Fauna Bio": [
    "Emeryville, California, USA"
  ],
  "Federov Investments": [
    "Moscow, Russia"
  ]
}
```
```json
{
  "Feldan Therapeutics": ["Quebec City, Canada"],
  "Feliqs Corporation": ["San Jose, California, USA"],
  "FemHealth Ventures": ["Menlo Park, California, USA"],
  "Femavet": ["New York, New York, USA"],
  "Fermelanta, Inc.": ["Miami, Florida, USA"],
  "Ferring Pharmaceuticals A/S": ["Saint-Prex, Switzerland", "Parsippany, New Jersey, USA", "Copenhagen, Denmark", "Frankfurt, Germany", "Beijing, China", "Mumbai, India"],
  "FibroBiologics": ["Houston, Texas, USA"],
  "Fiddlehead Ventures": ["London, UK"],
  "Fierce Healthcare": ["Remote", "Washington D.C., USA", "New York, New York, USA", "Boston, Massachusetts, USA"],
  "Financial Times": ["London, UK", "New York, New York, USA", "Hong Kong", "Tokyo, Japan", "Paris, France", "Frankfurt, Germany", "Dubai, UAE", "Singapore"],
  "Finchley Healthcare Ventures": ["New York, New York, USA"],
  "Find Therapeutics": ["Montreal, Canada"],
  "Finney Capital": ["San Francisco, California, USA"],
  "FirstWord Pharma": ["London, UK", "New York, New York, USA"],
  "Flag Bio, Inc": ["San Diego, California, USA"],
  "Flagship Pioneering": ["Cambridge, Massachusetts, USA"],
  "Flashpoint Therapeutics": ["San Diego, California, USA"],
  "Flerie": ["Stockholm, Sweden"],
  "Flu Lab": ["N/A - Not a singular company with fixed locations; typically refers to various research laboratories globally"],
  "FluidForm Bio": ["Boston, Massachusetts, USA"]
}
```
```json
{
  "FluoSphera SA": [
    "Epalinges, Switzerland"
  ],
  "FlyWorks America, Inc.": [
    "No public office found"
  ],
  "FoRx Therapeutics AG": [
    "Basel, Switzerland"
  ],
  "Focalpoint Partners": [
    "Los Angeles, CA, USA",
    "Chicago, IL, USA",
    "New York, NY, USA",
    "San Francisco, CA, USA"
  ],
  "Foley Hoag": [
    "Boston, MA, USA",
    "Washington, D.C., USA",
    "New York, NY, USA",
    "Denver, CO, USA",
    "Paris, France",
    "Copenhagen, Denmark"
  ],
  "Forbes": [
    "Jersey City, NJ, USA",
    "New York, NY, USA"
  ],
  "Forbion": [
    "Naarden, Netherlands",
    "Munich, Germany"
  ],
  "Forcyte Bio": [
    "San Diego, CA, USA"
  ],
  "Foreground Capital": [
    "San Francisco, CA, USA"
  ],
  "Forest Road Asset Management": [
    "New York, NY, USA",
    "Los Angeles, CA, USA"
  ],
  "Formation Bio": [
    "New York, NY, USA",
    "Boston, MA, USA",
    "San Francisco, CA, USA",
    "London, UK"
  ],
  "Fortrea": [
    "Durham, NC, USA",
    "Princeton, NJ, USA",
    "Indianapolis, IN, USA",
    "San Antonio, TX, USA",
    "Nashville, TN, USA",
    "Montreal, Canada",
    "Maidenhead, UK",
    "Berlin, Germany",
    "Paris, France",
    "Basel, Switzerland",
    "Madrid, Spain",
    "Singapore",
    "Shanghai, China",
    "Tokyo, Japan",
    "Sydney, Australia",
    "Bangalore, India",
    "São Paulo, Brazil",
    "Mexico City, Mexico",
    "Buenos Aires, Argentina"
  ],
  "Fortunatus Capital": [
    "London, UK"
  ],
  "Forward Equity Partners Co., Ltd.": [
    "Taipei, Taiwan"
  ],
  "Fosun Pharmaceutical AG": [
    "Berlin, Germany"
  ],
  "FoundersX Ventures": [
    "Palo Alto, CA, USA"
  ],
  "Foundery Biosciences": [
    "Cambridge, MA, USA"
  ],
  "Fraunhofer -Institut für Toxikologie und Experimentelle Medizin ITEM": [
    "Hannover, Germany",
    "Braunschweig, Germany"
  ],
  "FreeMind Group": [
    "Washington, D.C., USA",
    "Cambridge, MA, USA",
    "Herzliya Pituach, Israel"
  ],
  "FreeMind Investments": [
    "No public office found"
  ]
}
```
```json
{
  "Freedom Capital Family Office": [
    "Sydney, Australia",
    "Melbourne, Australia"
  ],
  "Freelance": [],
  "Freenome Holdings, Inc.": [
    "South San Francisco, USA",
    "Palo Alto, USA",
    "Singapore"
  ],
  "Frezent Biological Solutions": [
    "Chennai, India"
  ],
  "Friedman Bioventure Fund 1 LP": [
    "New York, USA"
  ],
  "Frontier Bio": [
    "New York, USA"
  ],
  "FujiFilm Irvine Scientific": [
    "Santa Ana, USA",
    "Tilburg, Netherlands",
    "Tokyo, Japan",
    "Kawasaki, Japan",
    "Wuxi, China"
  ],
  "Future Planet Capital": [
    "London, UK"
  ],
  "GC Biopharma Corp.": [
    "Yongin, South Korea",
    "Ochang, South Korea",
    "Fort Lee, USA",
    "Toronto, Canada",
    "Beijing, China",
    "Netherlands"
  ],
  "GCF Family Office": [
    "Zurich, Switzerland"
  ],
  "GEM NY": [
    "New York, USA",
    "Paris, France"
  ],
  "GEN": [
    "New Rochelle, USA"
  ],
  "GHO Capital": [
    "London, UK"
  ],
  "GL Chemtec International Ltd.": [
    "Oakville, Canada"
  ],
  "GO Therapeutics": [
    "Cambridge, USA"
  ],
  "GPG Ventures": [
    "New York, USA"
  ],
  "GSR Ventures": [
    "Palo Alto, USA",
    "Beijing, China"
  ],
  "Gain Therapeutics, Inc.": [
    "Bethesda, USA",
    "Barcelona, Spain",
    "Lausanne, Switzerland"
  ],
  "Galena Innovations": [
    "Houston, USA"
  ],
  "Galimedix Therapeutics": [
    "La Jolla, USA"
  ]
}
```
```json
{
  "Gamma Biosciences": [
    "Boston, Massachusetts, USA",
    "Novato, California, USA"
  ],
  "Gaorong Capital": [
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong, China"
  ],
  "Garland Holdings Inc": [
    "New York, New York, USA"
  ],
  "GelMEDIX": [
    "Cambridge, Massachusetts, USA"
  ],
  "GelSana": [
    "Boulder, Colorado, USA"
  ],
  "Gemseki Venture": [
    "Tokyo, Japan",
    "San Francisco, California, USA",
    "Seoul, South Korea",
    "Shanghai, China"
  ],
  "GenAssist Ltd": [
    "Cambridge, UK"
  ],
  "GenScript Biotech": [
    "Nanjing, China",
    "Shanghai, China",
    "Suzhou, China",
    "Piscataway, New Jersey, USA",
    "San Diego, California, USA",
    "Fremont, California, USA",
    "Research Triangle Park, North Carolina, USA",
    "Tokyo, Japan",
    "Singapore",
    "Leiden, Netherlands",
    "Dublin, Ireland",
    "London, UK"
  ],
  "GeneCapture, Inc.": [
    "Huntsville, Alabama, USA"
  ],
  "GeneQuantum Healthcare (Suzhou) Co. Ltd.": [
    "Suzhou, China"
  ],
  "Genenta (NASDAQ: GNTA)": [
    "Milan, Italy"
  ],
  "General Inception": [
    "San Diego, California, USA"
  ],
  "Genescience Pharmaceutical Co. Ltd.": [
    "Changchun, China",
    "Beijing, China",
    "Shanghai, China"
  ],
  "Genesis Capital": [
    "Beijing, China",
    "Shanghai, China"
  ],
  "Genesys Capital": [
    "Toronto, Ontario, Canada"
  ],
  "Genialis, Inc": [
    "Houston, Texas, USA",
    "Ljubljana, Slovenia"
  ],
  "Genicity limited": [
    "Cambridge, UK"
  ],
  "GenoMeCoin": [],
  "Genoa Ventures": [
    "San Francisco, California, USA"
  ],
  "Genopore": [
    "Boulder, Colorado, USA"
  ]
}
```
```json
{
  "Genvara Biopharma": [
    "Morris Plains, New Jersey, USA"
  ],
  "GeoVax Labs, Inc.": [
    "Smyrna, Georgia, USA"
  ],
  "George Clinical": [
    "Sydney, Australia",
    "Philadelphia, Pennsylvania, USA",
    "Beijing, China",
    "Bangalore, India",
    "Singapore",
    "Kuala Lumpur, Malaysia",
    "Hong Kong",
    "Amsterdam, Netherlands",
    "Auckland, New Zealand",
    "London, UK",
    "Cape Town, South Africa"
  ],
  "Georgia Bio": [
    "Atlanta, Georgia, USA"
  ],
  "Gimv NV": [
    "Antwerp, Belgium",
    "The Hague, Netherlands",
    "Munich, Germany",
    "Paris, France"
  ],
  "Global Alpha Ventures": [
    "San Francisco, California, USA"
  ],
  "Global BioAccess Fund": [
    "Palo Alto, California, USA"
  ],
  "Global Brain": [
    "Tokyo, Japan",
    "San Francisco, California, USA",
    "Seoul, South Korea",
    "London, UK",
    "Singapore"
  ],
  "Global Climate Solutions Institute": [
    "Washington D.C., USA"
  ],
  "Global Pharma Solutions": [
    "Hyderabad, India"
  ],
  "Global Source Ventures": [
    "San Francisco, California, USA"
  ],
  "Global Webcasting Group": [
    "San Francisco, California, USA"
  ],
  "GlobalData": [
    "London, UK",
    "Hyderabad, India",
    "New York, New York, USA",
    "Sydney, Australia"
  ],
  "Glucotrack Inc": [
    "Santa Clara, California, USA"
  ],
  "Gluetacs Therapeutics (Shanghai) Co., Ltd.": [
    "Shanghai, China"
  ],
  "GlycoNex Inc.": [
    "Taipei, Taiwan"
  ],
  "Glytherix": [
    "Sydney, Australia"
  ],
  "Golden Eagle Partners": [
    "San Diego, California, USA"
  ],
  "GondolaBio": [
    "Toronto, Ontario, Canada"
  ],
  "Good Growth Capital": [
    "Charleston, South Carolina, USA",
    "Boston, Massachusetts, USA",
    "Atlanta, Georgia, USA",
    "Miami, Florida, USA",
    "Philadelphia, Pennsylvania, USA",
    "San Francisco, California, USA"
  ]
}
```
```json
{
  "Good Health Capital LLC": [
    "San Francisco, CA, USA"
  ],
  "Gradiant Corporation": [
    "Boston, MA, USA",
    "Singapore",
    "Dubai, UAE",
    "Perth, Australia",
    "São Paulo, Brazil",
    "Santiago, Chile",
    "Shanghai, China",
    "Chennai, India",
    "Delhi, India",
    "Mumbai, India",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Madrid, Spain",
    "Houston, TX, USA"
  ],
  "Grassi": [
    "New York, NY, USA",
    "Jericho, NY, USA",
    "Lake Success, NY, USA",
    "White Plains, NY, USA",
    "Pearl River, NY, USA",
    "Rochester, NY, USA",
    "Newburgh, NY, USA",
    "Miami, FL, USA",
    "Palm Beach, FL, USA",
    "Sarasota, FL, USA",
    "Park Ridge, NJ, USA",
    "Needham, MA, USA",
    "Austin, TX, USA",
    "Stamford, CT, USA"
  ],
  "Gray Strategic Advisors, LLC": [
    "Alexandria, VA, USA"
  ],
  "Greenwillow Capital": [
    "Houston, TX, USA"
  ],
  "Grifols SA": [
    "Barcelona, Spain",
    "Parets del Vallès, Spain",
    "Los Angeles, CA, USA",
    "Clayton, NC, USA",
    "Dublin, Ireland",
    "Raleigh, NC, USA",
    "San Diego, CA, USA",
    "Washington D.C., USA",
    "Goleta, CA, USA",
    "Boca Raton, FL, USA",
    "Miami, FL, USA",
    "Toronto, ON, Canada",
    "Madrid, Spain",
    "Frankfurt, Germany",
    "London, UK",
    "Rome, Italy",
    "Paris, France",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Lisbon, Portugal",
    "Zurich, Switzerland",
    "Sydney, Australia",
    "Shanghai, China",
    "Beijing, China",
    "Tokyo, Japan",
    "Singapore",
    "Seoul, South Korea",
    "Mumbai, India",
    "São Paulo, Brazil",
    "Mexico City, Mexico",
    "Buenos Aires, Argentina",
    "Bogotá, Colombia",
    "Santiago, Chile",
    "Dubai, UAE",
    "Johannesburg, South Africa"
  ],
  "Gunston Ventures": [
    "Washington, D.C., USA"
  ],
  "Gyder Surgical": [
    "Miami, FL, USA"
  ],
  "H Tree Capital": [
    "New York, NY, USA"
  ],
  "H.C. Wainwright": [
    "New York, NY, USA"
  ],
  "HCVC": [
    "Paris, France"
  ],
  "HDAX Therapeutics": [
    "Houston, TX, USA"
  ],
  "HEDA Ventures": [
    "San Francisco, CA, USA"
  ],
  "HELP Therapeutics Co. Ltd.": [
    "Seongnam-si, Gyeonggi-do, South Korea"
  ],
  "HJ Partners": [
    "Seoul, South Korea"
  ],
  "HK InnoN": [
    "Seoul, South Korea",
    "Yongin, Gyeonggi-do, South Korea",
    "Osong, Chungcheongbuk-do, South Korea"
  ],
  "HM Venture Partners": [
    "Seoul, South Korea"
  ],
  "HTuO Biosciences": [
    "Toronto, ON, Canada"
  ],
  "HYUNDAI BIOSCIECNE USA INC": [
    "San Jose, CA, USA"
  ],
  "Hadean Ventures": [
    "Oslo, Norway",
    "London, UK"
  ]
}
```
```json
{
  "Halloran Consulting Group": [
    "Boston, MA, USA",
    "Raleigh, NC, USA"
  ],
  "Halo Pharma": [
    "Whippany, NJ, USA (former HQ)",
    "Mirabel, Quebec, Canada (former site)",
    "San Jose, Costa Rica (former site)"
  ],
  "HanchorBio Inc": [
    "San Francisco, CA, USA",
    "Shanghai, China"
  ],
  "Hanmi Pharmaceutical": [
    "Seoul, South Korea",
    "Beijing, China",
    "Ridgefield, NJ, USA"
  ],
  "Hansoh Pharma": [
    "Lianyungang, Jiangsu, China",
    "Shanghai, China",
    "Beijing, China",
    "Nanjing, China",
    "Boston, MA, USA"
  ],
  "Harbor Biomedicines": [
    "Cambridge, MA, USA"
  ],
  "Harbour BioMed": [
    "Cambridge, MA, USA",
    "Shanghai, China",
    "Suzhou, China",
    "Rotterdam, Netherlands"
  ],
  "Harmony Pharma Group": [
    "Paris, France"
  ],
  "Harness Therapeutics": [
    "Cambridge, UK"
  ],
  "HatchBio Fund": [
    "Cambridge, MA, USA"
  ],
  "Hatteras Venture Partners": [
    "Durham, NC, USA"
  ],
  "Havah Therapeutics, Inc": [
    "San Diego, CA, USA"
  ],
  "Headlamp Health": [
    "San Francisco, CA, USA"
  ],
  "Health Innovation Capital": [
    "New York, NY, USA"
  ],
  "Health Technology Holding - HTH": [
    "Dubai, UAE"
  ],
  "Health2047 Capital Partners LLC": [
    "San Francisco, CA, USA"
  ],
  "HealthCap": [
    "Stockholm, Sweden"
  ],
  "HealthTech capital": [
    "Menlo Park, CA, USA"
  ],
  "Healthcare Capital Partners": [
    "Atlanta, GA, USA"
  ],
  "Hemay": [
    "Chengdu, Sichuan, China"
  ]
}
```
```json
{
  "Hemogenyx Pharmaceuticals": [
    "3rd Floor, 168 Shoreditch High Street, London, E1 6HU, United Kingdom",
    "590 Madison Avenue, 21st Floor, New York, NY 10022, USA"
  ],
  "Henlius USA": [
    "1840 Gateway Drive, Suite 250, San Mateo, CA 94404, USA"
  ],
  "Hercules Capital": [
    "525 University Ave, Suite 700, Palo Alto, CA 94301, USA",
    "One Post Office Square, Suite 3300, Boston, MA 02109, USA",
    "12275 El Camino Real, Suite 275, San Diego, CA 92130, USA",
    "100 Field Point Road, Suite 200, Greenwich, CT 06830, USA",
    "401 Congress Ave, Suite 1540, Austin, TX 78701, USA",
    "35 Berkeley Square, 1st Floor, London W1J 5BF, UK"
  ],
  "Hestia Investments Ltd.": [
    "C/O Stephenson Harwood Llp, 1 Finsbury Circus, London, EC2M 7SH, United Kingdom"
  ],
  "Hevolution Foundation": [
    "Laysen Valley, Office Building 10-A, Riyadh, Kingdom of Saudi Arabia",
    "125 High Street, Boston, MA 02110, USA"
  ],
  "Hexembio Inc.": [
    "2368 Walsh Avenue, Santa Clara, CA 95051, USA",
    "Building C11, Optics Valley Bio-City, 666 Gaoxin 2nd Road, Wuhan, Hubei Province, China"
  ],
  "High Cape Capital": [
    "152 West 57th Street, New York, NY 10019, USA"
  ],
  "Highlight Capital HLC Fund": [
    "Unit 2001, Highlight Center, 1000 Changping Rd, Jing'an Dist, Shanghai, China",
    "Room 1301, China Central Place Office Building 1, 81 Jianguo Rd, Chaoyang Dist, Beijing, China",
    "Room 2002-04, 20/F, Two International Finance Centre, 8 Finance Street, Central, Hong Kong"
  ],
  "Hike Ventures": [
    "512 2nd Street, San Francisco, CA 94107, USA"
  ],
  "Hill Research - TheraGPT": [
    "San Diego, CA, USA"
  ],
  "Hillhouse Investment": [
    "Unit 2201-02, Two Pacific Place, 88 Queensway, Hong Kong",
    "Suite 4101, China World Office 2, No.1 Jian Guo Men Wai Avenue, Chaoyang District, Beijing, China",
    "18 Marina Boulevard, Level 31, Marina Bay Financial Centre Tower 1, Singapore 018980",
    "9 West 57th Street, 43rd Floor, New York, NY 10019, USA",
    "25 Berkeley Square, 3rd Floor, London, W1J 6HL, UK",
    "Unit 2003, Wheelock Square, 1717 West Nanjing Road, Jing An District, Shanghai, China",
    "1 Sansome Street, Suite 3500, San Francisco, CA 94104, USA"
  ],
  "HistoSonics, Inc.": [
    "1100 Victors Way, Suite 10, Ann Arbor, MI 48108, USA"
  ],
  "HitGen Inc.": [
    "No. 719, B-1, 1st Floor, Tianfu Life Science Park, No. 88, Keyuan South Road, Hi-Tech Zone, Chengdu 610041, China",
    "12900 N. I-35, Suite 1400, Austin, TX 78753, USA",
    "BioHub at Alderley Park, Macclesfield, SK10 4TG, UK"
  ],
  "Hogan Lovells US LLP": [
    "One Atlantic Center, 1201 West Peachtree Street, NE, Suite 1900, Atlanta, GA 30309, USA",
    "100 International Drive, Suite 2000, Baltimore, MD 21202, USA",
    "100 Federal Street, Suite 3300, Boston, MA 02110, USA",
    "111 South Tejon Street, Suite 600, Colorado Springs, CO 80903, USA",
    "1675 Broadway, Suite 2600, Denver, CO 80202, USA",
    "609 Main Street, Suite 3700, Houston, TX 77002, USA",
    "1999 Avenue of the Stars, Suite 1400, Los Angeles, CA 90067, USA",
    "400 West Market Street, Suite 2300, Louisville, KY 40202, USA",
    "600 Brickell Avenue, Suite 2700, Miami, FL 33131, USA",
    "80 South Eighth Street, Suite 900, Minneapolis, MN 55402, USA",
    "875 Third Avenue, New York, NY 10022, USA",
    "7930 Jones Branch Drive, Suite 1500, Tysons, VA 22102, USA",
    "1700 Market Street, Suite 2500, Philadelphia, PA 19103, USA",
    "1 Market Street, Spear Tower, Suite 2500, San Francisco, CA 94105, USA",
    "4085 Campbell Avenue, Suite 200, Menlo Park, CA 94025, USA",
    "555 13th Street, NW, Washington, DC 20004, USA"
  ],
  "Hongjing Capital": [
    "Room 1605, Kingkey 100 Tower, Shennan East Road, Luohu District, Shenzhen, China",
    "Room 2006, South Tower, China World Office 1, No.1 Jian Guo Men Wai Avenue, Chaoyang District, Beijing, China",
    "Room 3901-3902, Two International Finance Centre, 8 Century Avenue, Pudong New Area, Shanghai, China"
  ],
  "Horizon 3 Healthcare Fund": [
    "200 Clarendon Street, 52nd Floor, Boston, MA 02116, USA"
  ],
  "Horizon Technology Finance": [
    "355 Research Parkway, Suite 100, Farmington, CT 06032, USA",
    "525 University Ave, Suite 700, Palo Alto, CA 94301, USA",
    "One Post Office Square, Suite 3300, Boston, MA 02109, USA",
    "12275 El Camino Real, Suite 275, San Diego, CA 92130, USA"
  ],
  "Huahai Investment Co., Ltd (A subsidiary of Huahai Pharmaceutical Co., Ltd)": [
    "18 Chunhui Road, Duqiao, Linhai, Zhejiang, P.R. China",
    "Room 1701, Huashan Road, Xuhui District, Shanghai, P.R. China"
  ],
  "Huangpu River Capital": [
    "Room 2307, Building 1, No. 666, Tianyaoqiao Road, Xuhui District, Shanghai, China"
  ],
  "Huicheng Biotechnology, Inc.": [
    "1530 The Alameda Suite 110, San Jose, CA 95126, USA"
  ]
}
```
```json
{
  "Human Longevity Inc": [
    "San Diego, CA, USA"
  ],
  "Hummingbird Ventures": [
    "London, UK",
    "Ghent, Belgium"
  ],
  "Hunniwell Lake Ventures": [
    "San Jose, CA, USA"
  ],
  "Huonslab": [
    "Seongnam-si, Gyeonggi-do, South Korea"
  ],
  "Hypatia Group": [
    "New York, NY, USA"
  ],
  "IAG Capital Partners": [
    "Bethesda, MD, USA"
  ],
  "IAPP Media": [
    "Portsmouth, NH, USA",
    "London, UK",
    "Brussels, Belgium",
    "Singapore",
    "Washington D.C., USA"
  ],
  "IASO BIOTECHNOLOGY": [
    "Shanghai, China",
    "Princeton, NJ, USA"
  ],
  "ICG Life Sciences, ICG Capital": [
    "London, UK",
    "New York, NY, USA",
    "Paris, France",
    "Frankfurt, Germany",
    "Hong Kong",
    "Singapore",
    "Sydney, Australia"
  ],
  "ICON Plc.": [
    "Dublin, Ireland",
    "Philadelphia, PA, USA",
    "Raleigh-Durham, NC, USA",
    "London, UK",
    "Singapore",
    "Sydney, Australia",
    "Hyderabad, India",
    "Tokyo, Japan"
  ],
  "IDG Capital": [
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong",
    "New York, NY, USA",
    "San Francisco, CA, USA",
    "London, UK",
    "Boston, MA, USA"
  ],
  "IGI": [
    "Seoul, South Korea"
  ],
  "ILIAS Biologics Inc.": [
    "Daejeon, South Korea"
  ],
  "IMBiologics": [
    "Daejeon, South Korea"
  ],
  "IN CAPITAL": [
    "Moscow, Russia"
  ],
  "IN8bio": [
    "New York, NY, USA",
    "Pleasanton, CA, USA"
  ],
  "INCE Capital": [
    "Shanghai, China"
  ],
  "INOGROUP": [
    "Zug, Switzerland"
  ],
  "INOVAIT / Sunnybrook Research Institute": [
    "Toronto, ON, Canada"
  ],
  "IO Biotech": [
    "Copenhagen, Denmark"
  ]
}
```
```json
{
  "IPF Partners": [
    "London, UK",
    "Paris, France",
    "Singapore"
  ],
  "ITOCHU International, Inc.": [
    "New York, NY, USA"
  ],
  "ITR Laboratories": [
    "Montreal, Quebec, Canada"
  ],
  "IVIEW Therapeutics Inc.": [
    "Cranbury, NJ, USA"
  ],
  "Iaso Ventures": [
    "San Francisco, CA, USA"
  ],
  "Iconoclast Ventures": [
    "San Francisco, CA, USA"
  ],
  "IdB Holding": [
    "Rome, Italy"
  ],
  "IgGenix": [
    "South San Francisco, CA, USA"
  ],
  "Ignota Labs": [
    "Oxford, UK"
  ],
  "Ildong Pharmaceutical": [
    "Seoul, South Korea"
  ],
  "Illumina ventures": [
    "San Francisco, CA, USA"
  ],
  "ImBiome Inc.": [
    "Houston, TX, USA"
  ],
  "Imaginostics Inc.": [
    "Hanover, NH, USA"
  ],
  "Imbrium Therapeutics": [
    "Research Triangle Park, NC, USA"
  ],
  "Immetas Therapeutics": [
    "Waltham, MA, USA"
  ],
  "Immorta Bio, Inc": [
    "San Diego, CA, USA"
  ],
  "ImmuPharma PLC": [
    "London, UK"
  ],
  "Immugenia Inc.": [
    "Montreal, Quebec, Canada"
  ],
  "Immungenetics AG": [
    "Martinsried, Germany"
  ],
  "Immunis, Inc.": [
    "Irvine, CA, USA"
  ]
}
```
```json
{
  "Immunitas Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "ImmunoBiochem": [
    "Vancouver, BC, Canada"
  ],
  "Immunophotonics, Inc.": [
    "St. Louis, MO, USA"
  ],
  "Immunova": [
    "Uppsala, Sweden"
  ],
  "Immunowake Inc.": [
    "Tokyo, Japan"
  ],
  "Immunservice GmbH": [
    "Berlin, Germany"
  ],
  "Immunyx Pharma": [
    "London, UK"
  ],
  "Immuto Scientific": [
    "San Diego, CA, USA"
  ],
  "Imperial College London": [
    "London, UK (South Kensington Campus)",
    "London, UK (White City Campus)",
    "Ascot, UK (Silwood Park Campus)"
  ],
  "InCube Ventures": [
    "San Jose, CA, USA"
  ],
  "InVivo Biosystems": [
    "Eugene, OR, USA"
  ],
  "Inaya Therapeutics": [
    "Boston, MA, USA"
  ],
  "Inceptor Bio": [
    "Research Triangle Park, NC, USA",
    "San Diego, CA, USA"
  ],
  "Indaco Bio Fund": [
    "Milan, Italy"
  ],
  "Indegene": [
    "Bengaluru, India",
    "Hyderabad, India",
    "Chennai, India",
    "Mumbai, India",
    "Gurgaon, India",
    "Ahmedabad, India",
    "Pune, India",
    "Princeton, NJ, USA",
    "New York, NY, USA",
    "Atlanta, GA, USA",
    "Bridgewater, NJ, USA",
    "San Bruno, CA, USA",
    "San Mateo, CA, USA",
    "London, UK",
    "Dublin, Ireland",
    "Basel, Switzerland",
    "Frankfurt, Germany",
    "Madrid, Spain",
    "Paris, France",
    "Tokyo, Japan",
    "Shanghai, China",
    "Singapore",
    "Manila, Philippines",
    "Kuala Lumpur, Malaysia"
  ],
  "Independent": [],
  "Independent investor": [],
  "IndieBio/SOSV": [
    "San Francisco, CA, USA",
    "New York, NY, USA",
    "London, UK",
    "Princeton, NJ, USA",
    "Cork, Ireland",
    "Shenzhen, China",
    "Shanghai, China",
    "Taipei, Taiwan"
  ],
  "Individual Investor": [],
  "Infinant Health, Inc": [
    "San Francisco, CA, USA"
  ]
}
```
```json
{
  "Infinimmune": [
    "Cambridge, MA, USA"
  ],
  "Infinitopes Precision Immunomics": [
    "Oxford, England, UK"
  ],
  "Infinity Bio Inc.": [
    "Foster City, CA, USA"
  ],
  "InflaRx": [
    "Jena, Germany",
    "Ann Arbor, MI, USA",
    "Munich, Germany"
  ],
  "Informa": [
    "London, UK",
    "New York, NY, USA",
    "Hong Kong",
    "São Paulo, Brazil",
    "Singapore",
    "Sydney, Australia",
    "Dubai, UAE"
  ],
  "Informa Connect": [
    "London, UK",
    "New York, NY, USA",
    "Boston, MA, USA"
  ],
  "Ingenew Pharma Inc.": [
    "Taipei, Taiwan",
    "San Diego, CA, USA"
  ],
  "Inhalon Biopharma, Inc.": [
    "Durham, NC, USA"
  ],
  "Inherent Biosciences": [
    "Salt Lake City, UT, USA"
  ],
  "InkSpace Imaging": [
    "Cleveland, OH, USA"
  ],
  "InnoPath Therapeutics": [
    "Houston, TX, USA"
  ],
  "InnoPinnacle Fund": [
    "Princeton, NJ, USA"
  ],
  "Innophore": [
    "Graz, Austria"
  ],
  "Innospark Ventures": [
    "Boston, MA, USA"
  ],
  "Innostellar Biotherapeutics Co.,Ltd": [
    "Shanghai, China"
  ],
  "Innovacell K.K.": [
    "Tokyo, Japan"
  ],
  "Innovating Capital": [
    "New York, NY, USA",
    "San Francisco, CA, USA"
  ],
  "Innovestor Life Science Ltd": [
    "Helsinki, Finland"
  ],
  "Innovius Capital": [
    "New York, NY, USA"
  ],
  "Inside Precision Medicine": [
    "New Rochelle, NY, USA"
  ]
}
```
```json
{
  "Insight Partners": [
    "New York, NY",
    "London, UK",
    "Tel Aviv, Israel"
  ],
  "Insmed Inc": [
    "Bridgewater, NJ",
    "Oxford, UK",
    "Tokyo, Japan",
    "Frankfurt, Germany",
    "Amsterdam, Netherlands",
    "Singapore"
  ],
  "Inspire Medical Systems, Inc.": [
    "Golden Valley, MN",
    "Germany",
    "United Kingdom",
    "Australia"
  ],
  "Integrated Nanotherapeutics": [
    "Toronto, Ontario, Canada"
  ],
  "Inteligex Inc": [
    "Toronto, Ontario, Canada"
  ],
  "Interaxon": [
    "Toronto, Ontario, Canada"
  ],
  "Interface Biosciences": [
    "Vancouver, BC, Canada"
  ],
  "Interna Therapeutics": [
    "Cambridge, MA"
  ],
  "Intract Pharma": [
    "London, UK"
  ],
  "InveniAI": [
    "Branford, CT"
  ],
  "Inventage Lab": [
    "Daejeon, South Korea"
  ],
  "Inveready Asset Management": [
    "Barcelona, Spain",
    "Madrid, Spain",
    "San Sebastián, Spain",
    "Lisbon, Portugal"
  ],
  "Invest Ontario": [
    "Toronto, Ontario, Canada"
  ],
  "Investissement Québec": [
    "Montréal, Quebec, Canada",
    "Québec City, Quebec, Canada",
    "Bécancour, Quebec, Canada",
    "Gatineau, Quebec, Canada",
    "Rimouski, Quebec, Canada",
    "Saguenay, Quebec, Canada",
    "Sherbrooke, Quebec, Canada",
    "Sept-Îles, Quebec, Canada",
    "Rouyn-Noranda, Quebec, Canada",
    "Paris, France",
    "Munich, Germany",
    "London, UK",
    "New York, NY",
    "Boston, MA",
    "Chicago, IL",
    "Los Angeles, CA",
    "Seoul, South Korea",
    "Shanghai, China",
    "Tokyo, Japan",
    "Tel Aviv, Israel"
  ],
  "Investors Circle": [
    "San Francisco, CA",
    "New York, NY"
  ],
  "IowaIBO, Inc": [
    "Iowa City, IA"
  ],
  "Ipsen": [
    "Boulogne-Billancourt, France",
    "Cambridge, MA",
    "Slough, UK",
    "Munich, Germany",
    "Shanghai, China",
    "Tokyo, Japan",
    "São Paulo, Brazil",
    "Madrid, Spain",
    "Milan, Italy"
  ],
  "Ipsos Advisory Healthcare": [
    "Paris, France",
    "New York, NY",
    "London, UK",
    "Chicago, IL",
    "Shanghai, China",
    "Tokyo, Japan",
    "Munich, Germany",
    "Singapore"
  ],
  "Iseehear Inc.": [
    "Toronto, Ontario, Canada"
  ],
  "Island Pharmaceuticals Ltd": [
    "Melbourne, Australia"
  ]
}
```
```json
{
  "JAFCO Group Co., Ltd.": [
    "Tokyo, Japan",
    "Nagoya, Japan",
    "Osaka, Japan"
  ],
  "JD Bioscience": [
    "Seoul, South Korea",
    "Chuncheon-si, South Korea"
  ],
  "JEDFam Group": [
    "Mumbai, India",
    "Bangalore, India",
    "Hyderabad, India"
  ],
  "JETRO": [
    "Tokyo, Japan",
    "Osaka, Japan",
    "Nagoya, Japan",
    "Yokohama, Japan",
    "Kobe, Japan",
    "Fukuoka, Japan",
    "Sapporo, Japan",
    "Sendai, Japan",
    "Niigata, Japan",
    "Shizuoka, Japan",
    "Hamamatsu, Japan",
    "Kanazawa, Japan",
    "Kyoto, Japan",
    "Hiroshima, Japan",
    "Takamatsu, Japan",
    "Matsuyama, Japan",
    "Oita, Japan",
    "Kumamoto, Japan",
    "Kagoshima, Japan",
    "Naha, Japan",
    "Chiba, Japan",
    "Seoul, South Korea",
    "Busan, South Korea",
    "Beijing, China",
    "Shanghai, China",
    "Guangzhou, China",
    "Dalian, China",
    "Hong Kong, China",
    "Taipei, Taiwan",
    "Ulaanbaatar, Mongolia",
    "Jakarta, Indonesia",
    "Surabaya, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Penang, Malaysia",
    "Manila, Philippines",
    "Bangkok, Thailand",
    "Hanoi, Vietnam",
    "Ho Chi Minh City, Vietnam",
    "Vientiane, Laos",
    "Phnom Penh, Cambodia",
    "Yangon, Myanmar",
    "Dhaka, Bangladesh",
    "Kolkata, India",
    "Mumbai, India",
    "New Delhi, India",
    "Bengaluru, India",
    "Karachi, Pakistan",
    "Colombo, Sri Lanka",
    "Dubai, UAE",
    "Abu Dhabi, UAE",
    "Riyadh, Saudi Arabia",
    "Doha, Qatar",
    "Sydney, Australia",
    "Perth, Australia",
    "Melbourne, Australia",
    "Auckland, New Zealand",
    "New York, USA",
    "Atlanta, USA",
    "Chicago, USA",
    "Houston, USA",
    "Los Angeles, USA",
    "San Francisco, USA",
    "Toronto, Canada",
    "Vancouver, Canada",
    "Mexico City, Mexico",
    "São Paulo, Brazil",
    "Rio de Janeiro, Brazil",
    "Buenos Aires, Argentina",
    "Santiago, Chile",
    "Bogota, Colombia",
    "Lima, Peru",
    "London, UK",
    "Paris, France",
    "Düsseldorf, Germany",
    "Hamburg, Germany",
    "Munich, Germany",
    "Berlin, Germany",
    "Brussels, Belgium",
    "Amsterdam, Netherlands",
    "Milan, Italy",
    "Rome, Italy",
    "Madrid, Spain",
    "Barcelona, Spain",
    "Zurich, Switzerland",
    "Geneva, Switzerland",
    "Vienna, Austria",
    "Copenhagen, Denmark",
    "Stockholm, Sweden",
    "Helsinki, Finland",
    "Oslo, Norway",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Bucharest, Romania",
    "Sofia, Bulgaria",
    "Kyiv, Ukraine",
    "Istanbul, Turkey",
    "Moscow, Russia",
    "St. Petersburg, Russia",
    "Cairo, Egypt",
    "Rabat, Morocco",
    "Tunis, Tunisia",
    "Algiers, Algeria",
    "Nairobi, Kenya",
    "Lagos, Nigeria",
    "Johannesburg, South Africa"
  ],
  "JIC Venture Growth Investments Co., Ltd.": [
    "Tokyo, Japan"
  ],
  "JIFENG VENTURES": [
    "Shanghai, China"
  ],
  "JLS Fund": [
    "Information not readily available publicly for a singular, identifiable entity."
  ],
  "JP Morgan": [
    "New York, USA",
    "Chicago, USA",
    "San Francisco, USA",
    "Los Angeles, USA",
    "Dallas, USA",
    "Houston, USA",
    "Miami, USA",
    "Boston, USA",
    "Atlanta, USA",
    "Seattle, USA",
    "Washington D.C., USA",
    "Toronto, Canada",
    "Montreal, Canada",
    "London, UK",
    "Paris, France",
    "Frankfurt, Germany",
    "Dublin, Ireland",
    "Luxembourg City, Luxembourg",
    "Geneva, Switzerland",
    "Zurich, Switzerland",
    "Milan, Italy",
    "Madrid, Spain",
    "Amsterdam, Netherlands",
    "Brussels, Belgium",
    "Warsaw, Poland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Oslo, Norway",
    "Helsinki, Finland",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Athens, Greece",
    "Istanbul, Turkey",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Bucharest, Romania",
    "Hong Kong, China",
    "Singapore",
    "Tokyo, Japan",
    "Shanghai, China",
    "Beijing, China",
    "Seoul, South Korea",
    "Mumbai, India",
    "Bangalore, India",
    "New Delhi, India",
    "Sydney, Australia",
    "Melbourne, Australia",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Manila, Philippines",
    "Bangkok, Thailand",
    "Taipei, Taiwan",
    "Ho Chi Minh City, Vietnam",
    "São Paulo, Brazil",
    "Mexico City, Mexico",
    "Buenos Aires, Argentina",
    "Santiago, Chile",
    "Bogota, Colombia",
    "Lima, Peru",
    "Dubai, UAE",
    "Riyadh, Saudi Arabia",
    "Abu Dhabi, UAE",
    "Doha, Qatar",
    "Johannesburg, South Africa",
    "Cairo, Egypt",
    "Casablanca, Morocco"
  ],
  "JP Morgan Life Sciences and Healthcare": [
    "New York, USA",
    "Chicago, USA",
    "San Francisco, USA",
    "Los Angeles, USA",
    "Dallas, USA",
    "Houston, USA",
    "Miami, USA",
    "Boston, USA",
    "Atlanta, USA",
    "Seattle, USA",
    "Washington D.C., USA",
    "Toronto, Canada",
    "Montreal, Canada",
    "London, UK",
    "Paris, France",
    "Frankfurt, Germany",
    "Dublin, Ireland",
    "Luxembourg City, Luxembourg",
    "Geneva, Switzerland",
    "Zurich, Switzerland",
    "Milan, Italy",
    "Madrid, Spain",
    "Amsterdam, Netherlands",
    "Brussels, Belgium",
    "Warsaw, Poland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Oslo, Norway",
    "Helsinki, Finland",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Athens, Greece",
    "Istanbul, Turkey",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Bucharest, Romania",
    "Hong Kong, China",
    "Singapore",
    "Tokyo, Japan",
    "Shanghai, China",
    "Beijing, China",
    "Seoul, South Korea",
    "Mumbai, India",
    "Bangalore, India",
    "New Delhi, India",
    "Sydney, Australia",
    "Melbourne, Australia",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Manila, Philippines",
    "Bangkok, Thailand",
    "Taipei, Taiwan",
    "Ho Chi Minh City, Vietnam",
    "São Paulo, Brazil",
    "Mexico City, Mexico",
    "Buenos Aires, Argentina",
    "Santiago, Chile",
    "Bogota, Colombia",
    "Lima, Peru",
    "Dubai, UAE",
    "Riyadh, Saudi Arabia",
    "Abu Dhabi, UAE",
    "Doha, Qatar",
    "Johannesburg, South Africa",
    "Cairo, Egypt",
    "Casablanca, Morocco"
  ],
  "JSR Corporation": [
    "Tokyo, Japan",
    "Yokkaichi, Japan",
    "Chiba, Japan",
    "Tsukuba, Japan",
    "Sunnyvale, CA, USA",
    "San Diego, CA, USA",
    "Phoenix, AZ, USA",
    "Portland, OR, USA",
    "Leuven, Belgium",
    "Darmstadt, Germany",
    "Munich, Germany",
    "Seoul, South Korea",
    "Shanghai, China",
    "Beijing, China",
    "Taipei, Taiwan",
    "Singapore",
    "Bangkok, Thailand",
    "Kuala Lumpur, Malaysia",
    "Gurgaon, India"
  ],
  "JT Pharma": [
    "Osaka, Japan",
    "Tokyo, Japan"
  ],
  "JT Ventures": [
    "Tokyo, Japan"
  ],
  "JW Holdings": [
    "Seoul, South Korea"
  ],
  "JW Pharmaceutical Corporation": [
    "Seoul, South Korea",
    "Dangjin, South Korea",
    "Siheung, South Korea"
  ],
  "Jaguar Health, Inc.": [
    "San Francisco, CA, USA"
  ],
  "Japan Bioindustry Association": [
    "Tokyo, Japan"
  ],
  "Jene Advisors": [
    "Shanghai, China"
  ],
  "JetStart VC": [
    "San Francisco, CA, USA"
  ],
  "Jiahao Huang": [
    "This is an individual's name, not a company with public locations."
  ],
  "Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd.": [
    "Nanjing, China",
    "Liyang, China"
  ]
}
```
```json
{
  "Johnson & Johnson Innovation": [
    "Cambridge (MA, USA)",
    "San Francisco (CA, USA)",
    "London (UK)",
    "Shanghai (China)",
    "Beerse (Belgium)",
    "San Diego (CA, USA)",
    "New York (NY, USA)"
  ],
  "Johnson & Johnson Innovation - JJDC, Inc.": [
    "New Brunswick (NJ, USA)",
    "Cambridge (MA, USA)",
    "San Francisco (CA, USA)"
  ],
  "Johnston Associates Inc.": [
    "Princeton (NJ, USA)"
  ],
  "Jones Boys Ventures": [
    "Vancouver (BC, Canada)"
  ],
  "JourneyOne Ventures": [
    "San Francisco (CA, USA)"
  ],
  "Joyance Partners": [
    "San Francisco (CA, USA)"
  ],
  "Jubilant Biosys Limited": [
    "Bengaluru (India)",
    "Noida (India)",
    "Malvern (PA, USA)"
  ],
  "Julius Clinical Research B.V.": [
    "Zeist (Netherlands)"
  ],
  "Jupiter Neurosciences": [
    "Jupiter (FL, USA)"
  ],
  "Juvena Therapeutics": [
    "Menlo Park (CA, USA)"
  ],
  "K2 HealthVentures": [
    "New York (NY, USA)",
    "Menlo Park (CA, USA)"
  ],
  "K2X Technology and Life Science (formerly Kyto Technology and Life Science)": [
    "Munich (Germany)"
  ],
  "KARIBU DUKANI": [
    "N/A (No single corporate entity widely known by this name in relevant industries)"
  ],
  "KELES Digital Health": [
    "Berlin (Germany)"
  ],
  "KESA Partners Inc": [
    "New York (NY, USA)"
  ],
  "KIOMED PHARMA": [
    "Montreal (QC, Canada)"
  ],
  "KKH Advisors": [
    "New York (NY, USA)"
  ],
  "KLOTHO NEUROSCIENCES, INC.": [
    "South San Francisco (CA, USA)"
  ],
  "KO Law": [
    "Denver (CO, USA)",
    "Boulder (CO, USA)",
    "San Diego (CA, USA)"
  ],
  "KOTRA": [
    "Seoul (South Korea)",
    "New York (NY, USA)",
    "London (UK)",
    "Tokyo (Japan)",
    "Beijing (China)",
    "Frankfurt (Germany)",
    "Los Angeles (CA, USA)"
  ]
}
```
```json
{
  "KP Healthcare Partners": [
    "Salt Lake City, Utah, USA"
  ],
  "KUPANDO GmbH": [
    "Munich, Germany"
  ],
  "Kaleida Capital": [
    "London, United Kingdom"
  ],
  "Kancera AB": [
    "Huddinge, Sweden"
  ],
  "Kanglin Biotec (Hangzhou) Co., Ltd.": [
    "Hangzhou, China"
  ],
  "Kapoose Creek Bio": [
    "Vancouver, British Columbia, Canada"
  ],
  "KeifeRx": [
    "New York, New York, USA"
  ],
  "Keiretsu Forum": [
    "San Francisco, California, USA",
    "London, United Kingdom",
    "Singapore",
    "Sydney, Australia",
    "Beijing, China"
  ],
  "Kerna Ventures": [
    "Cambridge, Massachusetts, USA"
  ],
  "Key2Meds": [
    "London, United Kingdom"
  ],
  "Keybanc Capital Markets": [
    "Atlanta, Georgia, USA",
    "Boston, Massachusetts, USA",
    "Charlotte, North Carolina, USA",
    "Chicago, Illinois, USA",
    "Cleveland, Ohio, USA",
    "Dallas, Texas, USA",
    "Denver, Colorado, USA",
    "Houston, Texas, USA",
    "Los Angeles, California, USA",
    "New York, New York, USA",
    "Philadelphia, Pennsylvania, USA",
    "Portland, Oregon, USA",
    "San Francisco, California, USA",
    "Seattle, Washington, USA",
    "Stamford, Connecticut, USA",
    "Toronto, Ontario, Canada"
  ],
  "Keylika Inc": [
    "Menlo Park, California, USA"
  ],
  "Keystra Funds": [
    "Zug, Switzerland"
  ],
  "Khosla Ventures": [
    "Menlo Park, California, USA"
  ],
  "Kicker Ventures": [
    "London, United Kingdom"
  ],
  "Kidron Capital Assets": [
    "New York, New York, USA"
  ],
  "Kidswell Bio Corporation": [
    "Tokyo, Japan"
  ],
  "Kindling Investment Partners": [
    "New York, New York, USA"
  ],
  "Kinea Bio, Inc.": [
    "South San Francisco, California, USA"
  ],
  "Kineo Finance": [
    "London, United Kingdom",
    "Amsterdam, Netherlands"
  ]
}
```
```json
{
  "Kinexcs Pte Ltd": [
    "Singapore"
  ],
  "Kinexum": [
    "Boulder, CO, USA",
    "Silicon Valley, CA, USA"
  ],
  "KisoJi Biotechnology Inc.": [
    "Boston, MA, USA",
    "Kobe, Japan"
  ],
  "Kivu Biosciences": [
    "San Francisco, CA, USA"
  ],
  "Komo Biosciences, Inc.": [
    "San Diego, CA, USA"
  ],
  "Koneksa": [
    "New York, NY, USA"
  ],
  "Kowa Research Institute": [
    "Durham, NC, USA"
  ],
  "Kreamedica Holdings Inc.": [
    "Seongnam-si, Gyeonggi-do, South Korea"
  ],
  "Kurma Partners SA": [
    "Paris, France",
    "Munich, Germany"
  ],
  "Kyowa Kirin, Inc": [
    "Princeton, NJ, USA"
  ],
  "Kyung Hee University": [
    "Seoul, South Korea",
    "Suwon, Gyeonggi-do, South Korea",
    "Namyangju, Gyeonggi-do, South Korea"
  ],
  "L&J Bio": [
    "Seongnam-si, Gyeonggi-do, South Korea"
  ],
  "LABORATORIOS RUBIO SA": [
    "Rubí, Barcelona, Spain"
  ],
  "LDV Partners": [
    "New York, NY, USA"
  ],
  "LOUD Capital": [
    "Columbus, OH, USA",
    "Los Angeles, CA, USA"
  ],
  "LPOXY Therapeutics, Inc": [
    "San Francisco, CA, USA"
  ],
  "LRI": [
    "New Brunswick, NJ, USA"
  ],
  "LYFE Capital": [
    "Shanghai, China",
    "Palo Alto, CA, USA"
  ],
  "LYZZ Capital": [
    "Shanghai, China"
  ],
  "Labcorp": [
    "Burlington, NC, USA",
    "San Diego, CA, USA",
    "Indianapolis, IN, USA",
    "Geneva, Switzerland",
    "Singapore"
  ]
}
```
```json
{
  "LabyRx Immuno -Oncology": [
    "San Francisco, CA, USA"
  ],
  "Ladenburg Thalmann & Co": [
    "New York, NY, USA"
  ],
  "Lafana Holding": [
    "Luxembourg"
  ],
  "Lahjavida, Inc.": [
    "Wilmington, DE, USA"
  ],
  "Lair East Labs, LLC": [
    "New York, NY, USA"
  ],
  "LallianSe": [
    "Paris, France"
  ],
  "Landmark Capital Group, Inc.": [
    "Newport Beach, CA, USA"
  ],
  "Latham BioPharm Group": [
    "Cambridge, MA, USA"
  ],
  "LatticePoint Consulting": [
    "Princeton, NJ, USA"
  ],
  "Laurent Pharmaceuticals": [
    "Montreal, Canada"
  ],
  "Laverock Therapeutics": [
    "Edinburgh, Scotland, UK"
  ],
  "Law360": [
    "New York, NY, USA"
  ],
  "Leapfrog Bio": [
    "Zurich, Switzerland"
  ],
  "Leman Biotech": [
    "Geneva, Switzerland"
  ],
  "Leon Precision Capital": [
    "Toronto, Canada"
  ],
  "Levine Media Group / The Bio Report": [
    "New York, NY, USA"
  ],
  "LiVeritas Biosciences, Inc.": [
    "San Mateo, CA, USA"
  ],
  "Liberi Group": [
    "London, UK"
  ],
  "Life Science Angels": [
    "San Francisco Bay Area, CA, USA"
  ],
  "Life Science Connect": [
    "Erie, PA, USA"
  ]
}
```
```json
{
  "Life Sciences British Columbia": [
    "Vancouver, British Columbia, Canada"
  ],
  "LifeLens Technologies": [
    "San Diego, California, USA"
  ],
  "LifeLink Ventures": [
    "Palo Alto, California, USA"
  ],
  "Lifespan Vision Ventures LLC": [
    "Newton, Massachusetts, USA"
  ],
  "Lift Biosciences Ltd": [
    "London, England, United Kingdom"
  ],
  "Liftt": [
    "Montreal, Quebec, Canada"
  ],
  "LigaChem Biosciences (formerly LegoChem Biosciences)": [
    "Daejeon, Republic of Korea",
    "Cambridge, Massachusetts, USA"
  ],
  "Lightbank": [
    "Chicago, Illinois, USA"
  ],
  "Lightstone Ventures": [
    "Palo Alto, California, USA",
    "Cambridge, Massachusetts, USA"
  ],
  "Lilac Therapuetics": [
    "San Francisco, California, USA"
  ],
  "Lime Therapeutics": [
    "San Diego, California, USA"
  ],
  "LincSwitch Therapeutics, Inc.": [
    "San Francisco, California, USA"
  ],
  "Lincoln Park Capital Fund, LLC": [
    "Chicago, Illinois, USA"
  ],
  "Linear Clinical Research": [
    "Perth, Australia"
  ],
  "Lingmed Limited": [
    "Beijing, China"
  ],
  "Lipo -Immuno Tech, LLC": [
    "North Bethesda, Maryland, USA"
  ],
  "Liscure Biosciences": [
    "Gyeonggi-do, Republic of Korea"
  ],
  "Live.Long.Life": [
    "Hong Kong"
  ],
  "Livionex Inc.": [
    "San Jose, California, USA"
  ],
  "Livivos Inc": [
    "San Diego, California, USA"
  ]
}
```
```json
{
  "Lmito Therapeutics Inc.": [
    "Cambridge, Massachusetts, USA"
  ],
  "Locust Walk": [
    "Boston, Massachusetts, USA",
    "San Francisco, California, USA",
    "New York, New York, USA",
    "London, UK",
    "Tokyo, Japan",
    "Paris, France",
    "Zurich, Switzerland"
  ],
  "LongGame Venture Capital": [
    "San Francisco Bay Area, California, USA"
  ],
  "LongeVC": [
    "Riga, Latvia"
  ],
  "Longeveron Inc.": [
    "Miami, Florida, USA"
  ],
  "Longview Innovation": [
    "Philadelphia, Pennsylvania, USA"
  ],
  "Longwood Biopharmaceuticals Co., Ltd.": [
    "Shanghai, China"
  ],
  "Lonza Biologics": [
    "Basel, Switzerland",
    "Portsmouth, New Hampshire, USA",
    "Slough, UK",
    "Visp, Switzerland",
    "Porriño, Spain",
    "Singapore",
    "Guangzhou, China",
    "Houston, Texas, USA",
    "Hayward, California, USA",
    "Geleen, Netherlands"
  ],
  "LoopLab Bio GmbH": [
    "Berlin, Germany"
  ],
  "Lotte Holdings": [
    "Seoul, South Korea",
    "Tokyo, Japan",
    "New York, New York, USA",
    "Moscow, Russia",
    "Ho Chi Minh City, Vietnam",
    "Shanghai, China",
    "Jakarta, Indonesia"
  ],
  "Lowenstein Sandler": [
    "Roseland, New Jersey, USA",
    "New York, New York, USA",
    "Palo Alto, California, USA",
    "Washington, D.C., USA",
    "Boston, Massachusetts, USA"
  ],
  "Loxigen": [
    "Philadelphia, Pennsylvania, USA"
  ],
  "Loyal Valley Capital": [
    "Shanghai, China",
    "Hong Kong, China"
  ],
  "Ludicrous Ventures": [
    "San Francisco, California, USA"
  ],
  "Lumanity": [
    "London, UK",
    "Boston, Massachusetts, USA",
    "New York, New York, USA",
    "San Francisco, California, USA",
    "Toronto, Canada",
    "Basel, Switzerland",
    "Munich, Germany",
    "Tokyo, Japan",
    "Shanghai, China"
  ],
  "Luminous Therapeutics": [
    "Cambridge, Massachusetts, USA"
  ],
  "Lumira Ventures": [
    "Toronto, Ontario, Canada",
    "Montreal, Quebec, Canada",
    "Boston, Massachusetts, USA",
    "Vancouver, British Columbia, Canada"
  ],
  "Lunar Biosciences": [
    "Cambridge, Massachusetts, USA"
  ],
  "Lunar Ventures": [
    "Berlin, Germany"
  ],
  "Lupin Inc": [
    "Mumbai, India",
    "Baltimore, Maryland, USA",
    "Somerset, New Jersey, USA",
    "Amsterdam, Netherlands",
    "Tokyo, Japan",
    "Mexico City, Mexico",
    "Johannesburg, South Africa",
    "Sydney, Australia",
    "Paris, France"
  ]
}
```
```json
{
  "Lymo Ventures": [
    "San Francisco, California, United States"
  ],
  "Lynx Dx": [
    "Ann Arbor, Michigan, United States"
  ],
  "Lynx Financial": [
    "New York, New York, United States",
    "Boston, Massachusetts, United States",
    "Los Angeles, California, United States",
    "Denver, Colorado, United States"
  ],
  "LynxDx, Inc.": [
    "Ann Arbor, Michigan, United States"
  ],
  "M Ventures": [
    "Amsterdam, Netherlands",
    "Boston, Massachusetts, United States",
    "Darmstadt, Germany",
    "Menlo Park, California, United States",
    "Tel Aviv, Israel"
  ],
  "M.I.A.M.I. AI Ventures & Future Fortune Fund": [
    "Miami, Florida, United States"
  ],
  "M.S.Q. Ventures Inc.": [
    "New York, New York, United States",
    "Shanghai, China"
  ],
  "MAIA BIOTECHNOLOGY INC": [
    "Chicago, Illinois, United States"
  ],
  "MAPREG": [
    "Paris, France"
  ],
  "MC Services, Inc.": [
    "Dusseldorf, Germany",
    "Munich, Germany",
    "Boston, Massachusetts, United States",
    "San Francisco, California, United States"
  ],
  "MD Anderson Cancer Center": [
    "Houston, Texas, United States",
    "League City, Texas, United States",
    "The Woodlands, Texas, United States",
    "Sugar Land, Texas, United States",
    "Katy, Texas, United States",
    "Nassau Bay, Texas, United States",
    "Bellaire, Texas, United States",
    "Cypress, Texas, United States"
  ],
  "MDB Capital Holdings": [
    "Santa Monica, California, United States"
  ],
  "MEDiC Life Sciences": [
    "Houston, Texas, United States"
  ],
  "MEKanistic Therapeutics, Inc.": [
    "Cambridge, Massachusetts, United States"
  ],
  "MFI, Inc.": [
    "Lincoln, Rhode Island, United States"
  ],
  "MICHBIO": [
    "Ann Arbor, Michigan, United States"
  ],
  "MIDI Medical Development": [
    "Irvine, California, United States"
  ],
  "MII Fund": [
    "Columbia, Maryland, United States"
  ],
  "MILKY WAY INVESTMENTS": [
    "New York, New York, United States",
    "London, United Kingdom"
  ],
  "MJH LIFE SCIENCES": [
    "Cranbury, New Jersey, United States"
  ]
}
```
```json
{
  "MKC Biotherapeutics, Inc.": [
    "Cambridge, MA, USA"
  ],
  "MM +M": [
    "New York, NY, USA",
    "London, UK"
  ],
  "MOLCURE Inc.": [
    "Yokohama, Japan"
  ],
  "MP Healthcare Venture Management": [
    "Boston, MA, USA"
  ],
  "MPC Investments": [
    "Hamburg, Germany"
  ],
  "MQB Partners Limited": [
    "London, UK"
  ],
  "MRL Ventures Fund, Merck": [
    "Cambridge, MA, USA",
    "South San Francisco, CA, USA"
  ],
  "MRM Health": [
    "Ghent, Belgium"
  ],
  "MULTIGENIX": [
    "Princeton, NJ, USA"
  ],
  "Mabion S.A.": [
    "Konstancin-Jeziorna, Poland"
  ],
  "Macuject Pty Ltd": [
    "Brisbane, Australia"
  ],
  "Magnet Ventures": [
    "San Francisco, CA, USA"
  ],
  "Magsorbeo Biomedical": [
    "Singapore"
  ],
  "MaidStone Life Sciences": [
    "Ann Arbor, MI, USA"
  ],
  "Mannin Research": [
    "Toronto, Canada"
  ],
  "Manta Ray": [
    "Berlin, Germany",
    "London, UK"
  ],
  "March of Dimes": [
    "Arlington, VA, USA"
  ],
  "Marengo Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "Maruho": [
    "Osaka, Japan",
    "Gotemba, Japan",
    "Tamba, Japan"
  ],
  "Maryland Department of Commerce": [
    "Baltimore, MD, USA",
    "Germany",
    "UK",
    "China",
    "Taiwan",
    "Japan",
    "South Korea",
    "Israel",
    "India",
    "UAE",
    "Ethiopia",
    "Nigeria",
    "Australia",
    "Brazil",
    "Mexico"
  ]
}
```
```json
{
  "Maryland Tech Council": [
    "Rockville, Maryland, USA"
  ],
  "MassBio": [
    "Cambridge, Massachusetts, USA"
  ],
  "MassMutual Ventures": [
    "Boston, Massachusetts, USA",
    "London, UK",
    "Singapore"
  ],
  "Matisse Pharmaceuticals B.V.": [
    "Maastricht, The Netherlands"
  ],
  "Mauve Social": [
    "Remote"
  ],
  "Maxwell Biosciences, Inc.": [
    "Austin, Texas, USA"
  ],
  "Mayewell Capital": [
    "Sydney, Australia"
  ],
  "Mayo Clinic Ventures": [
    "Rochester, Minnesota, USA"
  ],
  "McKesson Compile": [
    "Irving, Texas, USA"
  ],
  "McQuade Center for Strategic Research & Development": [
    "Lawrence, Kansas, USA"
  ],
  "Mecwins SA": [
    "Madrid, Spain"
  ],
  "Med-Fine Capital": [
    "Hong Kong"
  ],
  "MedTech Advantage Fund": [
    "Cincinnati, Ohio, USA"
  ],
  "MedTech Strategist": [
    "South San Francisco, California, USA"
  ],
  "Medexplore Ventures": [
    "Paris, France"
  ],
  "Medical Excellence Capital": [
    "Palo Alto, California, USA"
  ],
  "Medical Incubator Japan K.K.": [
    "Tokyo, Japan"
  ],
  "Medicenna Therapeutics": [
    "Toronto, Ontario, Canada"
  ],
  "Medico Distribution DMCC": [
    "Dubai, UAE"
  ],
  "Medipal Holdings Corporation": [
    "Tokyo, Japan"
  ]
}
```
```json
{
  "Mediphage": [
    "Toronto, Canada"
  ],
  "Mediwhale": [
    "San Francisco, California, USA",
    "Seoul, South Korea"
  ],
  "Meiji Pharma USA Inc.": [
    "Parsippany, New Jersey, USA"
  ],
  "Meltwind": [
    "London, UK"
  ],
  "Men's Health - Sarah Richards": [
    "Not Applicable (individual writer/editor)"
  ],
  "Merck & Co., Inc.": [
    "Rahway, New Jersey, USA",
    "Kenilworth, New Jersey, USA",
    "Upper Gwynedd, Pennsylvania, USA",
    "West Point, Pennsylvania, USA",
    "Boston, Massachusetts, USA",
    "South San Francisco, California, USA",
    "London, UK",
    "Tokyo, Japan",
    "Singapore"
  ],
  "Merck Digital Sciences Studio": [
    "Boston, Massachusetts, USA",
    "South San Francisco, California, USA",
    "Rahway, New Jersey, USA"
  ],
  "Merck KGaA, Darmstadt, Germany": [
    "Darmstadt, Germany",
    "Billerica, Massachusetts, USA",
    "Rockland, Massachusetts, USA",
    "Molsheim, France",
    "Tokyo, Japan"
  ],
  "Mercury": [
    "San Francisco, California, USA"
  ],
  "Mercury Bio": [
    "San Francisco, California, USA"
  ],
  "Merge Therapeutics": [
    "Durham, North Carolina, USA"
  ],
  "Mergermarket - ION Analytics Group": [
    "London, UK",
    "New York, New York, USA",
    "Hong Kong",
    "Singapore",
    "Dubai, UAE",
    "Frankfurt, Germany"
  ],
  "Meritage Venture Group": [
    "Denver, Colorado, USA"
  ],
  "Mesa Verde Venture Partners": [
    "San Diego, California, USA"
  ],
  "Mesh Bio": [
    "Singapore"
  ],
  "Mesoblast": [
    "Melbourne, Australia",
    "New York, New York, USA"
  ],
  "Methuselah Fund": [
    "Springfield, Virginia, USA"
  ],
  "MetrioPharm AG": [
    "Berlin, Germany"
  ],
  "Meyers Investments Family LP": [
    "Los Altos, California, USA"
  ],
  "Michigan Capital Network": [
    "Grand Rapids, Michigan, USA"
  ]
}
```
```json
{
  "Micron Biomedical, Inc": ["Atlanta, GA, USA"],
  "Microplate Dx": ["South San Francisco, CA, USA"],
  "Microvascular Therapeutics, Inc": ["Boulder, CO, USA"],
  "Mid Atlantic Bio Angels": ["New York, NY, USA"],
  "Mighty Spark Communications": ["New York, NY, USA"],
  "Militia Hill Ventures": ["Blue Bell, PA, USA"],
  "Milkomeda Capital": ["London, UK"],
  "Mind Pharmaceuticals Corporation": ["Lexington, MA, USA"],
  "MindImmune Therapeutics, Inc.": ["Newport, RI, USA"],
  "MindRank": ["Guangzhou, China", "Boston, MA, USA"],
  "Mineralys Therapeutics": ["Radnor, PA, USA"],
  "Minnow ventures": ["London, UK"],
  "Mint Venture Partners, Inc.": ["Menlo Park, CA, USA"],
  "MiraBiologics": ["Menlo Park, CA, USA"],
  "Misogi Labs": ["London, UK"],
  "Mission BioCapital": ["Cambridge, MA, USA"],
  "MitoRx Therapeutics Limited": ["Oxford, UK"],
  "Mitomed Pharma Inc.": ["Fremont, CA, USA"],
  "MitrAssist Lifesciences Limited": ["London, UK"],
  "Mitsubishi Tanabe Pharma": ["Osaka, Japan", "Boston, MA, USA", "London, UK"]
}
```
```json
{
  "Mitsubishi UFJ Capital Co.,Ltd.": [
    "Tokyo, Japan"
  ],
  "Mitsui Global Investment": [
    "Tokyo, Japan"
  ],
  "Mobius Scientific, Inc.": [
    "San Carlos, CA, USA"
  ],
  "Mochida Pharmaceutical Co., Ltd.": [
    "Tokyo, Japan",
    "Gotemba, Japan",
    "Shiga, Japan",
    "Fuji, Japan",
    "Hanamaki, Japan"
  ],
  "Modality.AI, Inc.": [
    "Berkeley, CA, USA"
  ],
  "Modi Venture": [
    "New Delhi, India"
  ],
  "MoglingBio": [
    "Freiburg, Germany"
  ],
  "Molecular You": [
    "Vancouver, BC, Canada"
  ],
  "Molecule to Market": [
    "San Diego, CA, USA",
    "London, UK"
  ],
  "Momentum Biotech": [
    "San Diego, CA, USA"
  ],
  "Montrose Capital Partners": [
    "Greenwich, CT, USA"
  ],
  "Moore Capital": [
    "New York, NY, USA",
    "London, UK"
  ],
  "Moore Venture Partners": [
    "Sausalito, CA, USA"
  ],
  "Morgan Stanley": [
    "New York, NY, USA",
    "London, UK",
    "Hong Kong",
    "Tokyo, Japan",
    "Mumbai, India",
    "Sydney, Australia",
    "Frankfurt, Germany"
  ],
  "Morningside Ventures": [
    "Cambridge, MA, USA"
  ],
  "Morphocell Technologies": [
    "Toronto, ON, Canada"
  ],
  "Mosaica Therapeutics": [
    "La Jolla, CA, USA"
  ],
  "MultiOmic Health Limited": [
    "Cambridge, UK"
  ],
  "Multimeric Biotherapeutics, Inc.": [
    "San Diego, CA, USA"
  ],
  "Mustbio": [
    "Singapore"
  ]
}
```
```json
{
  "Myostellar": [
    "Basel, Switzerland"
  ],
  "Myria Biosciences AG": [
    "Basel, Switzerland"
  ],
  "Myrio Therapeutics Pty Ltd": [
    "Melbourne, Australia"
  ],
  "NACO Canada": [
    "Toronto, Ontario, Canada"
  ],
  "NAYA Biosciences": [
    "Cambridge, MA, USA",
    "London, UK"
  ],
  "NEUMOUS INC.": [
    "Berkeley, CA, USA"
  ],
  "NEVA SGR": [
    "Rome, Italy",
    "Milan, Italy"
  ],
  "NEXA BIO PARTNERS": [
    "Singapore"
  ],
  "NFL Biosciences": [
    "Montpellier, France"
  ],
  "NFX capital": [
    "San Francisco, CA, USA",
    "Palo Alto, CA, USA"
  ],
  "NH Theraguix": [
    "Grenoble, France"
  ],
  "NIA/NIH": [
    "Bethesda, MD, USA"
  ],
  "NIBEC Co.,Ltd.": [
    "Seoul, South Korea"
  ],
  "NINDS": [
    "Bethesda, MD, USA"
  ],
  "NKILT Therapeutics, Inc.": [
    "Cambridge, MA, USA"
  ],
  "NOBO Medicine Inc.": [
    "Philadelphia, PA, USA"
  ],
  "NS Pharma Inc.": [
    "Paramus, NJ, USA"
  ],
  "NSIP LLC": [
    "Albuquerque, NM, USA"
  ],
  "NUAgo Therapeutics Inc": [
    "Saskatoon, Saskatchewan, Canada"
  ],
  "NUP -CTx Inc.": [
    "Hanam City, Gyeonggi Province, South Korea"
  ]
}
```
```json
{
  "NUTSHELL THERAPEUTICS": [
    "Cambridge, MA, USA"
  ],
  "NY Ventures at Empire State Development": [
    "New York, NY, USA",
    "Albany, NY, USA"
  ],
  "Nabugen Therapeutics": [
    "New Haven, CT, USA"
  ],
  "Nalu Bio": [
    "San Diego, CA, USA"
  ],
  "Nammi Therapeutics, Inc.": [
    "San Francisco, CA, USA"
  ],
  "Nano4Imaging GmbH": [
    "Aachen, Germany"
  ],
  "NanoSyrinx Ltd": [
    "Oxford, UK"
  ],
  "NanoViricides, Inc.": [
    "Shelton, CT, USA"
  ],
  "Nanobiotix": [
    "Paris, France",
    "Cambridge, MA, USA"
  ],
  "Nanograb": [
    "Daejeon, South Korea"
  ],
  "Nanopath": [
    "Cambridge, MA, USA"
  ],
  "Narwhal Bio, Inc": [
    "Cambridge, MA, USA"
  ],
  "Nasdaq": [
    "New York, NY, USA",
    "Stockholm, Sweden",
    "London, UK",
    "San Francisco, CA, USA",
    "Boston, MA, USA",
    "Vilnius, Lithuania"
  ],
  "National Newspaper Publishers Association": [
    "Washington D.C., USA"
  ],
  "Nature Portfolio, Evaluate": [
    "London, UK",
    "Boston, MA, USA",
    "New York, NY, USA",
    "Heidelberg, Germany"
  ],
  "Navigo Proteins": [
    "Braunschweig, Germany"
  ],
  "NeoVascularX, Inc.": [
    "San Mateo, CA, USA"
  ],
  "Neoventures Biotechnology Europe": [
    "London, UK"
  ],
  "Nest Catalyst Ventures": [
    "Hong Kong"
  ],
  "NeuExcell Therapeutics Inc": [
    "Gaithersburg, MD, USA"
  ]
}
```
```json
{
  "Neuland Laboratories Inc": [
    "Hyderabad, India",
    "Bonthapally, India",
    "Pashamylaram, India",
    "Gummadidala, India"
  ],
  "NeuraViva Therapeutics, Inc.": [
    "San Diego, CA, USA"
  ],
  "Neurenati Therapeutics Inc": [
    "Boston, MA, USA"
  ],
  "Neurocentrx Pharma Ltd": [
    "London, UK"
  ],
  "Neuroelectrics USA Corporation": [
    "Cambridge, MA, USA"
  ],
  "Neurotech Reports": [
    "San Francisco, CA, USA"
  ],
  "Neuvation Ventures": [
    "San Diego, CA, USA"
  ],
  "New England Hemolytics Inc.": [
    "Burlington, MA, USA"
  ],
  "New Frontier Enterprises, LLC": [
    "Princeton, NJ, USA"
  ],
  "New Perspectives, Inc": [
    "Basking Ridge, NJ, USA"
  ],
  "New Rhein Healthcare Investors": [
    "New York, NY, USA"
  ],
  "New Science Fund": [
    "San Francisco, CA, USA"
  ],
  "NewCo Biotech, Inc.": [
    "Cambridge, MA, USA"
  ],
  "NewYorkBio": [
    "New York, NY, USA"
  ],
  "Nex3": [
    "Cambridge, MA, USA"
  ],
  "NextRNA Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "Niche Biopharmaceuticals, LLC": [
    "Exton, PA, USA"
  ],
  "Nielsen BioSciences": [
    "San Diego, CA, USA"
  ],
  "Nieuw Amsterdam Advisors, LLC": [
    "New York, NY, USA"
  ],
  "Nippon Shinyaku Co. Ltd": [
    "Kyoto, Japan",
    "Parsippany, NJ, USA",
    "London, UK",
    "Munich, Germany"
  ]
}
```
```json
{
  "Niremia Collective": [
    "San Francisco, California, USA"
  ],
  "Nkarta": [
    "South San Francisco, California, USA"
  ],
  "No Patient Left Behind": [
    "Washington D.C., USA",
    "New York City, New York, USA"
  ],
  "Noa Therapeutics": [
    "Boston, Massachusetts, USA"
  ],
  "Noble Capital Markets": [
    "Boca Raton, Florida, USA",
    "New York City, New York, USA",
    "London, UK",
    "Boston, Massachusetts, USA",
    "San Francisco, California, USA"
  ],
  "Nodal Therapeutics": [
    "Cambridge, Massachusetts, USA"
  ],
  "Nodenza Venture Partners": [
    "Zug, Switzerland"
  ],
  "Nodes Advisors AG": [
    "Zurich, Switzerland"
  ],
  "Nordmark Pharma GmbH": [
    "Uetersen, Germany",
    "Hamburg, Germany"
  ],
  "Norstella": [
    "Yardley, Pennsylvania, USA",
    "London, UK",
    "Boston, Massachusetts, USA",
    "New York City, New York, USA",
    "Morrisville, North Carolina, USA"
  ],
  "North South Ventures": [
    "New York City, New York, USA"
  ],
  "Northlea Partners LLLP": [
    "New York City, New York, USA"
  ],
  "Norwest Venture Partners": [
    "Palo Alto, California, USA",
    "Bangalore, India"
  ],
  "Notogen, Inc.": [
    "Berkeley, California, USA"
  ],
  "NovaCina": [
    "Perth, Australia",
    "Adelaide, Australia"
  ],
  "NovaQuest Capital Management": [
    "Raleigh, North Carolina, USA"
  ],
  "Novago Therapeutics": [
    "Basel, Switzerland"
  ],
  "Novalis II General Partner BV": [
    "Ghent, Belgium"
  ],
  "Novastage Pharmaceuticals, Ltd.": [
    "Seoul, South Korea"
  ],
  "Novateur Ventures Inc.": [
    "Vancouver, British Columbia, Canada"
  ]
}
```
```json
{
  "Novatio Ventures": ["Boston, MA, USA"],
  "Novel Biotechnology Inc.": ["New York, NY, USA"],
  "Novigenix SA": ["Epalinges, Switzerland"],
  "Novo Holdings": ["Copenhagen, Denmark", "Boston, MA, USA", "San Francisco, CA, USA", "London, UK"],
  "Novo Nordisk": [
    "Bagsværd, Denmark",
    "Plainsboro, NJ, USA",
    "Kalundborg, Denmark",
    "Måløv, Denmark",
    "Zürich, Switzerland",
    "Seattle, WA, USA",
    "Oxford, UK",
    "Indianapolis, IN, USA",
    "Clayton, NC, USA"
  ],
  "Novotech": [
    "Sydney, Australia",
    "San Francisco, CA, USA",
    "Boston, MA, USA",
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong",
    "Seoul, South Korea",
    "Taipei, Taiwan",
    "Singapore",
    "Kuala Lumpur, Malaysia",
    "Bangkok, Thailand",
    "Manila, Philippines",
    "New Delhi, India",
    "Tokyo, Japan"
  ],
  "Nucleus Network": ["Melbourne, Australia", "Brisbane, Australia", "Minneapolis, MN, USA"],
  "Nucro -Technics": ["Toronto, ON, Canada"],
  "NuevaBio LLC": ["Miami, FL, USA"],
  "Nutmeg": ["London, UK"],
  "NuvOx Theraputics": ["Tucson, AZ, USA"],
  "OBI Pharma USA, Inc": ["South San Francisco, CA, USA"],
  "OBIO": ["Toronto, ON, Canada"],
  "OCMS Bio, LLC": ["San Diego, CA, USA"],
  "ONCOCROSS": ["Seoul, South Korea"],
  "ONEGENE BIOTECHNOLOGY": ["Taipei, Taiwan"],
  "ONO PHARMA USA, INC.": ["Cambridge, MA, USA", "South San Francisco, CA, USA"],
  "OPIS": [
    "Rockville, MD, USA",
    "Houston, TX, USA",
    "London, UK",
    "Singapore",
    "Kuala Lumpur, Malaysia",
    "Sydney, Australia"
  ],
  "ORCA Therapeutics": ["Rotterdam, Netherlands"],
  "OXcan": ["Oxford, UK"]
}
```
```json
{
  "Oath Surgical": [
    "Redwood City, CA, USA"
  ],
  "Object Pharma": [
    "London, UK"
  ],
  "Oblique Therapeutics": [
    "Gothenburg, Sweden"
  ],
  "Oblita Therapeutics": [
    "San Diego, CA, USA"
  ],
  "Octane Bio LLC": [
    "Cambridge, MA, USA"
  ],
  "Oculis": [
    "Lausanne, Switzerland",
    "Boston, MA, USA",
    "Reykjavik, Iceland"
  ],
  "Ohio Life Sciences": [],
  "Oji Pharma": [
    "Princeton, NJ, USA"
  ],
  "Olfera": [
    "Boston, MA, USA"
  ],
  "Olon USA": [
    "Concord, OH, USA",
    "Rochester, NY, USA",
    "Germantown, WI, USA"
  ],
  "Omios Biologics": [
    "Paris, France"
  ],
  "OmniaBio Inc.": [
    "Hamilton, Ontario, Canada"
  ],
  "Omniscope Inc": [
    "San Diego, CA, USA"
  ],
  "OncoRx Insights": [],
  "Oncodea Corporation": [
    "Houston, TX, USA"
  ],
  "Oncolytics Biotech INC.": [
    "Calgary, Alberta, Canada",
    "San Diego, CA, USA",
    "Cambridge, MA, USA",
    "London, UK"
  ],
  "Onconox Inc.": [
    "Irvine, CA, USA"
  ],
  "Oncoshot Pte Ltd": [
    "Singapore",
    "Bangalore, India"
  ],
  "Oncoustics": [
    "Waterloo, Ontario, Canada"
  ],
  "One Six 8 Ventures": [
    "San Francisco, CA, USA"
  ]
}
```
```json
{
  "One Therapeutics Assets Limited": [
    "Sutton, UK"
  ],
  "OniX Hub & Ventures": [
    "London, UK",
    "Bangkok, Thailand"
  ],
  "Only Orphans Cote": [
    "Ndola, Zambia"
  ],
  "Ontario Government": [
    "Toronto, Ontario, Canada"
  ],
  "Onyx": [
    "Sunderland, UK"
  ],
  "Opharmic Technology (HK) Limited": [
    "Hong Kong, China",
    "Waltham, MA, USA"
  ],
  "Oppenheimer & Co.": [
    "New York, NY, USA",
    "Boston, MA, USA",
    "London, UK",
    "Tel Aviv, Israel"
  ],
  "Oppilotech Ltd": [
    "London, UK"
  ],
  "Opthea": [
    "Melbourne, Australia",
    "Redwood City, CA, USA"
  ],
  "Optimum Strategic Communications": [
    "London, UK"
  ],
  "Opus8, Inc.": [
    "San Francisco, CA, USA"
  ],
  "Oracle Investment Management": [
    "New York, NY, USA"
  ],
  "Orange Grove Bio": [
    "Cincinnati, OH, USA",
    "New York, NY, USA"
  ],
  "OrbiMed": [
    "New York, NY, USA",
    "San Francisco, CA, USA",
    "Shanghai, China",
    "Herzliya, Israel",
    "London, UK",
    "Mumbai, India"
  ],
  "Orbit Discovery Ltd": [
    "Oxford, UK"
  ],
  "Ordaos Bio": [
    "Paris, France"
  ],
  "Oregon Bioscience Association": [
    "Portland, OR, USA"
  ],
  "Oregon Venture Fund": [
    "Portland, OR, USA"
  ],
  "Oresund Capital": [
    "Copenhagen, Denmark"
  ],
  "Ori Biotech": [
    "London, UK",
    "Milford, CT, USA"
  ]
}
```
```json
{
  "Origenis GmbH": ["Martinsried, Germany"],
  "Orikine Bio, S.L.": ["Barcelona, Spain"],
  "Orio Therapeutics": ["Baltimore, MD, USA"],
  "Orion Corporation Orion Pharma": ["Espoo, Finland", "Turku, Finland", "Oulu, Finland", "Kuopio, Finland", "Salo, Finland", "Nottingham, UK", "Stockholm, Sweden"],
  "Orion Therapeutics, Inc.": ["Cambridge, MA, USA"],
  "Orizuru Therapeutics, Inc.": ["Cambridge, MA, USA"],
  "Osaka University": ["Suita, Osaka, Japan", "Toyonaka, Osaka, Japan", "Minoh, Osaka, Japan"],
  "Osaka University Venture Capital Co., Ltd.": ["Suita, Osaka, Japan"],
  "Osmol Therapeutics, Inc.": ["Cambridge, MA, USA"],
  "Ostau Marque": [],
  "Osteogen Technology Corp.": ["Taipei, Taiwan"],
  "Outcome Capital": ["Boston, MA, USA"],
  "Outrun Therapeutics": ["Barcelona, Spain"],
  "Overseas Pharmaceuticals": ["Kolkata, India"],
  "Owl Therapeutics": ["Tokyo, Japan"],
  "OxSonics Therapeutics": ["Oxford, UK"],
  "Oxford Finance": ["Alexandria, VA, USA", "San Diego, CA, USA", "Palo Alto, CA, USA", "Boston, MA, USA"],
  "Oxford Medical Products Limited": ["Oxford, UK"],
  "P95": ["Leuven, Belgium", "Antwerp, Belgium"],
  "PDX Pharmaceuticals": ["Portland, OR, USA"]
}
```
```json
{
  "PG Pharma": [
    "Hyderabad, India",
    "Roorkee, India"
  ],
  "PHIOGEN": [
    "Gyeonggi-do, South Korea"
  ],
  "PNAS Therapeutics Ltd": [
    "Cambridge, UK"
  ],
  "POP Biotechnologies": [
    "Gainesville, Florida, USA"
  ],
  "POSTECH": [
    "Pohang, South Korea"
  ],
  "PRISM BioLab Co., Ltd.": [
    "Tokyo, Japan",
    "Kawasaki, Japan"
  ],
  "PROMISS Diagnostics, Inc.": [
    "Vancouver, British Columbia, Canada"
  ],
  "PRONAV Clinical": [
    "Research Triangle Park, North Carolina, USA"
  ],
  "PTM Therapeutics, Inc.": [
    "Cambridge, Massachusetts, USA"
  ],
  "PURMX Therapeutics, Inc.": [
    "Vancouver, British Columbia, Canada"
  ],
  "PURPLE BIOTECH": [
    "Daejeon, South Korea"
  ],
  "Pace Life Sciences": [
    "Minneapolis, Minnesota, USA",
    "San Jose, California, USA",
    "San Diego, California, USA",
    "Woburn, Massachusetts, USA",
    "Shanghai, China"
  ],
  "Pacific 8 Ventures": [
    "Vancouver, British Columbia, Canada"
  ],
  "Pacylex Pharmaceuticals, Inc.": [
    "Edmonton, Alberta, Canada"
  ],
  "PairX Bio": [
    "Oxford, UK"
  ],
  "Paladin Capital Group": [
    "Washington, D.C., USA",
    "New York, New York, USA",
    "London, UK",
    "Silicon Valley, California, USA"
  ],
  "Palden Management LLC": [
    "New York, New York, USA"
  ],
  "Pan Cancer T": [
    "Leiden, Netherlands"
  ],
  "Panacea Venture": [
    "San Francisco, California, USA",
    "Shanghai, China"
  ],
  "Panakes Partners SGRSPA": [
    "Milan, Italy"
  ]
}
```
```json
{
  "Pandect Bioventures": [
    "San Francisco, CA"
  ],
  "Pangen Fund I GP LLC": [
    "New York, NY"
  ],
  "Panorama Research, Inc.": [
    "La Jolla, CA"
  ],
  "Pappas Capital": [
    "Research Triangle Park, NC"
  ],
  "Paradigm Capital": [
    "San Francisco, CA",
    "New York, NY"
  ],
  "Parexel International": [
    "Newton, MA",
    "Durham, NC",
    "Berlin, Germany",
    "Hyderabad, India",
    "Singapore"
  ],
  "Particular Ventures LLC": [
    "Miami, FL"
  ],
  "Path Fertility": [
    "New York, NY"
  ],
  "Pathway Bioventures": [
    "San Diego, CA"
  ],
  "Pattern Computer": [
    "Bellevue, WA"
  ],
  "Pattern Pharma Inc.": [
    "Cambridge, MA"
  ],
  "Pear VC": [
    "Palo Alto, CA",
    "New York, NY"
  ],
  "Pearl Holdings Acquisition Corp": [
    "Richardson, TX"
  ],
  "Perceptive Advisors": [
    "New York, NY"
  ],
  "Peregrine Ventures": [
    "Herzliya Pituach, Israel"
  ],
  "Perfusion Medical": [
    "Los Gatos, CA"
  ],
  "Perseo pharma AG": [
    "Zürich, Switzerland"
  ],
  "Perseverance Capital Advisors LLC": [
    "New York, NY"
  ],
  "Persica Pharmaceuticals Ltd": [
    "Cheadle, UK"
  ],
  "Perspective Therapeutics": [
    "Coronado, CA",
    "Indianapolis, IN"
  ]
}
```
```json
{
  "Phaim Pharma": [
    "Basel, Switzerland"
  ],
  "PharmEnable Therapeutics Limited": [
    "Cambridge, UK"
  ],
  "Pharma Capital Partners": [
    "New York, NY, USA"
  ],
  "Pharma Manufacturing": [
    "Ramsey, NJ, USA"
  ],
  "PharmaCatalyst": [
    "San Francisco, CA, USA"
  ],
  "Pharmaphorum": [
    "London, UK"
  ],
  "Pharmascience Inc": [
    "Montreal, Quebec, Canada"
  ],
  "PharmassetX": [
    "Cambridge, MA, USA"
  ],
  "Phase Capital": [
    "London, UK"
  ],
  "Phase Scientific International Ltd (HK)": [
    "Hong Kong",
    "Santa Clara, CA, USA"
  ],
  "Phase Two Ventures": [
    "Sydney, Australia"
  ],
  "Phecda Medicine Co., Ltd.": [
    "Shanghai, China"
  ],
  "Philadelphia Business Journal": [
    "Philadelphia, PA, USA"
  ],
  "Philips": [
    "Amsterdam, Netherlands",
    "Cambridge, MA, USA",
    "Eindhoven, Netherlands",
    "Shanghai, China",
    "Bangalore, India"
  ],
  "Phoenix Venture Partners": [
    "Menlo Park, CA, USA"
  ],
  "Photonfund": [
    "London, UK"
  ],
  "PhotoniCare": [
    "Champaign, IL, USA"
  ],
  "Phrontline Biopharma": [
    "Cambridge, MA, USA"
  ],
  "Physiologas Technologies Inc.": [
    "Toronto, Ontario, Canada"
  ],
  "Picodya Technologies Ltd.": [
    "Rehovot, Israel"
  ]
}
```
```json
{
  "Pictura Bio": [
    "Cambridge, MA, USA"
  ],
  "Pilatus Biosciences SA": [
    "Lugano, Switzerland"
  ],
  "Pin Therapeutics": [
    "San Diego, CA, USA"
  ],
  "Piper Sandler": [
    "Aberdeen, UK",
    "Atlanta, GA, USA",
    "Austin, TX, USA",
    "Baltimore, MD, USA",
    "Beijing, China",
    "Belfast, UK",
    "Boston, MA, USA",
    "Charlotte, NC, USA",
    "Chicago, IL, USA",
    "Cleveland, OH, USA",
    "Dallas, TX, USA",
    "Denver, CO, USA",
    "Dublin, Ireland",
    "Edinburgh, UK",
    "Geneva, Switzerland",
    "Hong Kong",
    "Houston, TX, USA",
    "Irvine, CA, USA",
    "Kansas City, MO, USA",
    "London, UK",
    "Los Angeles, CA, USA",
    "Manchester, UK",
    "Minneapolis, MN, USA",
    "Nashville, TN, USA",
    "New York, NY, USA",
    "Oslo, Norway",
    "Philadelphia, PA, USA",
    "Reading, UK",
    "San Francisco, CA, USA",
    "Seattle, WA, USA",
    "Short Hills, NJ, USA",
    "Stockholm, Sweden",
    "Washington D.C., USA",
    "West Palm Beach, FL, USA",
    "Zürich, Switzerland"
  ],
  "Piramal Pharma Solutions": [
    "Ahmedabad, India",
    "Aurora, ON, Canada",
    "Digby, NS, Canada",
    "Ennore, India",
    "Grand Island, NY, USA",
    "Grangemouth, UK",
    "Heredia, Costa Rica",
    "Lexington, KY, USA",
    "Morpeth, UK",
    "Pithampur, India",
    "Riverview, MI, USA",
    "Sellersville, PA, USA",
    "Toronto, ON, Canada"
  ],
  "Pivotal bioVenture Partners": [
    "Menlo Park, CA, USA",
    "Shanghai, China"
  ],
  "Playground Global": [
    "Palo Alto, CA, USA"
  ],
  "Plug and Play": [
    "Abu Dhabi, UAE",
    "Amsterdam, Netherlands",
    "Antananarivo, Madagascar",
    "Bangkok, Thailand",
    "Beijing, China",
    "Belo Horizonte, Brazil",
    "Berlin, Germany",
    "Brussels, Belgium",
    "Calgary, Canada",
    "Casablanca, Morocco",
    "Cheonan, South Korea",
    "Chicago, IL, USA",
    "Detroit, MI, USA",
    "Dubai, UAE",
    "Guadalajara, Mexico",
    "Hamburg, Germany",
    "Helsinki, Finland",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Kyoto, Japan",
    "Lisbon, Portugal",
    "London, UK",
    "Madrid, Spain",
    "Manila, Philippines",
    "Melbourne, Australia",
    "Mexico City, Mexico",
    "Milan, Italy",
    "Munich, Germany",
    "New York, NY, USA",
    "Osaka, Japan",
    "Paris, France",
    "Pittsburgh, PA, USA",
    "Rio de Janeiro, Brazil",
    "Riyadh, Saudi Arabia",
    "Santiago, Chile",
    "São Paulo, Brazil",
    "Seoul, South Korea",
    "Shanghai, China",
    "Silicon Valley, CA, USA",
    "Singapore",
    "Stockholm, Sweden",
    "Stuttgart, Germany",
    "Sunnyvale, CA, USA",
    "Taipei, Taiwan",
    "Tel Aviv, Israel",
    "Tokyo, Japan",
    "Toronto, Canada",
    "Vienna, Austria",
    "Warsaw, Poland",
    "Washington, D.C., USA"
  ],
  "Plum Alley": [
    "New York, NY, USA"
  ],
  "Plurify": [
    "San Francisco, CA, USA"
  ],
  "Pluvia Biotech": [
    "San Diego, CA, USA"
  ],
  "Pneumagen Ltd": [
    "St Andrews, Scotland, UK"
  ],
  "PoC Capital, LLC": [
    "New York, NY, USA"
  ],
  "Polsky Center at UChicago": [
    "Chicago, IL, USA"
  ],
  "PolyPeptide Group": [
    "Berlin, Germany",
    "Boston, MA, USA",
    "Braine-l’Alleud, Belgium",
    "Cambridge, UK",
    "Colmar, France",
    "Herzliya, Israel",
    "Hillerød, Denmark",
    "Malmö, Sweden",
    "Mumbai, India",
    "Osaka, Japan",
    "San Diego, CA, USA",
    "Seoul, South Korea",
    "Shanghai, China",
    "Singapore",
    "Taipei, Taiwan",
    "Torrance, CA, USA"
  ],
  "Polyactiva Ltd": [
    "Perth, WA, Australia"
  ],
  "Polymed Biopharmaceuticals, Inc.": [
    "Burlington, MA, USA"
  ],
  "Ponce AI": [
    "Boston, MA, USA"
  ],
  "Portal Innovations": [
    "Chicago, IL, USA"
  ],
  "Portfolia Femtech Funds": [
    "Menlo Park, CA, USA"
  ]
}
```
```json
{
  "Potentia Fund": [
    "New York, NY, USA",
    "London, UK",
    "Hong Kong",
    "Singapore",
    "Sydney, Australia"
  ],
  "PraanaTech": [
    "Bengaluru, Karnataka, India"
  ],
  "Prazer Therapeutics": [
    "San Diego, CA, USA"
  ],
  "Preci -Health SA": [
    "Lausanne, Switzerland"
  ],
  "Precision for Medicine": [
    "Boston, MA, USA",
    "Cambridge, MA, USA",
    "New York, NY, USA",
    "Philadelphia, PA, USA",
    "Bethesda, MD, USA",
    "Gaithersburg, MD, USA",
    "Washington, DC, USA",
    "Austin, TX, USA",
    "Chicago, IL, USA",
    "Orlando, FL, USA",
    "Atlanta, GA, USA",
    "San Diego, CA, USA",
    "Los Angeles, CA, USA",
    "San Francisco, CA, USA",
    "Toronto, ON, Canada",
    "Vancouver, BC, Canada",
    "London, UK",
    "Marlow, UK",
    "Manchester, UK",
    "Edinburgh, UK",
    "Dublin, Ireland",
    "Paris, France",
    "Milan, Italy",
    "Munich, Germany",
    "Madrid, Spain",
    "Basel, Switzerland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Warsaw, Poland",
    "Istanbul, Turkey",
    "Tel Aviv, Israel",
    "Dubai, UAE",
    "Singapore",
    "Sydney, Australia",
    "Auckland, New Zealand",
    "Tokyo, Japan",
    "Seoul, South Korea",
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong"
  ],
  "Predictoma, Inc.": [
    "Cambridge, MA, USA"
  ],
  "PredxBio": [
    "Boston, MA, USA"
  ],
  "Premas Technologies Inc": [
    "Bengaluru, Karnataka, India",
    "Chennai, Tamil Nadu, India",
    "Hyderabad, Telangana, India",
    "Noida, Uttar Pradesh, India",
    "Pune, Maharashtra, India",
    "Trivandrum, Kerala, India",
    "Dubai, UAE",
    "Sydney, Australia"
  ],
  "Premier Consulting": [
    "Boston, MA, USA",
    "Cambridge, MA, USA",
    "Raleigh, NC, USA",
    "Basking Ridge, NJ, USA",
    "New York, NY, USA",
    "Orlando, FL, USA",
    "Austin, TX, USA",
    "Dallas, TX, USA",
    "Chicago, IL, USA",
    "Washington, DC, USA",
    "San Diego, CA, USA",
    "Los Angeles, CA, USA",
    "San Francisco, CA, USA",
    "Seattle, WA, USA",
    "Toronto, ON, Canada",
    "London, UK",
    "Reading, UK",
    "Cambridge, UK",
    "Glasgow, UK",
    "Dublin, Ireland",
    "Paris, France",
    "Nice, France",
    "Berlin, Germany",
    "Munich, Germany",
    "Frankfurt, Germany",
    "Milan, Italy",
    "Rome, Italy",
    "Madrid, Spain",
    "Barcelona, Spain",
    "Basel, Switzerland",
    "Geneva, Switzerland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Amsterdam, Netherlands",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Brussels, Belgium",
    "Singapore",
    "Sydney, Australia",
    "Melbourne, Australia",
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong",
    "Tokyo, Japan",
    "Seoul, South Korea",
    "Taipei, Taiwan",
    "Bengaluru, India",
    "Mumbai, India",
    "New Delhi, India",
    "Istanbul, Turkey",
    "Tel Aviv, Israel",
    "Dubai, UAE",
    "Johannesburg, South Africa"
  ],
  "Premier Research Ltd": [
    "Boston, MA, USA",
    "Cambridge, MA, USA",
    "Raleigh, NC, USA",
    "Basking Ridge, NJ, USA",
    "New York, NY, USA",
    "Orlando, FL, USA",
    "Austin, TX, USA",
    "Dallas, TX, USA",
    "Chicago, IL, USA",
    "Washington, DC, USA",
    "San Diego, CA, USA",
    "Los Angeles, CA, USA",
    "San Francisco, CA, USA",
    "Seattle, WA, USA",
    "Toronto, ON, Canada",
    "London, UK",
    "Reading, UK",
    "Cambridge, UK",
    "Glasgow, UK",
    "Dublin, Ireland",
    "Paris, France",
    "Nice, France",
    "Berlin, Germany",
    "Munich, Germany",
    "Frankfurt, Germany",
    "Milan, Italy",
    "Rome, Italy",
    "Madrid, Spain",
    "Barcelona, Spain",
    "Basel, Switzerland",
    "Geneva, Switzerland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Amsterdam, Netherlands",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Brussels, Belgium",
    "Singapore",
    "Sydney, Australia",
    "Melbourne, Australia",
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong",
    "Tokyo, Japan",
    "Seoul, South Korea",
    "Taipei, Taiwan",
    "Bengaluru, India",
    "Mumbai, India",
    "New Delhi, India",
    "Istanbul, Turkey",
    "Tel Aviv, Israel",
    "Dubai, UAE",
    "Johannesburg, South Africa"
  ],
  "Prevail Partners LLC.": [
    "Boston, MA, USA"
  ],
  "Primagene Therapeutics, Inc.": [
    "La Jolla, CA, USA"
  ],
  "Primarius Capital": [
    "Austin, TX, USA"
  ],
  "Prime Biotech Investments": [
    "New York, NY, USA"
  ],
  "Prime Movers Lab": [
    "Jackson, WY, USA",
    "San Francisco, CA, USA"
  ],
  "Prime Number Capital": [
    "New York, NY, USA"
  ],
  "PrimeLink Bio": [
    "Woburn, MA, USA"
  ],
  "ProJenX, Inc.": [
    "Boston, MA, USA"
  ],
  "ProPharma Group LLC": [
    "Overland Park, KS, USA",
    "Boston, MA, USA",
    "Raleigh, NC, USA",
    "Princeton, NJ, USA",
    "Philadelphia, PA, USA",
    "New York, NY, USA",
    "Orlando, FL, USA",
    "Houston, TX, USA",
    "Dallas, TX, USA",
    "Austin, TX, USA",
    "Chicago, IL, USA",
    "Washington, DC, USA",
    "San Diego, CA, USA",
    "Los Angeles, CA, USA",
    "San Francisco, CA, USA",
    "Seattle, WA, USA",
    "Toronto, ON, Canada",
    "Montreal, QC, Canada",
    "London, UK",
    "Reading, UK",
    "Cambridge, UK",
    "Dublin, Ireland",
    "Paris, France",
    "Nice, France",
    "Berlin, Germany",
    "Munich, Germany",
    "Frankfurt, Germany",
    "Milan, Italy",
    "Rome, Italy",
    "Madrid, Spain",
    "Barcelona, Spain",
    "Basel, Switzerland",
    "Geneva, Switzerland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Amsterdam, Netherlands",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Brussels, Belgium",
    "Singapore",
    "Sydney, Australia",
    "Melbourne, Australia",
    "Beijing, China",
    "Shanghai, China",
    "Hong Kong",
    "Tokyo, Japan",
    "Seoul, South Korea",
    "Taipei, Taiwan",
    "Bengaluru, India",
    "Mumbai, India",
    "New Delhi, India",
    "Istanbul, Turkey",
    "Tel Aviv, Israel",
    "Dubai, UAE",
    "Johannesburg, South Africa"
  ],
  "ProductLife Group": [
    "Paris, France",
    "Lyon, France",
    "Lille, France",
    "London, UK",
    "Reading, UK",
    "Dublin, Ireland",
    "Berlin, Germany",
    "Munich, Germany",
    "Frankfurt, Germany",
    "Milan, Italy",
    "Rome, Italy",
    "Madrid, Spain",
    "Barcelona, Spain",
    "Basel, Switzerland",
    "Geneva, Switzerland",
    "Stockholm, Sweden",
    "Copenhagen, Denmark",
    "Amsterdam, Netherlands",
    "Warsaw, Poland",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Vienna, Austria",
    "Lisbon, Portugal",
    "Brussels, Belgium",
    "Istanbul, Turkey",
    "Moscow, Russia",
    "Kyiv, Ukraine",
    "Bucharest, Romania",
    "Athens, Greece",
    "Helsinki, Finland",
    "Oslo, Norway",
    "Bratislava, Slovakia",
    "Ljubljana, Slovenia",
    "Zagreb, Croatia",
    "Sofia, Bulgaria",
    "Riga, Latvia",
    "Vilnius, Lithuania",
    "Tallinn, Estonia",
    "Belgrade, Serbia",
    "Boston, MA, USA",
    "Raleigh, NC, USA",
    "Philadelphia, PA, USA",
    "Toronto, ON, Canada",
    "Montreal, QC, Canada",
    "Singapore",
    "Sydney, Australia",
    "Bengaluru, India",
    "Tokyo, Japan",
    "Shanghai, China",
    "Seoul, South Korea",
    "Sao Paulo, Brazil",
    "Buenos Aires, Argentina",
    "Mexico City, Mexico",
    "Dubai, UAE",
    "Cairo, Egypt",
    "Johannesburg, South Africa"
  ]
}
```
```json
{
  "Profil IfS GmbH": [
    "Munich, Germany"
  ],
  "Profound Research": [
    "Darmstadt, Germany"
  ],
  "Profound Ventures": [
    "San Francisco, CA, USA"
  ],
  "Progeneer": [
    "Frankfurt am Main, Germany"
  ],
  "Progenicyte Therapeutics, Inc.": [
    "San Diego, CA, USA"
  ],
  "Prolevi Bio": [
    "Boston, MA, USA"
  ],
  "PromptBio Inc": [
    "New York, NY, USA"
  ],
  "Prosperity7": [
    "Beijing, China",
    "Riyadh, Saudi Arabia",
    "San Francisco, CA, USA"
  ],
  "ProteinQure Inc": [
    "London, UK"
  ],
  "ProteoWise": [
    "Shanghai, China"
  ],
  "Provisio Ventures": [
    "New York, NY, USA"
  ],
  "Proxima Ventures": [
    "Santiago, Chile"
  ],
  "Puhe Biopharma": [
    "Shanghai, China",
    "Boston, MA, USA",
    "San Diego, CA, USA"
  ],
  "Puissance Capital": [
    "New York, NY, USA",
    "Hong Kong, China"
  ],
  "Pullan Consulting": [
    "North Vancouver, BC, Canada"
  ],
  "Pulmatrix, Inc.": [
    "Lexington, MA, USA"
  ],
  "PureIMS bv": [
    "Leiderdorp, Netherlands"
  ],
  "Purohit Ventures": [
    "San Francisco, CA, USA"
  ],
  "Pylum Biosciences": [
    "London, UK"
  ],
  "Pyrojas Inc": [
    "Boston, MA, USA"
  ]
}
```
```json
{
  "QR Genetics": ["Hong Kong"],
  "Qiming Venture Partners": ["Beijing, China", "Shanghai, China", "Suzhou, China", "Hong Kong"],
  "Qritive": ["Singapore", "Bengaluru, India"],
  "Quan Capital": ["Hong Kong", "Shanghai, China", "Menlo Park, California, USA", "Palo Alto, California, USA"],
  "QuanMol Tech, Inc.": ["San Francisco, California, USA"],
  "Quantro Therapeutics": ["San Diego, California, USA"],
  "Qum Therapeutics, Inc.": ["Cambridge, Massachusetts, USA"],
  "Quotient Sciences": [
    "Nottingham, UK",
    "Rushden, UK",
    "Edinburgh, UK",
    "Reading, UK",
    "Philadelphia, Pennsylvania, USA",
    "Watertown, Massachusetts, USA",
    "South Plainfield, New Jersey, USA"
  ],
  "QurCan Therapeutics Inc.": ["Boston, Massachusetts, USA"],
  "RA Ventures": ["San Francisco, California, USA", "Boston, Massachusetts, USA", "New York, New York, USA"],
  "RAINBOW Inc.": ["Locations not readily available or company name is too generic to pinpoint a specific entity within the typical context of the other listed companies."],
  "RED TAILED HAWK VENTURE PARTNERS": ["Boston, Massachusetts, USA"],
  "RM Global Partners LLC": ["Boston, Massachusetts, USA"],
  "RS Oncology, LLC": ["Cambridge, Massachusetts, USA"],
  "RSM US LLP": [
    "Atlanta, Georgia, USA",
    "Austin, Texas, USA",
    "Boston, Massachusetts, USA",
    "Charlotte, North Carolina, USA",
    "Chicago, Illinois, USA",
    "Dallas, Texas, USA",
    "Denver, Colorado, USA",
    "Detroit, Michigan, USA",
    "Houston, Texas, USA",
    "Kansas City, Missouri, USA",
    "Los Angeles, California, USA",
    "Miami, Florida, USA",
    "Minneapolis, Minnesota, USA",
    "New York, New York, USA",
    "Philadelphia, Pennsylvania, USA",
    "Phoenix, Arizona, USA",
    "Portland, Oregon, USA",
    "San Francisco, California, USA",
    "Seattle, Washington, USA",
    "St. Louis, Missouri, USA",
    "Tampa, Florida, USA",
    "Washington D.C., USA",
    "and numerous other regional offices across the United States"
  ],
  "RT MicroDx": ["San Jose, California, USA"],
  "RTW Investments, LP": ["New York, New York, USA", "London, UK"],
  "RUMI Scientific, Inc.": ["San Diego, California, USA"],
  "RV Invest GmbH": ["Berlin, Germany"],
  "RVC - Rockies Venture Club / Angel investor": ["Denver, Colorado, USA"]
}
```
```json
{
  "Ractigen Therapeutics": [
    "Daejeon, South Korea"
  ],
  "Radiance Biopharma": [
    "Hyderabad, India"
  ],
  "Radiopharm Theranostics": [
    "Sydney, Australia",
    "New York, USA"
  ],
  "Radyus Research": [
    "Palo Alto, California, USA"
  ],
  "Raglan Capital": [
    "Dublin, Ireland"
  ],
  "Rakuten Medical, Inc.": [
    "San Diego, California, USA",
    "Tokyo, Japan",
    "Kanagawa, Japan",
    "Taipei, Taiwan"
  ],
  "Rambam AG": [
    "Stans, Switzerland"
  ],
  "Ranok Therapeutics": [
    "Hangzhou, China",
    "Boston, Massachusetts, USA"
  ],
  "Rapport Therapeutics": [
    "Boston, Massachusetts, USA"
  ],
  "RareMoon Consulting": [
    "London, UK"
  ],
  "Ray Therapeutics": [
    "San Diego, California, USA"
  ],
  "Raymond James": [
    "St. Petersburg, Florida, USA (Headquarters)",
    "Memphis, Tennessee, USA",
    "Southfield, Michigan, USA",
    "Calgary, Alberta, Canada",
    "London, UK",
    "Paris, France",
    "Frankfurt, Germany"
  ],
  "Receptor.AI": [
    "Lviv, Ukraine",
    "Boston, Massachusetts, USA"
  ],
  "Reed -Ventures": [
    "San Francisco, California, USA"
  ],
  "RegCell": [
    "Tokyo, Japan"
  ],
  "Rege Nephro Co., Ltd.": [
    "Tokyo, Japan"
  ],
  "Regend Therapeutics": [
    "Tokyo, Japan"
  ],
  "Regeneron Pharmaceuticals": [
    "Tarrytown, New York, USA (Headquarters)",
    "Rensselaer, New York, USA",
    "Dublin, Ireland",
    "Limerick, Ireland",
    "Basking Ridge, New Jersey, USA"
  ],
  "Reglagene, Inc.": [
    "San Francisco, California, USA"
  ],
  "Rejuve Biotech, Inc": [
    "Daejeon, South Korea"
  ]
}
```
```json
{
  "RejuvenRx Inc.": [
    "Boston, MA, USA"
  ],
  "Rejuvenate Bio": [
    "San Diego, CA, USA"
  ],
  "Rejuvenation Technologies Inc.": [
    "Mountain View, CA, USA"
  ],
  "Remedy Plan Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "Remiges Ventures": [
    "Cambridge, MA, USA",
    "Tokyo, Japan"
  ],
  "Ren Bioscience": [
    "San Diego, CA, USA"
  ],
  "Repair Biotechnologies, Inc.": [
    "New York, NY, USA"
  ],
  "Researcher": [
    "London, UK",
    "Bengaluru, India"
  ],
  "Resolian": [
    "York, UK",
    "Shrewsbury, PA, USA",
    "Newark, DE, USA",
    "Glasgow, UK",
    "Macclesfield, UK",
    "San Diego, CA, USA",
    "Worcester, MA, USA",
    "West Lafayette, IN, USA",
    "Gaithersburg, MD, USA",
    "Canton, MA, USA"
  ],
  "Retroviral Therapeutics": [
    "San Carlos, CA, USA"
  ],
  "Reuters": [
    "London, UK",
    "New York, NY, USA",
    "Toronto, Canada",
    "Singapore, Singapore",
    "Hong Kong",
    "Tokyo, Japan"
  ],
  "Rezolute": [
    "Redwood City, CA, USA"
  ],
  "Rhythm Biotherapeutics Inc": [
    "Waltham, MA, USA"
  ],
  "Rhythm VC": [
    "Cambridge, MA, USA"
  ],
  "Riverine Ventures": [
    "New York, NY, USA"
  ],
  "Rivermount VC Fund LP": [
    "New York, NY, USA"
  ],
  "Riverstone LLC": [
    "New York, NY, USA",
    "Houston, TX, USA",
    "London, UK",
    "Menlo Park, CA, USA"
  ],
  "Rize Oncology": [
    "Chicago, IL, USA"
  ],
  "Robles BioCeutics": [
    "Guaynabo, Puerto Rico, USA"
  ],
  "Rock Health": [
    "San Francisco, CA, USA"
  ]
}
```
```json
{
  "Root Venture Partners GP Limited": [
    "London, England, United Kingdom"
  ],
  "Rootstock Equity Partners": [
    "New York, NY, USA",
    "San Francisco, CA, USA"
  ],
  "Rosetta Capital": [
    "London, England, United Kingdom"
  ],
  "Roy Auty - Private investor": [
    "Vancouver, British Columbia, Canada"
  ],
  "Rubedo Life Sciences": [
    "Menlo Park, CA, USA"
  ],
  "Russo Partners": [
    "New York, NY, USA"
  ],
  "Rx Bandz": [
    "Los Angeles, CA, USA"
  ],
  "RyboDyn, Inc.": [
    "San Diego, CA, USA"
  ],
  "S.Biomedics": [
    "Madrid, Spain"
  ],
  "SBI investment Co., Ltd.": [
    "Tokyo, Japan"
  ],
  "SBIR/NCI/NIH": [
    "Bethesda, MD, USA"
  ],
  "SCHENA FAMILY TRUST": [],
  "SDK Therapeutics": [
    "San Diego, CA, USA"
  ],
  "SDL Ventures, LLC": [
    "San Francisco, CA, USA"
  ],
  "SEEDS Capital": [
    "Singapore"
  ],
  "SF500": [
    "San Francisco, CA, USA"
  ],
  "SFA Therapeutics, Inc.": [
    "Philadelphia, PA, USA"
  ],
  "SOTIO Biotech": [
    "Prague, Czech Republic",
    "Boston, MA, USA",
    "London, England, United Kingdom"
  ],
  "SPARC": [],
  "SPOC Proteomics Inc": [
    "Rockville, MD, USA"
  ]
}
```
```json
{
  "SPRIM Global Investments": [
    "Barcelona, Spain",
    "Bogotá, Colombia",
    "Boston, Massachusetts, USA",
    "Buenos Aires, Argentina",
    "Cologne, Germany",
    "Hong Kong, China",
    "London, United Kingdom",
    "Mexico City, Mexico",
    "Milan, Italy",
    "New York, New York, USA",
    "Paris, France",
    "Philadelphia, Pennsylvania, USA",
    "San Francisco, California, USA",
    "Santiago, Chile",
    "São Paulo, Brazil",
    "Seoul, South Korea",
    "Shanghai, China",
    "Singapore",
    "Tokyo, Japan",
    "Washington D.C., USA"
  ],
  "STA": [
    "Shanghai, China",
    "San Diego, California, USA",
    "Changzhou, China",
    "Suzhou, China",
    "Nantong, China",
    "Wuxi, China",
    "Boston, Massachusetts, USA",
    "Zurich, Switzerland"
  ],
  "STAT": [
    "Boston, Massachusetts, USA",
    "Washington, D.C., USA"
  ],
  "STIMIT AG": [
    "Kreuzlingen, Switzerland"
  ],
  "SV Health Investors": [
    "London, United Kingdom",
    "Boston, Massachusetts, USA"
  ],
  "Safi Biotherapeutics": [
    "Cambridge, Massachusetts, USA"
  ],
  "Sagard Healthcare": [
    "Paris, France",
    "London, United Kingdom",
    "Montreal, Canada",
    "Toronto, Canada",
    "New York, New York, USA",
    "San Francisco, California, USA",
    "Singapore",
    "Abu Dhabi, UAE"
  ],
  "Sage Therapeutics": [
    "Cambridge, Massachusetts, USA"
  ],
  "Saisei Ventures": [
    "Sausalito, California, USA"
  ],
  "Salem Partners LLC": [
    "Los Angeles, California, USA",
    "New York, New York, USA"
  ],
  "Samsung Biologics": [
    "Incheon, South Korea",
    "Songdo, Incheon, South Korea",
    "San Francisco, California, USA",
    "Boston, Massachusetts, USA",
    "New Jersey, USA",
    "Frankfurt, Germany",
    "Tokyo, Japan"
  ],
  "Samsung Ventures": [
    "Seoul, South Korea",
    "Menlo Park, California, USA",
    "Cambridge, Massachusetts, USA",
    "Tel Aviv, Israel",
    "London, United Kingdom"
  ],
  "Samyang Holdings Corp.": [
    "Seoul, South Korea",
    "Boston, Massachusetts, USA",
    "Tokyo, Japan",
    "Shanghai, China"
  ],
  "San Francisco Business Times": [
    "San Francisco, California, USA"
  ],
  "Sand Hill Angels": [
    "Palo Alto, California, USA"
  ],
  "SandboxAQ": [
    "Palo Alto, California, USA"
  ],
  "Sangel Capital": [
    "Seoul, South Korea"
  ],
  "Santen, Inc.": [
    "Emeryville, California, USA"
  ],
  "Sarcomatrix Therapeutics Corp.": [
    "Waltham, Massachusetts, USA"
  ],
  "Saros Therapeutics, Inc.": [
    "San Diego, California, USA"
  ]
}
```
```json
{
  "Sartorius": [
    "Göttingen, Germany",
    "Aubagne, France",
    "Yauco, Puerto Rico",
    "Stonehouse, UK",
    "Port Washington, NY, USA",
    "Fremont, CA, USA",
    "Bangalore, India",
    "Shanghai, China",
    "Tokyo, Japan",
    "Cork, Ireland",
    "Ann Arbor, MI, USA",
    "Singapore",
    "Sydney, Australia",
    "São Paulo, Brazil"
  ],
  "Sartortius": [
    "Göttingen, Germany",
    "Aubagne, France",
    "Yauco, Puerto Rico",
    "Stonehouse, UK",
    "Port Washington, NY, USA",
    "Fremont, CA, USA",
    "Bangalore, India",
    "Shanghai, China",
    "Tokyo, Japan",
    "Cork, Ireland",
    "Ann Arbor, MI, USA",
    "Singapore",
    "Sydney, Australia",
    "São Paulo, Brazil"
  ],
  "Scendea Ltd.": [
    "Cambridge, UK",
    "Dublin, Ireland"
  ],
  "ScienceMachine": [
    "Boston, MA, USA"
  ],
  "Scientia Clinical Research": [
    "Sydney, Australia",
    "Newtown, NSW, Australia"
  ],
  "Scioto Biosciences": [
    "Columbus, OH, USA"
  ],
  "Scotiabank": [
    "Toronto, Canada",
    "Mexico City, Mexico",
    "Kingston, Jamaica",
    "Santiago, Chile",
    "New York, NY, USA",
    "London, UK",
    "Singapore",
    "Hong Kong"
  ],
  "Scrip": [
    "London, UK",
    "New York, NY, USA",
    "Tokyo, Japan"
  ],
  "Seal Rock Therapeutics": [
    "San Francisco, CA, USA",
    "Redwood City, CA, USA"
  ],
  "Search Terms: Filtered List": [],
  "Second Swedish Pension Fund (AP2)": [
    "Göteborg, Sweden"
  ],
  "Secretech Singapore Pte.Ltd.": [
    "Singapore"
  ],
  "Seed4soft": [
    "Prague, Czech Republic"
  ],
  "SeedFolio": [
    "San Francisco, CA, USA"
  ],
  "SelectScience": [
    "Bath, UK"
  ],
  "Selvita": [
    "Krakow, Poland",
    "Poznań, Poland",
    "Cambridge, MA, USA"
  ],
  "Sen -Jam Pharmaceutical": [
    "Boca Raton, FL, USA"
  ],
  "Sentinel BioTherapeutics, Inc": [
    "San Diego, CA, USA"
  ],
  "Seoul National Univ. Hospital": [
    "Seoul, South Korea"
  ],
  "Seragene Therapeutics": [
    "Rockville, MD, USA"
  ]
}
```
```json
{
  "Seraxis Inc.": [
    "Basel, Switzerland"
  ],
  "Serpentine Ventures": [
    "Zurich, Switzerland"
  ],
  "Servier Pharmaceuticals": [
    "Suresnes, France",
    "Orléans, France",
    "Croissy-Beaubourg, France",
    "Boston, Massachusetts, USA",
    "Arklow, Ireland",
    "Jacareí, Brazil",
    "Tianjin, China",
    "Slough, UK",
    "Warsaw, Poland",
    "Laval, Quebec, Canada",
    "Lisbon, Portugal",
    "Prague, Czech Republic",
    "Budapest, Hungary",
    "Munich, Germany",
    "Madrid, Spain",
    "Milan, Italy",
    "Moscow, Russia",
    "Istanbul, Turkey",
    "Melbourne, Australia",
    "Tokyo, Japan",
    "Seoul, South Korea",
    "Ho Chi Minh City, Vietnam",
    "Mumbai, India",
    "Mexico City, Mexico",
    "Buenos Aires, Argentina",
    "Santiago, Chile",
    "Bogotá, Colombia",
    "Lima, Peru",
    "Cairo, Egypt",
    "Johannesburg, South Africa",
    "Dubai, United Arab Emirates",
    "Riyadh, Saudi Arabia",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Manila, Philippines",
    "Bangkok, Thailand",
    "Singapore, Singapore"
  ],
  "Shanghai Auzone Biotech Co.": [
    "Shanghai, China"
  ],
  "Shanghai CirCode Biomed Co., Ltd.": [
    "Shanghai, China"
  ],
  "Shanghai Healthcare Capital": [
    "Shanghai, China"
  ],
  "Shaperon": [
    "Seoul, South Korea",
    "Boston, Massachusetts, USA"
  ],
  "ShareVault": [
    "Los Gatos, California, USA"
  ],
  "Shaw Strategic Capital LLC": [
    "McLean, Virginia, USA"
  ],
  "Shenzhen Kexing Pharmaceutical Co., Ltd.": [
    "Shenzhen, China"
  ],
  "Shenzhen MagicRNA Biotech": [
    "Shenzhen, China"
  ],
  "Shenzhen Sungening Biological Co., Ltd": [
    "Shenzhen, China"
  ],
  "Shepherd Ventures III": [
    "San Diego, California, USA"
  ],
  "Sherpa Healthcare Partners": [
    "Seoul, South Korea"
  ],
  "Shinsei Capital Partners,Ltd": [
    "Tokyo, Japan"
  ],
  "Shinvestor & Pratners, LLC": [
    "New York, New York, USA"
  ],
  "Shorla Oncology": [
    "Clonmel, Ireland",
    "Boston, Massachusetts, USA"
  ],
  "SiVEC Biotechnologies, Inc.": [
    "Basel, Switzerland"
  ],
  "Sichuan Real & Best Biotech": [
    "Chengdu, Sichuan, China"
  ],
  "Signal Bioscience": [
    "Shanghai, China",
    "Boston, Massachusetts, USA"
  ]
}
```
```json
{
  "Signet Healthcare Partners": [
    "New York, NY, USA"
  ],
  "Sila B": [
    "Cambridge, MA, USA"
  ],
  "SillaJen Biotherapeutics": [
    "Busan, South Korea",
    "Seoul, South Korea",
    "San Francisco, CA, USA"
  ],
  "Simmons & Simmons LLP": [
    "Amsterdam, Netherlands",
    "Beijing, China",
    "Bristol, UK",
    "Brussels, Belgium",
    "Dublin, Ireland",
    "Düsseldorf, Germany",
    "Frankfurt, Germany",
    "Hong Kong",
    "Jeddah, Saudi Arabia (in association with Hammad & Al-Mehdar)",
    "London, UK",
    "Luxembourg, Luxembourg",
    "Madrid, Spain",
    "Milan, Italy",
    "Munich, Germany",
    "Paris, France",
    "Shanghai, China",
    "Singapore, Singapore",
    "Tokyo, Japan"
  ],
  "Sinaptica Therapeutics": [
    "South San Francisco, CA, USA"
  ],
  "Sinfonie Life Science Management GmbH": [
    "Gräfelfing, Germany"
  ],
  "Singapore Economic Development Board": [
    "Singapore, Singapore (Headquarters)",
    "Boston, MA, USA",
    "Chicago, IL, USA",
    "Dallas, TX, USA",
    "Los Angeles, CA, USA",
    "New York, NY, USA",
    "San Francisco, CA, USA",
    "Washington D.C., USA",
    "London, UK",
    "Paris, France",
    "Frankfurt, Germany",
    "Stockholm, Sweden",
    "Shanghai, China",
    "Beijing, China",
    "Shenzhen, China",
    "Guangzhou, China",
    "Chongqing, China",
    "Chengdu, China",
    "Suzhou, China",
    "Hong Kong",
    "Taipei, Taiwan",
    "Tokyo, Japan",
    "Osaka, Japan",
    "Seoul, South Korea",
    "Jakarta, Indonesia",
    "Kuala Lumpur, Malaysia",
    "Mumbai, India",
    "New Delhi, India",
    "Bangkok, Thailand",
    "Hanoi, Vietnam",
    "Ho Chi Minh City, Vietnam",
    "Melbourne, Australia",
    "Sydney, Australia",
    "Tel Aviv, Israel",
    "Dubai, UAE"
  ],
  "Sireau Labs": [
    "San Francisco, CA, USA"
  ],
  "SirnaMed Therapeutics Inc.": [
    "Toronto, ON, Canada"
  ],
  "Sirona Capital": [
    "Perth, Australia"
  ],
  "Sixty Degree Capital": [
    "Melbourne, Australia"
  ],
  "Skin Angels Inc": [
    "San Francisco, CA, USA"
  ],
  "Skin2neuron Pty Ltd": [
    "Sydney, Australia"
  ],
  "SmartLabs": [
    "Boston, MA, USA",
    "Cambridge, MA, USA",
    "Waltham, MA, USA",
    "South San Francisco, CA, USA",
    "San Diego, CA, USA",
    "Durham, NC, USA",
    "Philadelphia, PA, USA"
  ],
  "Smartlens, Inc.": [
    "Cambridge, MA, USA"
  ],
  "Smilegate Investment Inc.": [
    "Seoul, South Korea",
    "Shanghai, China",
    "Santa Monica, CA, USA"
  ],
  "Sofinnova Investments": [
    "Menlo Park, CA, USA"
  ],
  "Sofinnova Partners": [
    "Paris, France",
    "London, UK",
    "Milan, Italy"
  ],
  "SolasCure Ltd": [
    "Norwich, UK"
  ],
  "Solgate": [
    "Vienna, Austria"
  ]
}
```
```json
{
  "Solve FSHD Holdings Ltd": [
    "Cambridge, MA, USA"
  ],
  "Solvias AG": [
    "Kaiseraugst, Switzerland",
    "Basel, Switzerland",
    "Visp, Switzerland"
  ],
  "Sonire therapeutics Inc.": [
    "South San Francisco, CA, USA"
  ],
  "Sontag Innovation Fund": [
    "Jacksonville, FL, USA"
  ],
  "Sound Bioventures": [
    "Copenhagen, Denmark",
    "Cambridge, MA, USA"
  ],
  "Southern Star Research Pty Ltd": [
    "Sydney, Australia",
    "Melbourne, Australia",
    "Brisbane, Australia",
    "Perth, Australia",
    "Adelaide, Australia",
    "Auckland, New Zealand"
  ],
  "Sovargen": [
    "Basel, Switzerland"
  ],
  "Sozo Ventures": [
    "San Francisco, CA, USA",
    "Tokyo, Japan"
  ],
  "Spiderwort Biotechnologies Inc.": [
    "Ottawa, Ontario, Canada"
  ],
  "Spine BioPharma": [
    "South San Francisco, CA, USA"
  ],
  "Spirea": [
    "Cambridge, UK"
  ],
  "Sporos BioDiscovery": [
    "Houston, TX, USA"
  ],
  "SpringRock Ventures": [
    "Greenwich, CT, USA"
  ],
  "Springboard Enterprises": [
    "New York, NY, USA",
    "Washington, D.C., USA"
  ],
  "Springer Nature": [
    "Berlin, Germany",
    "Heidelberg, Germany",
    "London, UK",
    "New York, NY, USA",
    "Tokyo, Japan",
    "Beijing, China",
    "New Delhi, India",
    "Amsterdam, Netherlands",
    "Paris, France",
    "Boston, MA, USA",
    "San Francisco, CA, USA",
    "Toronto, Canada",
    "Melbourne, Australia"
  ],
  "Springhood Ventures": [
    "New York, NY, USA"
  ],
  "StageNext VC": [
    "Tel Aviv, Israel",
    "New York, NY, USA"
  ],
  "Stamm Bio": [
    "Boston, MA, USA"
  ],
  "Stanford Blood Center": [
    "Palo Alto, CA, USA",
    "Campbell, CA, USA",
    "Mountain View, CA, USA"
  ],
  "Stanford University": [
    "Stanford, CA, USA"
  ]
}
```
```json
{
  "Star Tree Ventures": [
    "Menlo Park, California"
  ],
  "Starbloom Capital": [
    "New York, New York"
  ],
  "Starton Therapeutics": [
    "Paramus, New Jersey"
  ],
  "Starvue Life Sciences": [
    "New York, New York"
  ],
  "Stately Bio, Inc.": [
    "San Francisco, California"
  ],
  "Stealth TechBio": [
    "Not publicly disclosed"
  ],
  "Stelliger Partners": [
    "New York, New York"
  ],
  "Stem Cell & Device Laboratory, Inc.": [
    "Los Angeles, California"
  ],
  "Stephens, Inc.": [
    "Little Rock, Arkansas",
    "New York, New York",
    "Atlanta, Georgia",
    "Boston, Massachusetts",
    "Charlotte, North Carolina",
    "Chicago, Illinois",
    "Dallas, Texas",
    "Denver, Colorado",
    "Houston, Texas",
    "London, UK",
    "San Francisco, California",
    "Washington, D.C."
  ],
  "SterlingBio Corp": [
    "San Diego, California"
  ],
  "SternAegis Ventures": [
    "New York, New York"
  ],
  "Stifel": [
    "St. Louis, Missouri",
    "New York, New York",
    "London, UK",
    "Chicago, Illinois",
    "San Francisco, California",
    "Boston, Massachusetts",
    "Baltimore, Maryland",
    "Dallas, Texas",
    "Denver, Colorado",
    "Houston, Texas",
    "Toronto, Canada",
    "Zurich, Switzerland"
  ],
  "Stimuliver": [
    "Lausanne, Switzerland"
  ],
  "Stingray Therapeutics, Inc.": [
    "South San Francisco, California"
  ],
  "StoneWise": [
    "Shanghai, China",
    "Boston, Massachusetts"
  ],
  "Storycast Productions": [
    "Atlanta, Georgia",
    "Santa Monica, California"
  ],
  "Stratum Biosciences": [
    "San Francisco, California"
  ],
  "Stroma Medical": [
    "San Clemente, California"
  ],
  "Subsense Inc.": [
    "South San Francisco, California"
  ],
  "Sumitomo Chemical America Inc.": [
    "New York, New York",
    "Houston, Texas",
    "Morristown, New Jersey",
    "Salt Lake City, Utah"
  ]
}
```
```json
{
  "Summer Capital": [
    "Shanghai, China",
    "Beijing, China",
    "Hong Kong, China",
    "Shenzhen, China"
  ],
  "Surv BioPharma": [
    "San Francisco, California, USA"
  ],
  "Suven Pharmaceuticals and Cohance Lifesciences": [
    "Hyderabad, India"
  ],
  "SwedenBIO": [
    "Stockholm, Sweden"
  ],
  "Swiss Business Hub USA": [
    "New York City, New York, USA",
    "Washington D.C., USA",
    "Atlanta, Georgia, USA",
    "Boston, Massachusetts, USA",
    "Chicago, Illinois, USA",
    "San Francisco, California, USA"
  ],
  "Swiss Rockets AG": [
    "Basel, Switzerland"
  ],
  "Sygnature Discovery Ltd": [
    "Nottingham, UK",
    "Alderley Park, UK",
    "Cambridge, UK"
  ],
  "Symcel": [
    "Kista, Stockholm, Sweden"
  ],
  "SynProx, Inc": [
    "San Diego, California, USA"
  ],
  "Syneos Capital Advisory, LLC": [
    "Morrisville, North Carolina, USA"
  ],
  "Syneos Health": [
    "Morrisville, North Carolina, USA",
    "Boston, Massachusetts, USA",
    "Philadelphia, Pennsylvania, USA",
    "San Diego, California, USA",
    "London, UK",
    "Maidenhead, UK",
    "Munich, Germany",
    "Frankfurt, Germany",
    "Paris, France",
    "Madrid, Spain",
    "Milan, Italy",
    "Basel, Switzerland",
    "Dublin, Ireland",
    "Amsterdam, Netherlands",
    "Stockholm, Sweden",
    "Toronto, Canada",
    "Montreal, Canada",
    "Bengaluru, India",
    "Hyderabad, India",
    "Shanghai, China",
    "Tokyo, Japan",
    "Sydney, Australia",
    "Sao Paulo, Brazil",
    "Mexico City, Mexico",
    "Singapore",
    "Seoul, South Korea"
  ],
  "Syner -G Biopharma Group": [
    "Rockville, Maryland, USA",
    "Gaithersburg, Maryland, USA"
  ],
  "Synergy Ventures": [
    "Menlo Park, California, USA"
  ],
  "Syngene International Ltd": [
    "Bengaluru, India",
    "Mangaluru, India",
    "Hyderabad, India",
    "Princeton, New Jersey, USA"
  ],
  "Synlico Inc.": [
    "Tokyo, Japan"
  ],
  "Syno Capital": [
    "New York City, New York, USA"
  ],
  "Syntekabio USA Inc.": [
    "Rockville, Maryland, USA"
  ],
  "SyntheX": [
    "South San Francisco, California, USA"
  ],
  "Synthekine": [
    "Menlo Park, California, USA"
  ],
  "Synthis Therapeutics, Inc.": [
    "Philadelphia, Pennsylvania, USA"
  ]
}
```
```json
{
  "Syridex Bio": [
    "San Francisco, California, USA"
  ],
  "TAISHO PHARMACEUTICAL CO., LTD.": [
    "Tokyo, Japan",
    "Saitama, Japan",
    "Wayne, Pennsylvania, USA"
  ],
  "TATUM bioscience": [
    "San Diego, California, USA"
  ],
  "TBD Angels": [
    "San Francisco, California, USA"
  ],
  "TCP Health Ventures (legal entity: The Capital Partenership UK Limited)": [
    "London, UK",
    "New York, USA",
    "Dubai, UAE"
  ],
  "TF Venture Capital Management Co., Ltd.": [
    "Shanghai, China"
  ],
  "TILT Biotherapeutics Ltd": [
    "Helsinki, Finland",
    "Boston, Massachusetts, USA"
  ],
  "TLR Therapeutics, Inc.": [
    "San Mateo, California, USA"
  ],
  "TMAB Therapeutics, Inc": [
    "Waltham, Massachusetts, USA"
  ],
  "TPG Life Sciences Innovations": [
    "Fort Worth, Texas, USA",
    "San Francisco, California, USA",
    "New York, USA",
    "Boston, Massachusetts, USA"
  ],
  "TRIO Pharmaceuticals, Inc.": [
    "Cambridge, Massachusetts, USA"
  ],
  "TWi Biotechnology": [
    "Taipei, Taiwan",
    "South San Francisco, California, USA"
  ],
  "TYK Medicines Inc": [
    "Waltham, Massachusetts, USA"
  ],
  "Tagomics": [
    "San Mateo, California, USA"
  ],
  "Taiho Ventures, LLC.": [
    "Princeton, New Jersey, USA"
  ],
  "Taipu Life Science Investment": [
    "Beijing, China"
  ],
  "Taiwania Capital": [
    "Taipei, Taiwan",
    "Boston, Massachusetts, USA"
  ],
  "Talentmark Ltd": [
    "London, UK",
    "Basel, Switzerland",
    "Boston, Massachusetts, USA"
  ],
  "Talus Bio": [
    "Seattle, Washington, USA"
  ],
  "Tamer Group": [
    "Jeddah, Saudi Arabia"
  ]
}
```
```json
{
  "Tandem Ventures Srl": [
    "Buenos Aires, Argentina",
    "New York, USA"
  ],
  "Tang Capital LLC": [
    "San Diego, CA, USA"
  ],
  "Tarnagulla Ventures Pty Ltd": [
    "Melbourne, VIC, Australia"
  ],
  "Tay Therapeutics Limited": [
    "Dundee, Scotland, UK"
  ],
  "Technomark Life Sciences": [
    "Mumbai, India",
    "Nashik, India"
  ],
  "Teclison": [
    "Seoul, South Korea",
    "Boston, MA, USA"
  ],
  "TegMine Therapeutics": [
    "Cambridge, MA, USA"
  ],
  "Teijin Pharma LTD": [
    "Tokyo, Japan"
  ],
  "Teitur Trophics": [
    "Copenhagen, Denmark"
  ],
  "Telegraph Hill Partners": [
    "San Francisco, CA, USA"
  ],
  "Tema": [
    "Bologna, Italy"
  ],
  "Teralys Capital": [
    "Montreal, Quebec, Canada"
  ],
  "Ternalys Therapeutics, Inc.": [
    "San Diego, CA, USA"
  ],
  "Teva Pharmaceuticals": [
    "Tel Aviv, Israel",
    "Parsippany, NJ, USA"
  ],
  "The 90 -10 Institute": [
    "Zurich, Switzerland"
  ],
  "The Benchmark Company, LLC": [
    "New York, NY, USA"
  ],
  "The Cambridge Group": [
    "Chicago, IL, USA"
  ],
  "The ChannelPro Network": [
    "Chesterland, OH, USA"
  ],
  "The Good Science Fund VC": [
    "New York, NY, USA"
  ],
  "The Imaging Wire": [
    "New York, NY, USA"
  ]
}
```
```json
{
  "The Innovation Space": [
    "Wilmington, DE, USA"
  ],
  "The Johns Hopkins Bloomberg School of Public Health": [
    "Baltimore, MD, USA"
  ],
  "The Money Channel NYC": [
    "New York, NY, USA"
  ],
  "The NuFund Venture Group": [
    "San Diego, CA, USA",
    "Boulder, CO, USA"
  ],
  "The Regenerative Health Association": [
    "Geneva, Switzerland"
  ],
  "The San Francisco Standard": [
    "San Francisco, CA, USA"
  ],
  "The University of Tokyo Edge Capital Partners Co., Ltd. (UTEC)": [
    "Tokyo, Japan"
  ],
  "The Venture Collective": [
    "London, UK"
  ],
  "TheraVac Biologics": [
    "La Jolla, CA, USA"
  ],
  "Theradex Oncology": [
    "Princeton, NJ, USA",
    "London, UK",
    "Philadelphia, PA, USA",
    "Leiden, Netherlands",
    "Osaka, Japan",
    "Sydney, Australia"
  ],
  "Thermo Fisher Scientific": [
    "Waltham, MA, USA",
    "Carlsbad, CA, USA",
    "Frederick, MD, USA",
    "Shanghai, China",
    "Bleiswijk, Netherlands",
    "Swindon, UK"
  ],
  "Thiel Capital - Bio Fund": [
    "San Francisco, CA, USA",
    "Los Angeles, CA, USA",
    "Austin, TX, USA"
  ],
  "Thinkhat Venture Studio": [
    "San Francisco, CA, USA"
  ],
  "ThinkingNodeLife.ai": [
    "Greater San Diego Area, CA, USA"
  ],
  "Thomas Jefferson University": [
    "Philadelphia, PA, USA",
    "East Falls, PA, USA"
  ],
  "TiCARos": [
    "Seoul, South Korea"
  ],
  "Tiba Biotech LLC": [
    "Cambridge, MA, USA"
  ],
  "Tiberend Strategic Advisors": [
    "New York, NY, USA"
  ],
  "TikkunLev Therapeutics": [
    "Greater Philadelphia Area, PA, USA"
  ],
  "Tikva Allocell Pte Ltd": [
    "Singapore"
  ]
}
```
```json
{
  "Timmerman Report": [
    "Seattle, WA, USA"
  ],
  "Tinkeso Therapeutics": [
    "Lexington, MA, USA"
  ],
  "TippingPoint Biosciences": [
    "South San Francisco, CA, USA"
  ],
  "Tiziana Life Sciences": [
    "New York, NY, USA",
    "London, UK"
  ],
  "Tokio Marine Holdings": [
    "Tokyo, Japan",
    "New York, NY, USA",
    "London, UK"
  ],
  "Tonix Pharmaceuticals": [
    "Chatham, NJ, USA",
    "New York, NY, USA"
  ],
  "Toray Industries (America), Inc.": [
    "New York, NY, USA"
  ],
  "Touchdown Ventures": [
    "Philadelphia, PA, USA",
    "San Francisco, CA, USA",
    "Los Angeles, CA, USA"
  ],
  "Trace Biosciences": [
    "Sydney, Australia"
  ],
  "Tranquil Clinical and Research Consulting Services": [
    "Chennai, India"
  ],
  "Transimmune": [
    "Boston, MA, USA"
  ],
  "Translink Capital": [
    "Palo Alto, CA, USA"
  ],
  "Transpacific Venture Capital Partners": [
    "Tokyo, Japan"
  ],
  "Travera": [
    "South San Francisco, CA, USA"
  ],
  "Trellis Bioscience, Inc.": [
    "Redwood City, CA, USA"
  ],
  "Treos Bio": [
    "London, UK"
  ],
  "Trestle Biotherapeutics": [
    "San Diego, CA, USA"
  ],
  "Treventis Corporation": [
    "Gaithersburg, MD, USA"
  ],
  "TriNetX": [
    "Cambridge, MA, USA",
    "London, UK",
    "Basel, Switzerland"
  ],
  "TrialWire": [
    "Sydney, Australia"
  ]
}
```
```json
{
  "Trill Impact": [
    "Stockholm, Sweden",
    "Luxembourg City, Luxembourg"
  ],
  "Trillion Ventures Global Capital Fund": [
    "Singapore",
    "Jakarta, Indonesia"
  ],
  "Triovance Development Co": [
    "Unit C, 12/F, Gemstar Tower, 23 Man Lok Street, Hung Hom, Kowloon, Hong Kong"
  ],
  "Triplebar Bio": [
    "855 Industrial Rd, San Carlos, CA 94070, USA"
  ],
  "Triquetra Medicines": [
    "124 Goodman St. Suite 1, Charlottesville, VA 22903, USA"
  ],
  "Trophic Communications": [
    "Seestrasse 13, 80802 Munich, Germany"
  ],
  "Tryp Therapeutics": [
    "11110 Roselle Street, Suite 210, San Diego, CA 92121, USA"
  ],
  "Tryptamine Therapeutics": [
    "1199 West Pender Street, Suite 1000, Vancouver, British Columbia, V6E 2R1, Canada"
  ],
  "Tundra Targeted Therapeutics": [
    "Winnipeg, Manitoba, Canada"
  ],
  "Tundra Ventures Management, LLC": [
    "New York, NY, USA"
  ],
  "Tungsten Advisors": [
    "220 Fifth Avenue, Suite 1605, New York, NY 10001, USA",
    "1400 Lavaca Street, Suite 105, Austin, TX 78701, USA"
  ],
  "Two Bear Capital": [
    "1200 US Hwy 93 N, Suite 230, Whitefish, MT 59937, USA"
  ],
  "Type6 Therapeutics": [
    "Hochstrasse 131, 4053 Basel, Switzerland"
  ],
  "U -Ploid Biotechnologies": [
    "Chesterford Research Park, Cambridge, CB10 1XL, UK"
  ],
  "US Angels and K2X": [
    "Silicon Valley, California, USA",
    "Los Angeles, California, USA"
  ],
  "US Capital Global": [
    "One Sansome Street, Suite 2350, San Francisco, CA 94104, USA",
    "575 Lexington Avenue, Suite 400, New York, NY 10022, USA",
    "100 Southeast 2nd Street, Suite 2000, Miami, FL 33131, USA",
    "750 N St Paul Street, Suite 250, Dallas, TX 75201, USA",
    "25 Canada Square, Canary Wharf, London, E14 5LB, UK",
    "General-Guisan-Quai 36, 8002 Zurich, Switzerland",
    "One Central, Offices 1 & 2, The Offices Building, Level 8, PO Box 31215, Dubai, UAE"
  ],
  "UTokyo Innovation Platform Co.,Ltd. (UTIPC)": [
    "Sanno Park Tower 19F, 2-11-1 Nagata-cho, Chiyoda-ku, Tokyo 100-6119, Japan"
  ],
  "Ubix Therapeutics": [
    "#901, 134, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea"
  ],
  "Umecrine Cognition": [
    "Novum, Plan 5, Hälsovägen 7, 141 57 Huddinge (Stockholm), Sweden"
  ],
  "Umlaut.bio GmbH": [
    "Köpenicker Str. 154, 10997 Berlin, Germany"
  ]
}
```
```json
{
  "Uncommon Bio": [
    "Cambridge, MA, USA"
  ],
  "UniGlobe Capital": [
    "London, UK",
    "Dubai, UAE"
  ],
  "University of Glasgow": [
    "Glasgow, Scotland, UK",
    "Dumfries, Scotland, UK",
    "London, England, UK"
  ],
  "University of Michigan Innovation Partnerships": [
    "Ann Arbor, MI, USA"
  ],
  "Unnatural Products": [
    "Austin, TX, USA"
  ],
  "UpStart Ventures": [
    "Los Angeles, CA, USA"
  ],
  "Urkworks": [
    "No public locations found"
  ],
  "Urth Capital Advisors": [
    "Newport Beach, CA, USA"
  ],
  "Uvax Bio, LLC": [
    "Spring House, PA, USA"
  ],
  "V -Bio Ventures": [
    "Ghent, Belgium"
  ],
  "V2 Clinical": [
    "Miami, FL, USA"
  ],
  "VA Bio": [
    "Richmond, VA, USA"
  ],
  "VCapital": [
    "Chicago, IL, USA"
  ],
  "VECT -HORUS": [
    "Marseille, France"
  ],
  "VERAXA GmbH": [
    "Heidelberg, Germany"
  ],
  "VERIMMUNE INC": [
    "Rockville, MD, USA"
  ],
  "VI Ventures": [
    "Beijing, China"
  ],
  "VICKERS VENTURE PARTNERS (S) P": [
    "Singapore",
    "Shanghai, China",
    "San Diego, CA, USA",
    "New York, NY, USA",
    "Hong Kong"
  ],
  "VJO Canada Inc.": [
    "Toronto, ON, Canada"
  ],
  "VRD HealthTech": [
    "San Francisco, CA, USA"
  ]
}
```
```json
{
  "VSPharmTech": [
    "Chengdu, Sichuan, China",
    "Lewes, DE, USA"
  ],
  "VXP fund": [
    "San Francisco, CA, USA"
  ],
  "Valink Therapeutics": [
    "Pointe-Claire, Quebec, Canada"
  ],
  "Valuence Ventures": [
    "Tokyo, Japan"
  ],
  "Vandria": [
    "Cambridge, MA, USA"
  ],
  "Variational AI": [
    "Vancouver, BC, Canada"
  ],
  "Varsity Healthcare Partners": [
    "Los Angeles, CA, USA",
    "New York, NY, USA"
  ],
  "VasoDynamics Ltd": [
    "Chatham, Kent, UK"
  ],
  "VectorPoint Ventures": [
    "Addison, TX, USA"
  ],
  "Veirulence Ltd": [
    "London, UK",
    "Cambridge, UK"
  ],
  "Venable LLP": [
    "Baltimore, MD, USA",
    "Chicago, IL, USA",
    "Denver, CO, USA",
    "Los Angeles, CA, USA",
    "Miami, FL, USA",
    "New York, NY, USA",
    "San Francisco, CA, USA",
    "Washington, DC, USA",
    "Tysons, VA, USA",
    "Wilmington, DE, USA",
    "San Diego, CA, USA"
  ],
  "Ventac Partners, LLC": [
    "Cambridge, MA, USA",
    "London, UK",
    "Zug, Switzerland",
    "Paris, France"
  ],
  "Ventum Financial": [
    "Montréal, Québec, Canada",
    "Calgary, Alberta, Canada"
  ],
  "Venture Valuation / Biotechgate": [
    "Zug, Switzerland",
    "Zürich, Switzerland"
  ],
  "Veritus Research": [
    "Boynton Beach, FL, USA"
  ],
  "Vertex Growth Fund": [
    "Singapore"
  ],
  "Vertex Pharmaceuticals": [
    "Boston, MA, USA",
    "San Diego, CA, USA",
    "Toronto, Canada",
    "Paris, France",
    "Munich, Germany",
    "Dublin, Ireland",
    "Rome, Italy",
    "Lausanne, Switzerland",
    "London, UK",
    "Sydney, Australia",
    "Vienna, Austria",
    "Brussels, Belgium",
    "Sao Paulo, Brazil",
    "Prague, Czech Republic",
    "Copenhagen, Denmark",
    "Amsterdam, Netherlands",
    "Madrid, Spain",
    "Solna, Sweden"
  ],
  "Vertex Ventures": [
    "Singapore",
    "Bangalore, India",
    "Jakarta, Indonesia",
    "Ho Chi Minh City, Vietnam",
    "Taipei, Taiwan",
    "Delhi, India",
    "Beijing, China",
    "Shanghai, China",
    "Shenzhen, China",
    "San Francisco, CA, USA",
    "Herzliya, Israel",
    "Boston, MA, USA",
    "Tokyo, Japan"
  ],
  "Vesica Health": [
    "North Ryde, NSW, Australia"
  ],
  "Vevo Therapeutics": [
    "Cambridge, MA, USA"
  ]
}
```
```json
{
  "ViCardia Therapeutics Inc.": [
    "Carlsbad, CA"
  ],
  "Vibrant Tx": [
    "San Diego, CA"
  ],
  "Vida Ventures": [
    "Boston, MA",
    "San Francisco, CA"
  ],
  "ViewMind": [
    "Boston, MA"
  ],
  "Vigonvita Life Sciences Co., Ltd.": [
    "Beijing, China"
  ],
  "Viking Scientific, Inc.": [
    "Huntington Beach, CA"
  ],
  "Virginia Venture Partners": [
    "Richmond, VA"
  ],
  "Vision Incubate": [],
  "Vision Ventures": [
    "Los Angeles, CA",
    "New York, NY"
  ],
  "Vista Capital Advisors, LLC": [
    "Miami, FL"
  ],
  "Viva BioInnovator": [
    "Shanghai, China"
  ],
  "Vivalyx | Organ Vitality Tech": [
    "Raleigh, NC"
  ],
  "Vivo Surgical": [
    "Singapore"
  ],
  "Vivodyne": [
    "Philadelphia, PA"
  ],
  "VivoxBio": [
    "San Diego, CA"
  ],
  "WARF Ventures": [
    "Madison, WI"
  ],
  "WBB Securities": [
    "Los Angeles, CA"
  ],
  "WIRED": [
    "San Francisco, CA",
    "New York, NY",
    "London, UK"
  ],
  "WONDFO BIOTECH": [
    "Guangzhou, China",
    "San Diego, CA"
  ],
  "WRF Capital": [
    "Seattle, WA"
  ]
}
```
```json
{
  "Wall Street Journal": [
    "New York, NY",
    "Washington D.C.",
    "London, UK",
    "Brussels, Belgium",
    "Hong Kong",
    "Singapore",
    "Tokyo, Japan"
  ],
  "Waterston Capital": [
    "New York, NY"
  ],
  "Wayfinder Biosciences": [
    "San Diego, CA"
  ],
  "Wayshine Biopharm": [
    "Shanghai, China"
  ],
  "Weave": [
    "Lehi, UT",
    "Draper, UT"
  ],
  "Wellovate": [
    "Denver, CO"
  ],
  "West Coast Angel Network": [
    "Palo Alto, CA"
  ],
  "Westlake BioPartners": [
    "Los Angeles, CA"
  ],
  "Westlake Genetech": [
    "Hangzhou, China"
  ],
  "Whale Bay Capital": [
    "Menlo Park, CA"
  ],
  "Wharton Alumni Angels": [
    "New York, NY",
    "San Francisco, CA",
    "Los Angeles, CA",
    "London, UK",
    "Boston, MA",
    "Atlanta, GA",
    "Chicago, IL",
    "Tel Aviv, Israel",
    "Austin, TX",
    "Dallas, TX",
    "Houston, TX"
  ],
  "Wheeler Bio, Inc.": [
    "Oklahoma City, OK"
  ],
  "WideTrial": [
    "New York, NY"
  ],
  "William Galle & Associates": [
    "Palo Alto, CA"
  ],
  "Winning Difference": [
    "Houston, TX"
  ],
  "Wisemont Capital": [
    "Palo Alto, CA"
  ],
  "World Economic Forum": [
    "Cologny, Switzerland",
    "New York, NY",
    "San Francisco, CA",
    "Beijing, China",
    "Tokyo, Japan",
    "Mumbai, India"
  ],
  "WuXi AppTec": [
    "Shanghai, China",
    "Suzhou, China",
    "Wuhan, China",
    "Tianjin, China",
    "Philadelphia, PA, USA",
    "San Diego, CA, USA",
    "Boston, MA, USA",
    "Cranbury, NJ, USA",
    "Leverkusen, Germany"
  ],
  "WuXi Biologics": [
    "Wuxi, China",
    "Shanghai, China",
    "Suzhou, China",
    "Hangzhou, China",
    "Cranbury, NJ, USA",
    "Worcester, MA, USA",
    "Dundalk, Ireland",
    "Leverkusen, Germany"
  ],
  "Wuhan YZY Biopharma Co., Ltd.": [
    "Wuhan, China"
  ]
}
```
```json
{
  "Wyss Center For Bio And Neuroengineering": [
    "Geneva, Switzerland"
  ],
  "X -tosis, Inc.": [
    "Cambridge, MA, USA"
  ],
  "XM Therapeutics, Inc.": [
    "Boston, MA, USA"
  ],
  "XOMA Royalty": [
    "Berkeley, CA, USA"
  ],
  "XYone Therapeutics Inc": [
    "San Diego, CA, USA"
  ],
  "Xcellerant Ventures": [
    "San Francisco, CA, USA"
  ],
  "Xella Health, PBC": [
    "San Francisco, CA, USA"
  ],
  "Xeraya Capital": [
    "Kuala Lumpur, Malaysia",
    "London, UK",
    "Boston, MA, USA"
  ],
  "Xizang Haisco Pharmaceutical Co., LTD.": [
    "Lhasa, Tibet, China",
    "Chengdu, Sichuan, China"
  ],
  "Xontogeny": [
    "Cambridge, MA, USA"
  ],
  "Xpand Partners": [
    "San Mateo, CA, USA"
  ],
  "Xylyx Bio, Inc.": [
    "Newark, NJ, USA"
  ],
  "Yafo Capital": [
    "Shanghai, China",
    "New York, NY, USA"
  ],
  "Yakumed Limited": [
    "London, UK"
  ],
  "Yale Ventures; Blavatnik Fund": [
    "New Haven, CT, USA"
  ],
  "Yantze Investment": [
    "Shanghai, China"
  ],
  "Yaqrit": [
    "London, UK"
  ],
  "Yonjin Venture": [
    "Seoul, South Korea"
  ],
  "Yorkville Advisors": [
    "Mountainside, NJ, USA"
  ],
  "Young Bio": [
    "Gyeonggi-do, South Korea"
  ]
}
```
```json
{
  "YourChoice Therapeutics Inc.": [
    "La Jolla, CA, USA"
  ],
  "YouthBio Therapeutics Inc.": [
    "Hong Kong, China",
    "Cambridge, MA, USA"
  ],
  "Yuhan Corporation": [
    "Seoul, South Korea",
    "Yongin, South Korea",
    "Cheongju, South Korea",
    "Chungju, South Korea",
    "Ridgefield Park, NJ, USA",
    "Beijing, China",
    "Ho Chi Minh City, Vietnam"
  ],
  "Z-Star Therapeutics": [
    "Downers Grove, IL, USA"
  ],
  "ZCube, Zambon Research Venture": [
    "Bresso, Italy"
  ],
  "ZHYL PRIVATE FUNDS 中和元良基金": [
    "Shanghai, China"
  ],
  "ZTI BIOSCIENCES": [
    "Mountain View, CA, USA"
  ],
  "ZYUS LIfe Sciences Inc.": [
    "Saskatoon, SK, Canada"
  ],
  "ZedanMorgan Capital": [
    "George Town, Cayman Islands"
  ],
  "Zeon Ventures": [
    "Tokyo, Japan"
  ],
  "Zhejiang Tianyu Pharmaceutical Co., Ltd.": [
    "Linhai, China",
    "Hangzhou, China"
  ],
  "ZhongMei Capital": [
    "New York, NY, USA"
  ],
  "Zilia": [
    "Quebec City, QC, Canada"
  ],
  "ZipBio": [
    "Chatsworth, CA, USA"
  ],
  "Zynext Ventures": [
    "Cambridge, MA, USA"
  ],
  "adMare BioInnovations": [
    "Vancouver, BC, Canada",
    "Montreal, QC, Canada"
  ],
  "aisling capital": [
    "New York, NY, USA"
  ],
  "argenx BV": [
    "Gent, Belgium",
    "Waltham, MA, USA",
    "Boston, MA, USA",
    "Tokyo, Japan"
  ],
  "biotx.ai Inc": [
    "Potsdam, Germany",
    "New York, NY, USA"
  ],
  "bit.bio": [
    "Cambridge, UK",
    "Cambridge, MA, USA"
  ]
}
```
```json
{
  "borex capital": [
    "London, UK"
  ],
  "brain4care": [
    "São Paulo, Brazil",
    "Campinas, Brazil",
    "Boston, USA"
  ],
  "catalyst -fund": [
    "Nairobi, Kenya",
    "New York, USA"
  ],
  "clock.bio": [
    "Cambridge, USA"
  ],
  "de Gruyter Publishers": [
    "Berlin, Germany",
    "Boston, USA",
    "Beijing, China"
  ],
  "e -Fund": [
    "Toronto, Canada",
    "Vancouver, Canada"
  ],
  "eGenesis, Inc.": [
    "Cambridge, USA"
  ],
  "eGlint": [
    "New York, USA"
  ],
  "eisnerAmper": [
    "New York, USA",
    "San Francisco, USA",
    "Iselin, USA",
    "Philadelphia, USA",
    "Dublin, Ireland",
    "London, UK",
    "Grand Cayman, Cayman Islands"
  ],
  "elirazventures": [
    "Tel Aviv, Israel"
  ],
  "i2020 Accelerator": [
    "Milan, Italy"
  ],
  "iBio, Inc.": [
    "San Diego, USA",
    "Bryan, USA"
  ],
  "iBody Inc.": [
    "Daejeon, South Korea"
  ],
  "iCLASS Discovery": [
    "Minneapolis, USA"
  ],
  "iClinic": [
    "São Paulo, Brazil"
  ],
  "iGan Partners": [
    "Toronto, Canada"
  ],
  "iQure Pharma Inc": [
    "San Diego, USA"
  ],
  "inCerebro Co., Ltd.": [
    "Bangkok, Thailand"
  ],
  "ingineeon - advanced immunotherapeutics": [
    "San Diego, USA"
  ],
  "inovation ventures": [
    "San Francisco, USA"
  ]
}
```
```json
{
  "invIOs": [
    "Vienna, Austria"
  ],
  "kez.biosolutions GmbH": [
    "Gera, Germany"
  ],
  "material impact": [
    "Boston, MA, USA"
  ],
  "o2h Ventures Ltd": [
    "Cambridge, UK",
    "Ahmedabad, India"
  ],
  "partneringONE": [
    "Carlsbad, CA, USA",
    "London, UK",
    "Munich, Germany",
    "Zurich, Switzerland"
  ],
  "rosewood capital": [
    "San Francisco, CA, USA"
  ],
  "rpv": [
    "Luxembourg City, Luxembourg"
  ],
  "seventure partners": [
    "Paris, France",
    "London, UK"
  ],
  "tenry pharmaceutical limitid": [
    "Hong Kong, China",
    "Guangzhou, China"
  ]
}
```
